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Abstract 
 
There is a growing realization that healthcare is a knowledge-intensive field. The ability to 
capture and leverage semantics via inference or query processing is crucial for supporting the 
various required processes in both primary (e.g. disease diagnosis) and long term care (e.g. 
predictive and preventive diagnosis). Given the wide canvas and the relatively frequent 
knowledge changes that occur in this area, we need to take advantage of the new trends in 
Semantic Web technologies. In particular, the power of ontologies allows us to share medical 
research and provide suitable support to physician's practices. There is also a need to integrate 
these technologies within the currently used healthcare practices. In particular the use of 
semantic web technologies is highly demanded within the clinicians' differential diagnosis 
process and the clinical pathways disease management procedures as well as to aid the 
predictive/preventative measures used by healthcare professionals.  
  
This thesis is a research attempt to employ various semantic web technologies to support 'as 
needed' data integration to aid clinicians in the process of disease diagnosis. This thesis describes 
a novel approach for supporting medical disease diagnosis by making recommendations through 
semantic based modeling of medical knowledge and inference making. The developed approach 
defines an ontology model able to represent relations between medical diseases and their signs 
and symptoms in two related semantic web components: the evidence-based and proximity-
based. These two components utilize two ontologies specially developed for the purpose of 
disease diagnosis recommendation: the Diseases Symptoms Ontology (DSO) and the Patient 
Ontology (PO). 
 
The evidence-based component identifies unique semantic web architecture for aiding clinicians 
to arrive at accurate disease diagnosis using the process of differential diagnosis (DDx). The core 
structure of the evidence-based component is composed of two main systems. The first system is 
a DSO crawler which provides clinicians with essential queries to eliminate irrelevant diseases 
and arrive at a correct diagnosis. The evidence-based model is also composed of a unique rule-
based inferential engine employing clinical pathways rules. The DSO uses variety of semantic 
web technologies including the Jena OWL framework along with a relational query component 
that replaces the traditional SPARQL query engine for the purpose of DDx recommendation.  
 
The proximity-based component employs data mining techniques for providing predictive 
diagnosis recommendations besides using similar semantic web technologies used at the 
evidence-based component (ontology crawler). The proximity-based component analyzes 
previously available clinical cases to predict the diagnosis of new cases. The proximity-based 
component provides clinicians with diagnostic recommendations based on classification 
algorithms as well as identifies new diagnostic rules via the use of association algorithms.  
Moreover, this thesis describes how these two components can be integrated where the evidence-
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based component provides continuous data that will be used by the proximity-based component. 
Conversely, the proximity-based component identifies further interesting diagnostic rules that 
can be incorporated into the evidence-based component’s rules. Finally, this thesis describes a 
prototype for testing the design concepts addressed by this thesis.  
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Chapter 1: Introduction 
 
1.1. Problem Statement and Motivation 
 
Recent advances in medical technology have significantly improved human health in many 
countries like Canada. However, these advances remain out of touch for much of the world 
population. We face unprecedented healthcare challenges in the 21st century. The health care 
industry is facing key changes and challenges which could dramatically affect healthcare 
provision (see Table 1.1). Thus, software engineers are expected to play a critical role in 
developing novel and affordable medical technology to solve global healthcare problems [Akay 
2008].  
Clinical advances versus 
Central to all these challenges is the issue of sensitive diagnosis and rapid treatment. In our 
current world, there are many different diseases where some are harder for doctors than others. 
There are some diseases that are often difficult to correctly diagnose. Any type of disease that is 
rare is often hard to diagnose, simply because doctors may not be familiar with its details1. There 
are many other examples of diseases that are hard to diagnose. The digestive system as an 
example has somewhat vague symptoms and ones that patients are often embarrassed about. It is 
also difficult to look inside the different parts of the digestive tract. Hence, it is difficult to 
diagnose between the various digestive disorders such as: Bacterial or viral infection of the 
digestive (e.g. infectious diarrhoea), Food poisoning, Irritable Bowel Syndrome (IBS), Crohn's 
disease, Ulcerative colitis, Celiac disease (gluten sensitivity), Diabetic gastroparesis (stomach 
nerve neuropathy), and Diabetic diarrhoea (intestine nerve neuropathy). 
 
Moreover, there are over-diagnosed conditions and under-diagnosed conditions. There are 
certain diseases that get over-diagnosed more often than others. This means that the doctor gives 
this disease as the diagnosis, when in fact there is some other cause or disease. Some common 
examples include2: Irritable Bowel Syndrome (IBS), Middle ear infection (acute otitis 
media) in children, Lyme disease, Alzheimer’s disease. 
 
Under-diagnosis is common for conditions that have either no symptoms or only vague or mild 
symptoms. Under-diagnosis can also occur for conditions that are rarer than other conditions and 
thus simply don't get considered by patients and their doctors. Examples on under-diagnosed 
diseases include3: High cholesterol, Hypertension, Infectious diarrhea, Lactose intolerance, 
Celiac disease. 
 
                                                          
1
 http://www.rightdiagnosis.com/intro/difficult.htm 
2 www.rightdiagnosis.com/intro/overdiag.htm 
3 
http://www.medlabstats.com/students/Over-under-diagnosis.pdf 
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Table 1.1: Global Healthcare Challenges3 
Global economics Increasing affluence in emerging economies sees increasing demand for integrated 
healthcare provision 
 
Demographics The proportion of people aged over 65 will increase from 7.3% to 9.4% of the overall 
population by 2020. The demands of age-specific ailments will place increasingly difficult 
demands on healthcare services. 
 
  
Epidemiological 
trends 
Genetics, diet and environmental factors all impinge on the prevalence and severity of 
disease affecting different populations. Increasing affluence in developing countries will 
see increases in chronic diseases associated with environment, age and lifestyle. For 
example, the World Health Organisation estimates that the number of obese people 
worldwide will increase from 400 million in 2005 to over 700 million by 2015. 
  
Pharmacogenomics Genetic variations also affect the way individuals respond to drug treatments. The 
responses can have varying consequences, ranging from poor responses to therapy to 
quite severe side effects. There is an increased need to understand the basis of these 
variations in order to improve the development of new treatments as well as patient care. 
  
Environmental 
changes 
The impact of climate change on human health is difficult to predict; however, an increase 
in prevalence or geographical reach of vector-borne diseases (eg malaria and sleeping 
sickness) is highly likely. Large health effects are also likely from food supply changes, 
environmental degradation and population movements. 
 
Thus the process of diagnosing diseases is challenging and imprecise, as the symptoms and signs 
vary widely. For this reason, differential diagnosis (DDx) (see section 1.2.1 below) is a common 
practice in medicine. 
This thesis attempts to develop various semantic web methods and techniques for providing 
recommendations for clinicians to assist them in the process of DDx. The methods and 
techniques developed in this thesis integrate both practical medical knowledge using clinical 
pathway rules for a set of common diseases as well as effective semantic web technologies (such 
as the development of a disease symptom ontology, development of patient ontology, using rule-
based recommenders based on clinical pathways and data mining).   
 
1.2. Differential Diagnosis and Clinical Pathways 
 
At many times, an exact diagnosis can be determined using a hybrid approach involving clinical 
pathways along with DDx [Colucciello et al. 1999]. In this hybrid approach, clinicians use the 
clinical pathways as a guide to narrow a list of possible diagnosis paths predicted using DDx, for 
a specific patient case, down to the correct diagnosis path(s). 
 
                                                          
3
 Medicines and Healthcare Strategy 2009-2012: http://www.innovateuk.org/_assets/pdf/Corporate-
Publications/MedicineHealthcareExecSum.pdf 
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1.2.1 Differential Diagnosis 
 
DDx is a systematic method used to identify unknowns. This method, essentially a process of 
elimination, is used by physicians, nurse practitioners, physician assistants, and other trained 
medical professionals to diagnose a specific disease in a patient [Wisconsin Fibromyalgia 
Network 2011]. It often involves first making a list of possible diagnoses, then attempting to 
remove diagnoses from the list until one diagnosis remains  [Cray 2011]. In some cases, there 
will remain no diagnosis; this suggests the physician has made an error, or that the true diagnosis 
is unknown to medicine. Removing diagnoses from the list is done by making observations and 
using tests that should have different results, depending on which diagnosis is correct. 
 
Differential diagnosis allows the physician to: 
 more clearly understand the condition or circumstance the patient is suffering from 
 assess reasonable prognosis 
 eliminate any imminently life-threatening conditions 
 plan treatment or intervention for the condition or circumstance 
 enable the patient and the family to integrate the condition or circumstance into their 
lives, until the condition or circumstance may be ameliorated, if possible 
 
DDx is often manual and requires the estimation of multiple distinct parameters in order to 
determine the most probable diagnosis. For this reason, there are many attempts to use computer-
based DDx software (e.g. ODDIN [García-Crespo et al. 2010], MEDBOLI [Rodriguez et al. 
2009]) to automate the process of diagnosis and increase its accuracy. Building a computer-based 
differential diagnosis system implies using a number of knowledge-based technologies which 
avoid ambiguity, such as ontologies representing specific structured information, but also 
strategies such as computation of probabilities of various factors and logical inference, whose 
combination outperforms similar approaches [García-Crespo et al. 2010]. 
 
1.2.2 Clinical Pathways 
 
Every healthcare institution uses documented "best practices" interventions and therapy 
standards when managing specific disease processes. Such best practices represent a set of 
“optimal” management models for a certain diagnosis and treatment (therapy), which are 
generally termed as “Clinical Pathways”. Clinical pathways, also known as care maps, are 
designed to be used in conjunction with the present standard of care as a tool to decrease 
variation in outcomes and maintain care within a specified community of practice. Clinical 
pathway programs aims to optimize clinical and economic outcomes for disease management by 
doing the following [Rossi 2003]: 
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 facilitating proper diagnosis 
 maximizing clinical effectiveness 
 eliminating ineffective diagnosis and therapeutic procedures 
 maximizing the efficiency of care delivery 
 
1.2.3 Combining Clinical Pathways and Differential Diagnosis (DDx) 
 
Clinical pathways assist to find solutions when differential diagnosis may face difficulties in 
sorting an overwhelming and confusing set of signs and symptoms. Imagine a physician in an 
emergency department trying to diagnose a critically ill infant who has feeding problems 
(vomiting, spitting up, refusing to feed), poor urine output, altered mental status (fussiness, 
somnolence, or unresponsiveness), respiratory difficulties (increased work of breathing, 
respiratory fatigue/failure), and temperature abnormalities (high or low) [Brown et al 2002]. 
Table 1.2 illustrates the differential diagnosis options for critically ill infants. Using differential 
diagnosis alone may provide very long list of possible diagnoses in some cases. The integration 
between DDx and clinical pathways requires a higher level of IT technology that utilizes the 
notion of semantic web [Niekerk & Griffiths 2008, Luc et al 2003] as well as support for 
incorporating emerging technologies such as data mining [Soni et al 2011].  
 
1.3. The Role of Semantic Web in Diagnosis Recommendation 
 
Generally, disease diagnosis processes heavily depend on both information and knowledge. 
Information systems are typically integrated into hospitals to support organization processes such 
disease management and result reporting, etc. Although medical databases and information 
management systems are common, healthcare knowledge, which is important for medical 
diagnosis and treatment, is rarely integrated into software systems supporting healthcare 
processes [Buranarach et al. 2009]. The semantic web is a concept that involves incorporating 
descriptions into data to make the data reusable and enable applications to be built that can take 
advantage of this describable collection of data. It features a common framework for data to be 
shared and reused across application, enterprise, and community boundaries. This opens a new 
set of opportunities that can be utilized to improve health care management. However, the 
support for semantic interoperability across a large number of sub-domains requires that rich, 
machine-understandable descriptions are consistently represented by well formulated 
vocabularies drawn from formal ontologies and that they can be easily composed and published 
by domain experts [Dumontier 2010]. For this purpose, our thesis starts by developing an 
ontology-based knowledge management framework that focuses on providing information and 
knowledge support for knowledge-enabled diagnosis services. 
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Table 1.2: DDx Possible Diagnosis for Critically Ill Infants [Brown et al. 2002] 
 
Our approach starts by developing a diseases symptoms ontology (DSO) for diagnosing chronic 
diseases that are common in any primary care healthcare unit. We have selected about a dozen 
diseases to include in our DSO ontology. Currently, there are no existing DSO ontologies in 
existence. However, there are separate ontologies for diseases and symptoms. We propose to 
build on these existing ontologies to create a model for the DSO ontology. A more detailed 
discussion of ontology as a knowledge structure, and a more detailed discussion of our DSO 
model is the subject of chapter 2. Once a DSO ontology knowledge structure is developed, 
outside entities/systems need to be able to make use of this knowledge structure. In other words, 
a query engine that has the ability to retrieve specific information (queries) from the DSO 
knowledge structure must be developed. The query engine will allow other systems to retrieve 
information from the DSO. We propose to use the Jena Java API to construct our query engine. 
This will be discussed in detail in chapter 3. We will also discuss in that chapter the design and 
implementation of common queries in differential diagnosis (DDx) as far as the relations 
between symptoms and diseases are concerned. We will call our query engine the DSO crawler. 
Another important knowledge support for disease management is various types of patient related 
information. Such patient attributes are mentioned in various medical documents. Examples of 
patient related attributes include age, weight, height, etc. This information is specifically 
important for disease diagnosis. Therefore, we also propose to include patient related information 
into an ontology knowledge structure. We call this ontology a patient ontology (PO). We will 
discuss the PO ontology and its query engine (PO crawler) in detail in chapter 4. On top of the 
DSO & PO crawlers, we will employ a flexible rule-based engine that can accommodate various 
clinical pathway rules used by the disease management process to recommend tests, procedures, 
and/or to provide a diagnosis. The clinical pathway rules should model the rules of differential 
diagnosis for the common diseases we have selected. A more detailed discussion of clinical 
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pathway and ontology driven differential diagnosis recommendation will be included in chapter 
4. 
Another approach for differential diagnosis recommendation is a data mining approach. Like the 
above approach, it is an ontology driven approach based on the DSO & PO crawlers. Unlike the 
above approach, it is based on data mining techniques rather than clinical pathways rules. The 
DSO & PO crawlers select the most important medical attributes, for a specific diagnostic case, 
from a patient dataset and feed these attributes to data mining algorithms. The data mining 
algorithms then process the data and come to certain diagnostic conclusions. This data mining 
and ontology driven differential diagnosis recommendation approach is discussed further in 
chapter 4. Moreover, the two approaches can cooperate to form an overall differential diagnosis 
recommendation approach. We call the overall approach the overall differential diagnosis 
recommendation approach and we will discuss it further in chapter 4. Figure 1.1 illustrates our 
overall differential diagnosis recommendation model.     
We followed that by querying the DSO ontology according to some common questions used for 
differential diagnosis to eliminate or confirm some diagnosis options. For this purpose we 
designed our own DSO crawler utilizing some generic relations that provide answers to the 
required queries. On top of the DSO crawler we developed our flexible rule-based engine that 
can accommodates the various clinical pathway rules used by the disease management process to 
recommend tests, procedures, and/or to provide a diagnosis. Our flexible rule-based 
recommender is able to store every approved recommendation as a training dataset. The training 
dataset can be used by clinicians to predict the diagnosis of future cases using some sound data 
mining techniques and algorithms. Our developed DDx recommender uses our developed patient 
ontology to guide mining new diagnostic trends and pattern in patient data. Figure 1.1 illustrates 
our overall development approach. 
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Fig. 1.1: Overall Architecture for the DDx Recommender 
 
1.4. Summaries of the Chapters 
 
Chapter 1 introduced essential concepts in our thesis such as DDx, Clinical Pathways, and 
Semantic Web technologies for DDx Recommendation. It also summarized our thesis problem 
statement. Chapter 2 will develop an ontology that relates symptoms to diseases. We call this 
ontology the diseases symptoms ontology (DSO). DSO is a hybrid ontology combining two 
OBO standard ontologies (DOID & SYMP). Chapter 3 will present a unique architecture for 
querying the DSO based on the notion of DDx. We call this architecture the DSO Ontology 
Crawler. Based on this crawler, clinicians are able through our six relational queries to answer 
representative DDx questions towards narrowing diagnosis options and providing primitive 
recommendation. Chapter 4 will develop another ontology called the patient ontology (PO) 
along with its crawler. It also develops two recommendation components based on interacting 
with clinicians and semantic web technologies. The first component introduces the notion of 
flexible rule-based engine that can accommodate various clinical pathway rules. It is a clinical 
pathway and ontology driven differential diagnosis recommendation model. The second 
component utilizes previous patient’s data to predict diagnosis for new patient cases. It is a data 
mining and ontology driven differential diagnosis recommendation model.  Chapter 4 ends by 
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introducing an overall semantic web based differential diagnosis recommendation framework 
that integrates the two recommendation components. Chapter 5 will introduce our 
experimentation and scenarios of using our integral recommendation framework prototype. 
Finally, chapter 6 summarizes our thesis conclusions and the future research that can build on 
our research. In addition, it discusses challenges of implementation of our integral 
recommendation framework. It then suggests some practical diagnosis recommendation 
applications that can be developed using our integral recommendation framework.  
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Chapter 2: Disease Diagnosis Ontology Engineering 
 
2.1. The Disease Diagnostic Dilemma 
  
 Many medical diagnosis systems are proposed in the medical domain to help solve the disease 
diagnosis problem. Table 2.1 lists some of the existing autonomous disease diagnoses systems. 
However, such systems reported limited acceptance and success in the clinical practice because 
of their lack of scalability as well as the complex and the dynamic nature of the medical 
diagnosis process.  Diagnosis is a very complex process as it involves identifying symptoms, 
signs and results of different diagnostic procedures (such as medical tests) as well as involving a 
higher level of decision making based on complex knowledge repositories and expert 
interactions between health professionals. In reality, a physician formulates a hypothesis of 
probable diagnoses, and, in many cases, will obtain further testing to confirm or clarify the 
diagnosis before providing treatment. The diagnosis process may thus continue for a number of 
iterations before the patient is finally diagnosed with enough certainty and the cause of the 
symptoms is recognized. For this reason a computer program used in the diagnostic procedure 
must incorporate all the dynamic issues and the required knowledge and semantics of the disease 
diagnosis process. Such systems are support systems as they are clearly designed to interact with 
health professionals and support decision making by health professionals.  Figure 2.1 illustrates a 
simple mindmap used for diagnosing Type 2 Diabetes [Schwimmer 2007]. 
 
Table 2.1: Some Medical Diagnosis Support Systems 
Diagnosis System Purpose Reference 
CDSS To Diagnose babies in neonatal 
intensive care unit. 
[Catley et al. 2003] 
DXplain Clinical decision support expert 
system that explains how it obtains its 
diagnosis recommendations and 
therefore can be used as an 
educational medical reference 
system. 
[Barnett et al. 1987] 
MADHS A multi agent diagnosis helping 
system. 
[Yang and  Shieh 
2008] 
RBDDS A temporal system to express 
temporal relationships among 
diseases that may have mutual affect 
potentially 
[Chien-Chih et al. 
2007] 
PROMEDAS Patient Specific Clinical Diagnostic 
Support System 
[Kappen et al. 2003] 
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Fig. 2.1: Mindmap for Type 2 Diabetes Diagnosis [Schwimmer 2007] 
2.2. Ontology Guided Disease Diagnosis 
 
Development of knowledge structures for healthcare is a research community-wide effort 
focused on the development of a set of interoperable knowledge modules that together provide 
solutions to many healthcare challenges of the 21st century.  Such efforts encompass a wide 
range of activities, including ontology engineering, biomedical modeling, data mining, 
knowledge discovery tools and database development, simulation, and visualization. However, 
effective knowledge representation requires the use of standardized vocabularies to ensure both 
shared understanding between people and interoperability between information systems. 
Internationally, there are countless existing biomedical vocabularies such as SNOMED-CT4, 
LOINC5, ICD-9 CM6, MeSH7 and UMLS8. Unfortunately, many of these existing biomedical 
vocabulary standards rest on incomplete, inconsistent, or confused accounts of basic terms 
pertaining to diseases, diagnoses, and clinical phenotypes [Scheuermann 2009]. There is no one 
universally accepted coding scheme that encapsulates all pertinent clinical information for the 
purposes of patient care, clinical research and disease diagnosis. There are indeed several 
attempts to harmonize such terminologies but such efforts are at their infancy [Hamm et al. 
2007]. Without a widely accepted clinical and medical terminology (nomenclatures, thesauri, 
classifications, etc.), disease identification and reporting remains mission incomplete especially 
when we consider that interpersonal communication is an essential activity in disease diagnosis. 
Solving this problem requires the effort of notable institutions to develop concepts and 
                                                          
4
 http://www.openclinical.org/medTermSnomedCT.html 
5
 http://loinc.org/ 
6
 http://icd9cm.chrisendres.com/ 
7
 http://www.ncbi.nlm.nih.gov/mesh 
8
 http://www.nlm.nih.gov/research/umls/ 
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classifications dedicated for disease identification in order to share information in a semantically 
unambiguous way, and to reuse domain knowledge.  Moreover we cannot rely on the human 
brain of the clinical experts to remember all diseases' details since the number of diseases which 
exist worldwide is enormous. For this reason we need an effective way to store and retrieve 
knowledge related to human diseases. In this direction ontologies play a crucial role in defining 
concepts and in establishing relations between these concepts. Ontologies are an important phase 
in the process of knowledge base development and management of any modern clinical system. 
They are dynamic and keep maturating over time due to changes in the local environments. 
Medical ontologies are much more than biomedical vocabularies. They arrange concepts into 
ISA and sibling hierarchies, which effectively relate these concepts in a structural way that 
provides valuable inferences upon retrieval.  
 
Two general strategies for ontology development are predominant, one is based on using 
sophisticated ontology modelling tools such as Protégé [Stanford 2011], Ontolingua9, Chimaera10 
and LOOM11 and the second one is based on inferential programming and logical reasoning. 
Although both approaches may be used at the same time, the advent of expressive ontology 
languages such as OWL12 and its close relation to Description Logics (DL)13, non-trivial implicit 
information, such as the is-a hierarchy of classes, can often be made explicit by OWL-API14 
inferential programming methods or through the use of logical reasoners15. Figure 2.2 illustrates 
the way ontology may define the concept of Diabetes Type 1 disease. 
 
Fig. 2.2: Disease Ontology ISA and Sibling Hierarchies Relate and Classify Diseases    
                                                          
9
 http://www.ksl.stanford.edu/software/ontolingua/ 
10
 http://www.ksl.stanford.edu/software/chimaera/ 
11
 http://www.bioontology.org/wiki/index.php/LOOM 
12
 http://www.w3.org/TR/owl-ref/ 
13
 http://en.wikipedia.org/wiki/Description_logic 
14
 http://owlapi.sourceforge.net/ 
15
 http://en.wikipedia.org/wiki/Semantic_reasoner 
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Common components of ontologies include16: 
 
 Individuals: instances or objects (the basic or "ground level" objects) 
 Classes: sets, collections, concepts, classes in programming, types of objects, or kinds of 
things 
 Attributes: aspects, properties, features, characteristics, or parameters that objects (and 
classes) can have 
 Relations: ways in which classes and individuals can be related to one another 
 Function terms: complex structures formed from certain relations that can be used in place 
of an individual term in a statement 
 Restrictions: formally stated descriptions of what must be true in order for some assertion to 
be accepted as input 
 Rules: statements in the form of an if-then (antecedent-consequent) sentence that describe 
the logical inferences that can be drawn from an assertion in a particular form 
 Axioms: assertions (including rules) in a logical form that together comprise the overall 
theory that the ontology describes in its domain of application. This definition differs from 
that of "axioms" in generative grammar and formal logic. In those disciplines, axioms 
include only statements asserted as a priori knowledge. As used here, "axioms" also include 
the theory derived from axiomatic statements 
 Events: the changing of attributes or relations 
2.3. Disease Diagnosis Ontology Engineering 
 
Ontology engineering (or ontology building) is a field that studies the methods and 
methodologies for building ontologies. It studies the ontology development process, the ontology 
life cycle, the methods and methodologies for building ontologies, and the tool suites and 
languages that support them. It aims to make explicit the knowledge contained within software 
applications, and within enterprises and business procedures for a particular domain. Ontology 
engineering offers a direction towards solving the interoperability problems brought about by 
semantic obstacles, such as the obstacles related to the definitions of business terms and software 
classes. Ontology engineering is a set of tasks related to the development of ontologies for a 
particular domain [Maniraj and Sivakumar 2010][De Nicola 2009]. For the last few decades 
software engineers and scientists have been exploring ways of ‘modeling’ or ‘representing’ the 
entities about which computers are expected to reason. But what do ‘modeling’ and 
‘representing’ mean? What is a ‘conceptual model’ or an ‘information model’ and how can they 
and their components be unambiguously described? The problem of multiple conflicting 
meanings arises also in regard to other terms, such as ‘class’, ‘object’, ‘instance’, ‘individual’, 
‘property’, ‘relation’, etc., all of which have established, but unfortunately non-uniform, 
meanings in a range of different disciplines including clinical diagnosis. In OWL, ‘instance’ 
means ‘element’ or ‘member’ of a class. A number of influences have played a role in the 
                                                          
16
 http://en.wikipedia.org/wiki/Ontology_components 
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development of terminology resources for applications in medicine [Smith and Brochhausen 
2011]: 
 
 The influence of library science and of dictionary and thesaurus makers, illustrated mostly by 
MeSH, the indexing resource maintained by the National Library of Medicine; 
 The influence of database design and conceptual modeling, illustrated for example by the 
HL7 initiative17; 
 The influence of biological science, illustrated by the Gene Ontology (GO)18 and by the other 
ontologies within the Open Biomedical Ontologies (OBO) Foundry initiative19 and the 
National Center for Biomedical Ontology20; 
 The influence of advances towards greater formal rigor, illustrated for example by current 
developments within SNOMED-CT and within the framework of the Semantic Web 
 
Several efforts by a variety of standardization agencies such as ISO, CEN and W3C have been 
undertaken to provide cross-disciplinary uniformity but with little or no success reported. The 
only notable result that can be positively identified is the one by the OWL-DL21 semantic web 
community where it has a rigorously defined semantics. This does not mean, however, that 
OWL-DL guarantees that an ontology formulated using OWL-DL is an error-free representation 
of its intended domain [Smith and Ceusters 2006]. Related to the goal of outlining a 
terminological framework that encompasses diseases, their causes and manifestations, and 
diagnostic acts, Table 2.2 lists some notable efforts in this direction. A careful inspection to the 
attempts listed in Table 2.2 reveals that such entities have not been adequately treated in standard 
vocabulary resources [Scheuermann 2009].  
 
Table 2.2: Notable Dedicated Disease Diagnosis Ontologies 
 
                                                          
17
 www.hl7.org 
18
 http://www.geneontology.org/ 
19
 http://www.obofoundry.org/ 
20
 http://www.bioontology.org/ 
21
 http://semanticweb.org/wiki/OWL_DL 
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2.3.1 The TMO Disease Diagnosis Ontology 
 
TMO is a high-level, patient-centric ontology that extends existing domain ontologies to 
integrate data across aspects of drug discovery and clinical practice. The ontology has been 
developed by participants in the W3C Semantic Web for Health Care and Life Sciences Interest 
Group and members of the National Center for Biomedical Ontology22. The ontology is available 
in OWL format23. The ontology enables silos in discovery research, hypothesis management, 
experimental studies, compounds, formulation, drug development, market size, competitive data, 
population data, etc. to be brought together. This will help pharmaceutical companies to model 
patient-centric information, which is essential for the tailoring of drugs, and for early detection of 
compounds that may have suboptimal safety profiles24.   
2.3.2 The Galen Disease Diagnosis Ontology 
 
GALEN is a project for developing terminology servers and data entry systems based on a 
Common Reference, or CORE, model for medical terminology [Rector 1996]. It is an attempt to 
represent clinical concepts using a logic-based formalism based on certain choices. These 
choices are embodied in the high level schemas of the resulting logical model or ontology. The 
GALEN Common Reference Model source files are available in both original GRAIL25 notation 
and also in OWL-RDF from the OpenGalen portal26. A key feature of the GALEN approach is 
that it divides the problem of clinical knowledge representation and terminology into distinct 
parts each implemented by different software: 
 
a) The concept representation, or ontology, schema and model expressed in GRAIL. 
b) The linguistic resources for presenting the model 
c) The mappings to and from the concept model and other representations 
d) Perspectives, views and intermediate representations of the model which adapt it to 
particular purposes 
e) Indexes to other knowledge based on the model 
f) Non-terminological computational or other reasoning mechanisms, e.g. unit conversion 
g) The terminology server and its API which make all of the other parts available as a 
coherent whole to applications and users. 
 
GALEN’s original idealized goal was an ontology which could express ‘all and only’ what was 
medically sensible. It was recognised from the start that this ideal was unobtainable and that the 
‘all’ would have to take precedence over the ‘only’ because [Rector and Rogers 1999]: 
                                                          
22
 http://code.google.com/p/translationalmedicineontology/ 
23 http://translationalmedicineontology.googlecode.com/svn/trunk/ontology/tmo.owl 
24
 http://bioportal.bioontology.org/ontologies/1461 
25
 http://www.opengalen.org/sources/sources.html 
26
 http://www.opengalen.org/sources/sources.html 
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a) There are well known trade-offs between expressiveness and computational tractability 
in formal systems. 
b) Reality is fractal – no matter how much detail is represented in the model, it is always 
possible to represent more 
c) Constraints on what is ‘sensible’ are slippery and difficult to formulate loosely enough 
to allow all sensible statements but strictly enough to exclude all nonsense 
d) The practical goal has been to have an ontology which is sufficiently expressive to 
capture the statements and abstractions used by clinicians and classify them correctly 
while rejecting patent nonsense. 
 
To use Galen for disease diagnosis there is need for complicated translation system like MoST 
(Model Standardisation using Terminology) Systems. The MoST system developed for this 
purpose aims to find semantically equivalent SNOMED-CT terminology codes to map to 
archetype data model fragments. The two key stages of MoST include, (i) term finding, and (ii) 
data mapping [Qamar 2008].  For this purpose it is very difficult to use the Galen ontology for 
disease diagnosis due to its complex structure, which is compromised of several module lists 
above, and which requires complex processing and translation. 
 
2.3.3 The HPO Disease Diagnosis Ontology 
 
Phenomizer is a web-based application27 for clinical diagnostics in human genetics using 
semantic similarity searches in ontologies [Köhler et al. 2009].  One can use the Phenomizer to 
infer semantic similarity metrics to measure phenotypic similarity between queries and 
hereditary diseases annotated with the use of the Human Phenotype Ontology (HPO). This can 
be done by developing a statistical model to assign probability values to the resulting similarity 
scores, which can be used to rank the candidate diseases. The annotated HPO provides an 
accurate description of phenotypic abnormalities and therefore provides the foundation of 
clinical diagnostics and the basis of our understanding of diseases. Unfortunately, HPO and the 
Phenomizer can only be used to represent hereditary diseases in humans, each of which displays 
a more or less specific combination of phenotypic features. Therefore it cannot be used for 
general disease diagnosis purposes. 
 
2.3.4 The IDO Disease Diagnosis Ontologies 
 
The IDO ontologies28 are designed as a set of interoperable ontologies that will together provide 
coverage of the infectious disease domain. At the core of the set is a general Infectious Disease 
Ontology (IDO-Core) of entities relevant to both biomedical and clinical aspects of most 
                                                          
27
 http://compbio.charite.de/phenomizer 
28
 http://infectiousdiseaseontology.org/page/Main_Page 
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infectious diseases. Sub-domain specific extensions of IDO-Core complete the set providing 
ontology coverage of entities relevant to specific pathogens or diseases.  
 
Similar to the Phenomizer, IDO is not general enough to be used for general disease diagnosis. 
 
2.3.5 The DOID Disease Ontology 
 
A human disease ontology is needed to identify all human diseases, provide a hierarchical 
structure where these diseases are related by parent-child and sibling relationships, and provide 
information about diseases such as their defining effects on human health. Organising diseases in 
an ontology hierarchy is extremely useful as it forms a pathological classification of diseases for 
use in medical systems. Such an undertaking is massive given the number of known human 
diseases and the fact that new diseases are discovered. The most prominent disease ontology 
developed to date is the Human Disease Ontology (DOID)29. Started in 2003 as part of the 
NUgene project at Northwestern University, it has been published in several versions over 
several years and contains to this date over 8600 known human diseases and 14,600 terms 
[Northwestern University 2003]. DOID is currently a standard ontology adopted by the OBO 
Foundry30. There are attempts under way to modify the human disease ontology to include 
symptoms and relations between those symptoms to diseases in the disease ontology.31 In the 
latest version of the DOID ontology this is clear as a has_symptom object property is already 
defined but no clear use of it has been proposed yet. Figure 2.3 shows the has_symptom property 
under the DOID.   
 
Fig. 2.3: The has_symptom Object Property of DOID Ontology      
                                                          
29
 http://do-wiki.nubic.northwestern.edu/index.php/Main_Page 
30
 http://obofoundry.org/ 
31
 http://do-wiki.nubic.northwestern.edu/index.php/Main_Page 
 24 
2.3.6 The SYMP Symptoms Ontology 
 
Symptom Ontology (SYMP) [University of Maryland 2005] was developed in 2005 by the 
Institute for Genome Sciences (IGS) at the University of Maryland, today it contains more than 
900 symptoms. SYMP's hierarchy categorizes symptoms under certain headings for example 
categorizing all types of pain (arm, leg, headache, back pain, chest pain, etc) under physical pain. 
SYMP became a standard ontology and was adopted by the OBO Foundry during 2008. Figure 
2.4 illustrates such categorizing.   
 
Fig. 2.4: Symptoms Ontology Defines and Relates Symptoms 
 
2.3.7 The GHDO Ontology 
 
The process of diagnosis needs both knowledge of disease hierarchies and symptom hierarchies. 
Moreover, it also needs relations between diseases and symptoms. For example, what are the 
symptoms of a certain disease, what diseases have a certain common symptom, what diseases a 
certain set of symptoms may point to, etc. These relations between symptoms and diseases can 
be ontologically established. One such proposed ontology model that has not yet been 
implemented is the GHDO (Generic Human Disease Ontology) [Hadzic and Chang, 2005]. It 
proposes an ontology model that relates diseases to symptoms (phenotypes) and to the other 
three elements that uniquely identify a disease: disease type, causes, and treatment. Figure 2.5 
shows the GHDO proposed model.       
 
Fig. 2.5: GHDO Model [Hadzic and Chang, 2005] 
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2.4 DSO Ontology: Aligning of DOID and SYMP Ontologies 
 
Ontologies in the age of semantic web tend to be put everywhere. They are viewed as the silver 
bullet for many applications. However, in open or evolving systems different parties would, in 
general, adopt different ontologies and thus growing research on linking or aligning ontologies is 
considered important [Marques 2005]. Ontology alignment is the idea of combining two (or 
more) ontologies into one and defining relationships between the concepts of the ontologies 
forming a new ontology in the process. Alignment between ontologies is a critical challenge for 
semantic interoperability [Hughes 2004] as well as for producing hybrid ontologies. When a 
domain is represented by multiple ontologies, there is a need for creating mappings among these 
ontologies elements in order to facilitate the integration of data and reasoning across these 
ontologies [Zhang and Bodenreider 2007]. There are two main approaches to alignment: 
Ontology Matching and Ontology Linking. Ontology matching techniques are for relating 
ontologies on the same domain or on partially overlapping domains. For example, ontology 
mapping works if two disease ontologies are to be aligned. In such case, disease classes from 
both ontologies are matched. Special mapping constructs are used to indicate how elements from 
different ontologies are semantically related or equivalent [Doan 2003]. Ontology linking, in 
contrast, allows elements from distinct ontologies to be coupled with links [Homola and Serafini 
2010]. A strict requirement is that the domains of the ontologies that are being combined are 
disjoint. This means that the classes/concepts of both ontologies must be separate for ontology 
linking to be applied. For example, ontology linking is appropriate for aligning disease and 
symptom ontologies as diseases and symptoms are separate concepts.  In the case of disease 
diagnosis, in order to link symptoms to diseases, combining the SYMP & DOID ontologies is 
necessary. In principle, the first step of ontology linking is combining the ontologies. To do this, 
the RDF elements (including all URLs) of both ontologies would need to be combined into a 
single OWL file. Unfortunately, the lack of copy-paste tools for ontologies makes this 
impossible. Simple ontology editors such as Protégé do not provide functionalities that would 
allow RDF elements to be dragged from one ontology into another. Therefore, using the 
available ontology editing tools to link ontologies is done by adding the elements of one 
ontology into the other while replicating the elements exactly so not to lose integrity and 
standard of the ontologies in the process. For the DOID & SYMP ontologies, it is logical to add 
the symptoms elements from SYMP into the DOID ontology because the DOID ontology is 
much larger. To do this on a full scale means adding all of the elements of the symptoms 
ontology into DOID, which is a massive undertaking. However, the process is simple & 
repetitive and can be applied to connect all diseases classes to their symptoms class. It may even 
be possible to semi-automate or automate this process. The following is our proposed algorithm 
of this process: 
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Module linkAlignment  (SYMP, DOID) { 
 for all diseases D € DOID { 
  copy D into DSO 
  fetch symptoms of D from a health website or server, a database, etc  
for all symptoms names S of D { 
 for symptoms S1 € SYMP { 
  if(S == S1.name) { 
1. copy S1 into revised DOID under a base symptoms class 
2. define a new has_symptom object property for D where D 
has_symptom S1 
  }  
 } 
} 
 }   
 output DSO 
}   
Listing 2.1: Algorithm for Linking Disease and Symptom Ontologies 
 
Using the above algorithm, the ontology symptoms of a few chosen diseases can be easily 
aligned with DOID forming a new ontology that is called Diseases Symptoms Ontology (DSO). 
The DSO includes all the diseases in DOID, and also the symptoms of 11 interrelated diseases. 
These diseases are Diabetes (type 1, type 2), Hypertension, Asthma, Adult Respiratory Distress 
Syndrome, Anemia, Calcemia, Renal Failure, Urinary Tract Infection. These diseases share 
some common symptoms are diagnosed on the basis of a certain type of blood or urine test. 
Figure 2.6 shows the first step in ontology alignment, which is as mentioned earlier combining 
the SYMP & DOID ontologies. 
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Fig. 2.6: Hierarchy of Symptoms in DSO 
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Disease and Symptoms classes have annotations that contain vital information such as 
disease/symptom name and definition. See figure 2.7. 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.7: DSO Diseases and Symptoms Class Annotations 
 
Now that the concepts/classes of separate ontologies are combined into a single ontology, it is 
important to establish relationships between the concepts of the ontologies. In the case of this 
research, this means establishing relations between the symptoms and diseases class. The most 
obvious relation is the has_symptom object property. A certain diseases class can be tied to 
several symptoms classes via several has_symptom properties. Table 2.3 gives is an example of 
this. 
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Table 2.3: Hypertension Disease Class (from DOID) linked to Symptoms Classes (from SYMP) 
representing the Symptoms of Hypertension 
Disease Class 
Name 
Disease Class 
DOID 
Ontology 
Code 
Object 
Property 
Symptom 
Class 
Symptom Class 
SYMP Ontology 
Code 
Hypertension DOID_10763 has_symptom blurred vision SYMP_000012 
Hypertension  DOID_10763 has_symptom drowsiness SYMP_000024 
Hypertension DOID_10763 has_symptom tinnitus SYMP_0000393 
Hypertension DOID_10763 has_symptom nosebleed SYMP_0000448 
Hypertension DOID_10763 has_symptom headache SYMP_0000504 
Hypertension DOID_10763 has_symptom flushing SYMP_0000511 
Hypertension DOID_10763 has_symptom Nausea SYMP_0000458 
Hypertension DOID_10763 has_symptom palpitation SYMP_0000530 
Hypertension DOID_10763 has_symptom frequent 
urination 
SYMP_0000563 
Hypertension DOID_10763 has_symptom urgency of 
urination 
SYMP_0000590 
Hypertension DOID_10763 has_symptom nocturia SYMP_0000564 
Hypertension DOID_10763 has_symptom dizziness SYMP_0000610 
Hypertension DOID_10763 has_symptom breathing 
difficulty 
SYMP_0019153 
Hypertension DOID_10763 has_symptom fatigue SYMP_0019177 
 
Using the protégé editor, this is simple to accomplish. As shown in figure 2.8 below, the above 
has_symptom properties can be added under the superclasses tab. For each symptom class 
related to the hypertension disease class, a new has_symptom object property need to be created.  
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Fig. 2.8: DSO has_symptom property relates a Disease Class to its Symptom Classes 
  
The next two figures are an illustration of how the has_symptom property connects diseases to 
symptoms. Figure 2.9 shows connections between several DOID diseases and SYMP symptoms, 
while figure 2.10 shows the connections between the hypertension disease classes to the 
corresponding symptoms classes in SYMP.  
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Fig. 2.9: DSO connects SYMP & DOID terms via the has_symptom Property   
 
Fig. 2.10: Hypertension DOID disease has_symptom Connections to some of its symptoms 
in SYMP Ontology 
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In this chapter we introduced our method to engineer an ontology for differential disease 
diagnosis. A careful survey of the current research on disease diagnosis ontologies reveals that 
no effective ontologies are available for general disease diagnosis. Specifically, there is yet no 
ontology relating diseases to their symptoms. However, our careful investigation also revealed 
the availability of two OBO standard ontologies that can be used for general disease diagnosis by 
relating diseases to their symptoms: DOID and SYMP. Section 2.4 described a detailed method 
and a general algorithm that can be used for linking DOID and SYMP ontologies.  The proposed 
method and process has been repeated for 11 inter-related diseases to produce an annotated and 
aligned new ontology that we call Diseases Symptoms Ontology (DSO). Indeed our method and 
process can be repeated for any number of diseases to create a larger, more complete version of 
the DSO. Our new DSO ontology has been published on our university Flash server 
(http://flash.lakeheadu.ca/~omohamme/DSO.owl) and can be used for analysis by other semantic 
web applications. In the next chapter, we will design an ontology crawler that can query DSO for 
specific differential diagnosis information that is of interest to clinicians. 
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Chapter 3: Developing a DSO OWL Ontology Crawler for Disease 
Diagnosis 
 
3.1. Ontology Management: Toward Filtering Relational Information 
 
Managing ontologies and annotated data throughout their life-cycles is at the core of semantic 
systems of all kinds [Hepp et al. 2008]. Ontology management infrastructures are needed for the 
increasing development of semantic applications especially in the corporate semantic web, which 
comprises the application of semantic technologies in an enterprise environment [Bloehdorn et 
al. 2009]. This is due to the fact that ontologies need to be properly accessed and maintained for 
ontology-based systems to remain usable. There are two main research approaches in the domain 
of ontology management. The first considers ontology management as pure steps of ontology 
accessibility and change performed by the programmer [Klein 2004], while the second takes into 
account dynamically updating the ontology through extensive learning and evolution 
management functionalities [Bloehdorn et al. 2006]. The first approach is a fundamental 
management approach required by every semantic web application. On the other hand, the 
second approach is considered as a secondary approach to ontology management where it is only 
required for ontology evolution and maturing [Braun et al. 2007].  This chapter is concerned 
with the first approach. It aims to develop an ontology mediator or a manager that handles the 
ontology accessibility for effective knowledge management through querying, filtering and 
searching. Other higher level ontology management functionalities such as consistency checking 
and more inferential primitives are left to our next chapter. Our ontology manager is therefore is 
called ontology crawler since it has a generic engine to filter information from a given ontology 
(DSO) in a relational way. The term crawler is chosen to describe higher cognitive searching 
activities by which people determine where places and things are, how to get to them, and 
actually retrieves them. Crawling is a complex process compared to more simple searching 
techniques. Our crawling process is designed to mimic the way doctors perform differential 
diagnosis. Doctors attempt to ask themselves question to know what is happening with their 
patient then go and test their ideas while keeping other options open. This means knowing 
diseases and conditions, their signs and symptoms, and conducting an investigation (including 
tests) to rule things in or out. The type of questions required for differential diagnosis represent 
relations between diseases and symptoms in a variety of formations. Examples of such questions 
are: 
 
 What are the symptoms of a given disease? 
 If a patient displays a number of symptoms, then what are the possible diseases he/she may 
have? 
 If a patient displays a number of symptoms, and a certain disease is suspected then what 
symptoms of the disease are not displayed by the patient (the so called missing symptoms)? 
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 What diseases are related to each symptom displayed by the patient? 
 
The crawling process should be driven by these questions to aid doctors with the process of 
diagnosis and narrowing their choices. The other motivation behind designing our own ontology 
crawling engine is based on the fact that the available semantic web engines like Swoogle32, 
OntoSearch33 and OntoKhoj [Patel et al. 2003] allow ontologies to be searched using only 
keywords (e.g. classes), but further refinement of the search criteria based on the relational 
structure of the ontology is not possible. Our developed ontology crawler filters relevant 
information subject to the relational structure of the given ontology. The developed ontology 
crawler is designed to search for properties associated with classes in variety of relational 
formations. Our ontology crawler provides higher applications with primitives for ontology 
navigation which make the task of finding information more effective, efficient, and interactive. 
3.2. The Basic Infrastructure for Programming the Ontology Crawler 
 
The infrastructure that we are describing in this section uses a popular open source Semantic 
Framework: Jena34. Jena is a Java framework for building Semantic Web applications. Jena 
provides a programmatic environment for RDF, RDFS and OWL, including a rule-based 
inference engine (see Figure 3.1).  Jena uses SPARQL to query the ontology. However, the use 
of SPARQL query engine is restrictive for the purposes of the hierarchical relational navigation 
required for our ontology crawler. Also, in order to write SPARQL queries, the programmer 
must manually match the exact RDF/OWL ontology structure for the prescribed query [Polleres 
et al. 2009]. This process is restrictive and low level as it requires exact pattern matching 
expertise for aligning the query to the specified ontology. By using Jena OWL primitives, the 
programmer is relieved from this pattern matching. These primitives can be used to retrieve 
information including class labels (for example disease names and synonyms), object and data 
type properties from an ontology class. This is one of the reasons that motivated our work to 
develop higher level of ontology querying module using Jena. The next section describes the 
functionalities of our OWL ontology crawler. 
 
                                                          
32
 http://swoogle.umbc.edu/ 
33
 http://www.ontosearch.org/ 
34
 http://jena.sourceforge.net/ 
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Fig. 3.1: Jena Ontology Query Architecture 
3.3. Developing the DSO Crawling Relational Primitives 
 
In this section we are describing our DSO ontology crawler software architecture consisting of 
Jena components along with the required relations for combining the ontological attributes in a 
meaningful way for the purpose of inferring new knowledge necessary for the differential 
diagnosis process. The ontology crawler replaces the Jena SPARQL querying engine by 
implementing the necessary differential diagnosis relations using Jena OWL API primitives. Our 
ontology crawler is part of an overall architecture that aims to serve health care providers with 
the notion of a differential diagnosis recommendation system. Figure 3.2 illustrates an overview 
of our overall architecture where the ontology crawler is one of its major components. 
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Fig. 3.2: An Overview of the Semantic Web Differential Diagnosis Recommendation Engine 
Model 
 
The ontology crawler is primarily used in our differential diagnosis engine for retrieving 
information from the DSO ontology using representative relations. The representative relations 
address common queries that health care professionals use during the process of differential 
diagnosis. Figure 3.3 provides the most important representative relations that we employed 
within our ontology crawler along with their formal representation.  
 
 37 
 
Fig. 3.3: DSO Ontology Crawler's Six Representative Relations  
 
Each of the representative relations (R1 to R6) interact with the DSO ontology where their 
domain represents the inputs and their range represents the outputs. The relation's 
domains/ranges include the set of the DSO ontology attributes including disease, diseases, 
symptom, symptoms and pathology. Figure 3.4 illustrates each relation targeted domain and 
range. 
 
Fig. 3.4: The Ontology Crawler's Six Representative Relations 
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In the following sections we describe each relation in details. 
3.3.1 The R1 Relation Description 
 
The R1 relation takes a symptom as input and outputs DSO diseases that display that symptom. 
It is designed to answer the question in diagnosis which is: If a patient displays a certain 
symptom, then what diseases may he/she have? Figure 3.5 is a graphical representation of R1. 
R1 is a special case of R2. R1 takes a single symptom as input, but R2 can take more than one 
symptom.  
 
 
Fig. 3.5: R1 Relation 
 
3.3.2 The R2 Relation Description 
 
The R2 relation is designed to answers a fundamental question in the differential diagnosis 
process. It replies to question: If a patient displays a number of symptoms, then what are the 
possible diseases the patient may have? The layout of R2 is shown in figure 3.6. 
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Fig. 3.6: R2 Relation 
 
The pseudo code for R2 is shown below. 
 
Module R2(Symptoms S[M1], OntModel m) { 
 // R2: Find diseases sharing number of common symptoms 
diseaseList[][] = null; 
counter = 0; 
diseases[] = null; 
returnedDiseases[] = null; 
begin 
searchForDiseasesWithSymptoms(S[M1], m) 
returnedDiseases[] = diseaseList[0][] ∩ diseaseList[1][] ∩ diseaseList[2][] ∩ diseaseList[3] 
∩ ............ ∩ diseaseList[M1 - 1]; 
output returnedDiseases[] 
end 
} 
void searchForDiseasesWithSymptoms(Symptom[] S1, OntModel m) { 
              for (int i = 0; i < S1.size; i++) { 
 searchForDiseasesWithSymptom(S1[i], m); 
             }               
} 
void searchForDiseasesWithSymptom(Symptom S, OntModel m) { 
             for each OntClass c in OntModel m {  
             checkDiseaseClassForSymptom(c, S);     
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             } 
           diseaseList[counter][] = diseases; 
           counter++; 
           diseases = null;  
} 
void checkDiseaseClassForSymptom(OntClass c, Symptom S) { 
              List<OntClass> disjointClasses = c.listDisjointWith(); 
              String symptom = null; 
              List<RDFNode> disjointLabel = null; 
              while(disjointClasses.hasNext()) { 
disjointLabel = disjoint.next().listLabels(LANG); 
       while (disjointLabel.hasNext()) { 
symptom = 
disjointLabel.next().asLiteral().toString() ; 
        if(symptom.equalsIgnoreCase(symptomName)) 
         diseases.add(c);  
   }  
              }  
               } 
 
Figure 3.7 shows one execution of R2. Here, the input to R2 is the symptoms Nausea and 
Fatigue. The output is some DSO diseases that have Fatigue and Nausea among their symptoms. 
These diseases are listed below: 
diabetes mellitus type 2 
diabetic ketoacidosis 
lipoatrophic diabetes mellitus 
diabetic peripheral angiopathy 
hypertension 
renal failure 
hypercalcemia 
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Fig. 3.7: Executing R2 to Find the Diseases that Display Nausea and Fatigue as Symptoms 
 
Figure 3.8 illustrates a UML sequence diagram for the dynamics of executing R2 for an input 
scenario used in figure 3.7.  
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The pseudo code for R3 is as follows: 
Module R3(Disease D, OntModel m) { 
symp[] = null; 
Iterator<OntClass> clsDisjoint; 
begin 
           for each OntClass c in OntModel m {   
 if(c.getLabel() == D) { 
          clsDisjoint = c.listDisjointWith(); 
while(clsDisjoint.hasNext()) {  
sympt = clsDisjoint.next().getLabel(LANG); 
if(!symp.contains(sympt)) { 
         symp.add(sympt);      
   }  
 }    
            } 
end 
} 
 
The figure below (figure 3.10) is the sequence diagram for R3. 
 
Fig. 3.10: R3 Sequence Diagram 
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One example input to R3 is the disease anemia. The output of R3 in this case would be the 
symptoms of anemia. These symptoms are listed below: 
fatigue 
headache 
shortness of breath 
chest pain 
abnormal heart beats 
paleness 
dizzy 
3.3.4 The R4 Relation Description 
 
The R4 relation displays the hierarchy of a disease showing the pathology classification it 
belongs to as well as its sibling diseases. Figure 3.11 is a graphical representation of R4.   
 
Fig. 3.11: R4 Relation 
 
The output below shows the disease hierarchy of type 2 diabetes (diabetes mellitus type 2). 
Class :DOID#DOID_0050013 carbohydrate metabolism disease 
      Class :DOID#DOID_4194 glucose metabolism disease 
        Class :DOID#DOID_9993 hypoglycaemia 
        Class :DOID#DOID_9351 diabetes mellitus 
          Class :DOID#DOID_9744 diabetes mellitus type 1 
          Class :DOID#DOID_9352 diabetes mellitus type 2 
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            Class :DOID#DOID_1837 diabetic ketoacidosis 
            Class :DOID#DOID_11712 lipoatrophic diabetes mellitus 
            Class :DOID#DOID_10182 diabetic peripheral angiopathy 
          Class :DOID#DOID_11717 neonatal diabetes mellitus 
          Class :DOID#DOID_11716 prediabetes syndrome 
          Class :DOID#DOID_11714 gestational diabetes 
        Class :DOID#DOID_4195 hyperglycemia 
3.3.5 The R5 Relation Description 
Like R2, the R5 relation takes in a number of symptoms as input and finds the diseases that 
display the inputted symptoms. However, R5 goes further than R2 by asking the user to select 
one of these diseases. For the selected disease, it displays the missing symptoms. The missing 
symptoms of are symptoms of the selected diseases that were not given as input to R5. R5 gets 
the missing symptoms by using R3 to get the symptoms of the disease and subtracting the input 
symptoms from the symptoms of the disease. Figure 3.12 is a graphical representation of R5.   
 
Fig. 3.12: R5 Relation 
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One example input to R5 would be the symptoms Fatigue and Nausea. R5 would use R2 to link 
the two symptoms to the diseases that display them. Then R2 would ask the user to choose one 
of the diseases. Then R2 would display the missing symptoms for the selected disease. Figure 
3.13 illustrates the above example execution of R5. Figure 3.13 shows the diseases the display 
the symptoms fatigue and headache. It then shows the user selecting one the diseases 
(hypertension). After the user selects a disease, the missing symptoms of the disease are 
displayed. 
 
 
Fig. 3.13: Example R5 Result 
 
3.3.6 The R6 Relation Description 
 
The R6 relation is similar to R2. Like R2, it finds diseases that share a number of given 
symptoms. However, R2 searches the entire DSO for diseases that share the given symptoms 
while R6 searches specified disease pathology only. Therefore, R6 would take a number of 
symptoms and a disease pathology as input and output diseases that share the inputted symptoms 
and also belong to the given disease pathology. Figure 3.14 is an illustration of R6. 
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Fig. 3.14: R6 Relation 
 
One example R6 execution would be to find the diseases that are considered to be vascular 
diseases and display the Nausea and Fatigue symptoms. The results of this R6 example are as 
follows:         hypertension 
3.4. Enhancing the Power of the Ontology Crawler: The Integration of Pellet 
Reasoner 
 
In order to enhance the power of the six relationships described above, a variety of ontology-
based reasoners (e.g. Pellet35, Fact++36, KAON237) should be used to derive additional truths 
about concepts from the provided ontology model. For our purpose we used Pellet because it is a 
complete OWL 2 DL reasoner implemented in Java and it is open source. It also features some 
rule-based capability (e.g. SWRL).  
 
The Pellet inference engine adds power to the Ontology Crawler. For example when executing 
R2 with a Jena-only ontology crawler, solely the diseases in DSO where the given symptoms are 
                                                          
35
 http://clarkparsia.com/pellet 
36
 http://owl.man.ac.uk/factplusplus/ 
37
 http://kaon2.semanticweb.org/ 
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defined are returned. This is called direct inference. This is an approach that does not make use 
of the parent-child relationships of DSO. When adding a reasoner however, it can infer further 
findings through the parent-child relationships. For R2 for example, the reasoner makes the 
following conclusion: If the given symptoms are defined for a certain parent disease in DSO, 
then all its child diseases inherit these symptoms. This is called indirect inference making and is 
semantically correct, in OWL 2 DL, as all child diseases' classes are subtypes of a base disease 
class and inherit its symptoms, and in fact all of its attributes.  From a clinician's point of view, 
the additional inference making provides further diagnosis options that can be considered 
especially when the options obtained from direct inference are ruled out.    
 
Jena includes support for a variety of reasoners through the inference API. A common feature of 
Jena reasoners is that they create a new RDF model, which appears to contain the triples that are 
derived from reasoning, as well as the triples that were asserted in the base model. This extended 
model still conforms to the contract for Jena models. So it can be used wherever a base model 
can be used. The ontology API exploits this feature: the convenience methods the ontology API 
provides can query an extended inference model in just the same way as a plain RDF model. 
There are two different ways to use Pellet in a Jena program: either using a direct Pellet interface 
(common approach); or using Jena DIG interface (less common approach). The direct Pellet 
interface is much more efficient (e.g. does not have the HTTP communication overhead) and 
provides more inferences (DIG protocol has some limitations). Based on the direct interface, we 
can easily integrate pellet into our Jena Ontology Crawler as follows: 
 
OntModel ontModel = ModelFactory.createOntologyModel( PelletReasonerFactory.THE_SPEC); 
ontModel.getDocumentManager().addAltEntry(null, "c:/ActionRecognition/Ontology/DSO.owl"); 
ontModel.getDocumentManager().addAltEntry(null, "c:/ActionRecognition/Ontology/DSO.owl" ); 
ontModel.read("file:/C:/ActionRecognition/Ontology/DSO.owl"); 
// get the underlying Pellet graph 
PelletInference pellet = new PelletInference((PelletInfGraph) ontModel.getGraph()); 
//progressBar.setIndeterminate(true); 
boolean consistent = pellet.isConsistent(); 
System.out.println("Consistency = " + consistent); 
// Trigger classification 
pellet.classify(); 
// Trigger realization 
pellet.realize(); 
 
In the above code, the new Jena RDF model is created using a PelletInference object, which 
takes the base Jena RDF model (OntModel m) and converts it to the new pellet-reasoned model. 
The same object can then be used to check the new model for consistency (pellet.isConsistent()) 
and add the additional pellet inferences to it (pellet.classify()).  Results, with pellet, of R2 using 
the symptom Nausea are shown below: 
 
renal failure 
chronic kidney failure 
end stage renal failure 
uremia 
hemolytic-uremic syndrome 
uremic neuropathy 
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acute kidney failure 
acute kidney tubular necrosis 
hepatorenal syndrome 
renal hypertension 
malignant hypertensive renal disease 
renovascular hypertension 
benign hypertensive renal disease 
HELLP syndrome 
hypertension 
pre-eclampsia 
eclampsia 
severe pre-eclampsia 
mild pre-eclampsia 
malignant hypertension 
malignant essential hypertension 
malignant secondary hypertension 
malignant renovascular hypertension 
hypertensive cardiopathy 
malignant hypertensive heart disease 
benign hypertensive heart disease 
secondary hypertension 
benign secondary hypertension 
benign renovascular hypertension 
pulmonary hypertension 
persistent fetal circulation syndrome 
essential hypertension 
benign essential hypertension 
diabetes mellitus type 2 
diabetic peripheral angiopathy 
lipoatrophic diabetes mellitus 
diabetic ketoacidosis 
hypercalcemia 
 
Results of R2,with pellet reasoning, using the two symptoms fatigue and headache are shown 
below. 
 
hemolytic-uremic syndrome 
renal hypertension 
malignant hypertensive renal disease 
renovascular hypertension 
benign hypertensive renal disease 
hemoglobinuria 
HELLP syndrome 
pancytopenia 
Fanconi's anemia 
anemia 
microcytic anemia 
fetal erythroblastosis 
hypochromic anemia 
congenital anemia 
congenital hemolytic anemia 
congenital nonspherocytic hemolytic anemia 
congenital dyserythropoietic anemia 
hereditary spherocytosis 
hemoglobinopathy 
methemoglobinemia 
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hemoglobin D disease 
hemoglobin E disease 
hemoglobin C disease 
Diamond-Blackfan anemia 
deficiency anemia 
protein-deficiency anemia 
neonatal anemia 
kernicterus due to isoimmunization 
twin-to-twin transfusion syndrome 
anemia of prematurity 
macrocytic anemia 
megaloblastic anemia 
aplastic anemia 
pure red-cell aplasia 
sideroblastic anemia 
sideroblastic anemia with spinocerebellar ataxia 
X-linked sideroblastic anemia 
pyridoxine-responsive sideroblastic anemia 
pyridoxine-refractory autosomal recessive sideroblastic anemia 
congenital hypoplastic anemia 
normocytic anemia 
hemolytic anemia 
hypertension 
pre-eclampsia 
eclampsia 
severe pre-eclampsia 
mild pre-eclampsia 
malignant hypertension 
malignant essential hypertension 
malignant secondary hypertension 
malignant renovascular hypertension 
hypertensive cardiopathy 
malignant hypertensive heart disease 
benign hypertensive heart disease 
secondary hypertension 
benign secondary hypertension 
benign renovascular hypertension 
pulmonary hypertension 
persistent fetal circulation syndrome 
essential hypertension 
benign essential hypertension 
 
Two major achievements have been introduced in this chapter. The first is to formulate the high-
level clinical queries related to differential diagnosis investigations into generic programmable 
relations. This chapter introduces six fundamental relations that link symptoms and diseases for 
the purpose of differential diagnosis. The second achievement is to integrate the developed 
relations as a new relational query engine for the Jena framework instead of its traditional 
SPARQL low-level query engine. This chapter terms the new Jena relational query engine as the 
DSO Crawler. The crawler is a component of a semantic web based model for differential 
diagnosis recommendation (Figure 3.2). Finally this chapter demonstrates the design and use of 
the various developed relational queries using several software engineering forms including 
screen shots, code snippets, block diagrams and sequence diagrams. These illustrations shed light 
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on the complexity of the development work behind the DSO crawler as well as the simplicity of 
using these relations by the clinicians for inference and decision making.  
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Chapter 4: Rule-based and Proximity-based Differential Diagnosis 
Recommenders 
 
A health provider's ability to make correct decisions regarding patient care is predicated on the 
correct identification of a patient's disease. However, the process of developing diagnostic 
certainty remains a challenging task despite an increasingly sophisticated array of available 
diagnostic modalities and techniques. Clinicians need support to integrate a broad range of 
findings from these tools along with a patient's symptoms and signs [Weiner, Pifer, and Williams 
2005]. This chapter develops a rule-based recommender as a utility: computer-aided differential 
diagnostic decision recommender using two new approaches. The first approach uses semantic 
web technologies based on flexible clinical pathways for guiding clinicians to provide test results 
for determining a diagnostic decision. This approach is called evidence-based approach. The 
second approach utilizes semantic web technologies for navigating clinical documents and 
mining clinical and diagnostic indicators. The second approach is called the proximity-based 
approach. This chapter demonstrates that the process of disease diagnosis requires both these 
approaches. 
4.1. Disease Diagnosis: Evidence-based vs. Proximity-based 
 
Clinical diagnosis is a process of finding and establishing the characteristics and type of an 
illness that a person is suffering from based on signs, symptoms and laboratory findings along 
with some predictive methods. Therefore the clinical diagnosis process is a complex, loosely 
defined, and it is a multistep process that requires analysis from different perspectives. 
Generally, clinical diagnosis involves a series of iterative steps [Reddy 2010]: 
 
1. Taking patient’s history 
2. Physical examination and systemic examination 
3. Analyzing the patient’s data 
4. Differential diagnosis (DDx) to yield provisional diagnosis 
5. Further examinations including laboratory examination 
6. Confirming or refuting the diagnosis (which requires going back to step 4) 
7. Starting the treatment 
 
Traditionally, this iterative process can be guided using medical decision support systems. 
Legacy medical diagnosis systems, in general, represent some sort of content-based 
recommendation system which analyzes symptoms, signs, and descriptions to identify diagnoses 
that are of particular interest to the clinician [Pazzani et al. 2007]. Many researchers 
implemented the content-based diagnostic principles via a decision support system or expert 
system that provides suggested actions for physicians based on individual patient characteristics 
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and established treatment protocols. Such systems may enable physicians to make better-quality 
decisions, and may enable patients to more consistently follow medical recommendations 
[Diamond 2004]. For this purpose, rules have been used to model whatever available knowledge 
that can help in the diagnosis process. Table 4.1 illustrates some of the notable legacy attempts in 
this direction. Most proposed systems cover a limited number of diseases and some utilize very 
restrictive types of diagnostic technologies such as direct deductive systems [Yeh et al .1990], 
decision trees [Wim et al. 2003] or neutral networks [Matsumoto et al. 2004].  
 
The rule-based representation for clinical diagnosis began gaining research support after the 
MYCIN [Buchanan and Shortliffe 1984] reported success during the early seventies. MYCIN is 
the name of a decision support system developed by Stanford University, built to assist 
physicians in the diagnosis of infectious diseases. The system (also known as an "expert 
system") would ask a series of questions designed to emulate the thinking of an expert in the 
field of infectious diseases. From the responses to these questions, the system gives a list of 
possible diagnoses with a probability attached to each possible diagnosis, as well as recommend 
treatment (i.e. it provides "decision support")38. The name "MYCIN" actually comes from 
antibiotics, many of which have the suffix "-mycin". In literature there are many other medical 
diagnosis systems that use rules (e.g. Easy Diagnosis [Martin 2004], INTERNIST-I [Kumar et 
al. 2009] and ONCOCIN [Wiederhold et al. 2001]). The specification of rule-based knowledge 
is a flexible way for designing medical recommendation systems. Rules are a way of intuitive 
knowledge representation for building intelligent systems.  Additionally, in the context of the 
semantic web initiative, the definition of a general rule interchange format (RIF39) has been 
established to enable distributed services for using rule-based knowledge from different sources. 
In general, a rule-based system uses a rule base to derive new facts from a given fact base or 
facts provided interactively by a user. However, surveys of the preferences of clinicians related 
to the use of such rule-based systems have identified the importance of the understandability of 
the reasoning used by these systems as an important factor for their acceptability [Teach and 
Shortliffe 1981].  
 
The research of these decision support recommendation systems has evolved from focusing on 
standalone systems where clinicians are expected to enter all the required information about 
patients, to focusing on systems integrated into clinical information systems (CIS) so to easily 
and automatically retrieve information about patients, and now most recently to focusing on 
service-oriented systems that are expected to be able to connect to CIS without being integrated 
into these systems. This latest research model saves clinicians from the tedious work of entering 
information about patients that were already entered into CIS, while also maintaining the 
independence of the decision support system from CIS with the advantage being adaptability 
across a wide range and varieties of CIS [Wright and Sittig 2008].            
                                                          
38
 http://neamh.cns.uni.edu/MedInfo/mycin.html 
39
 http://www.w3.org/2005/rules/wiki/RIF_Working_Group 
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Table 4.1: Notable Medical Diagnosis Expert Systems 
Medical diagnosis 
System 
Diagnosis Expert Area Knowledge 
Representation 
Reference 
MYCIN Antimicrobial selection 
for patients with 
bacteraemia 
or meningitis 
Rule-Based (BC) [Buchanan and Shortliffe 
1984] 
PIP  Renal disease Frame-Based [Pauker et al. 1976] 
INTERNIST-1 Internal Medicine Relational Database [Miller et al. 1982] 
ONCOCIN Clinical Oncology Rule-Based (BC) [Shortliffe et al. 1981] 
MDSS Diabetes Rule-Based (BC) [Shortliffe 1987] 
FuzzyDiagnose Six Diseases Fuzzy-Neural Net 
 
[Moein et al. 2008] 
MADHS 
 
Traditional Chinese 
Medicine 
 
Multiple Agents [Qiao Yang  Shieh 2008] 
                               BC means backward chaining or goal-directed reasoning. 
 
In this chapter, we will present our rule-based diagnostic system based on the notion of 
differential diagnosis (DDx) recommendation. Our system is composed of two cooperating 
disease diagnosis recommendation approaches. The first approach we call the Evidence-based 
DDx approach. Basically, rules are employed to represent clinical pathways40, which are used by 
the health care providers to describe the processes of disease diagnosis and treatment. The idea is 
to design an adaptive rule-based DDx recommender that can adapt to changes in clinical pathway 
knowledge. The recommender systematically guides clinicians, according to the diseases 
symptoms ontology (DSO), to identify possible diagnoses, and prompts clinicians, according to 
clinical pathways rules, to provide lab test results in order to determine a diagnostic decision. 
The second approach is called the Proximity-based DDx approach. It utilizes semantic web 
technologies for navigating, with the aid of the DSO and a patient ontology (PO), clinical 
documents to extract important clinical and diagnostic variables. To find data for these variables, 
it uses diagnostic data produced by the first approach as well as from sound diagnostic datasets. 
Data mining techniques will then be applied to the data in order reach a diagnostic decision. 
 
Both rule-based approaches employ challenging semantic web technologies which identify them 
as notable solutions for the problem of disease diagnosis. Both approaches build on our progress 
and methodologies developed in our previous chapters. Although clinicians may use either type 
to analyze a disease diagnosis case study, the evidence-based DDx recommendation approach 
must be the first analytic option in the absence of proper diagnostic datasets. In any case the 
evidence-based approach, when used frequently will generate more data that can be added to a 
dataset that will eventually grow to be used by the proximity-based approach. The evidence-
based and proximity-based approaches for DDx recommendation can cooperate to form an 
                                                          
40
 http://en.wikipedia.org/wiki/Clinical_pathway 
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overall DDx recommendation model. Results generated by the evidence-based DDx 
recommender can be used for prediction by the data mining algorithms of the proximity-based 
DDx recommender. On the other hand, data mining algorithms from the proximity-based 
approach generate rules that can be used to update the rule base of the evidence-based approach. 
Figure 4.1 illustrates our vision of developing a DDx recommender based on the two approaches. 
Figure 4.2 illustrates the overall architecture of our rule based DDx recommender. 
 
 
Fig. 4.1: The Integral Model of Evidence-based & Proximity-based DDx Recommendations 
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Fig. 4.2: Technologies of our DDx Rule-Based Recommender and their Connectivity 
 
Clinical pathways are the blueprint for a plan of care representing the best clinical practice for 
specified groups of patients with a particular diagnosis. They are a documented sequence of 
clinical interventions that help a patient with a specific condition or diagnosis move 
progressively through a clinical experience to a desired outcome. Predominantly, they are 
management tools, clinical audit tools and recommenders that are based on sound clinical 
information which may change with time [Audimoolam et al. 2005]. Clinical Pathways are 
thought to improve the quality of patient care and make a more efficient usage of health 
resources [Fernandez-Llatas et al. 2010, Every 2000]. 
In this chapter, we describe a new method for representing and reasoning based on clinical 
pathways. Our representation enriches the event/evidence-based clinical logs with information 
about disease indicators using information provided from our DSO ontology crawler (Chapter 3). 
Using the evidence-based approach, it will be possible to start with the full collection of diseases, 
and zoom-in to a small enough subset of diseases for direct inspection. The reasoning used in our 
approach employs a forward chaining dynamic strategy to confirm a disease diagnosis based on 
the provincially identified diseases suggested by the DSO ontology crawler. The clinical 
pathway rules, of the evidence-based approach, determine a diagnosis through a series of 
interactions with the clinician to recommend and elicit medical tests, procedures and other 
information needed from the patient record for proving a diagnosis recommendation.  The 
proximity rules, of our proximity-based approach, attempt to provide clinicians with approximate 
inferences about disease diagnosis since many of the signs and symptoms may involve fuzzy and 
incomplete concepts. In this direction, we rely on the power of knowledge discovery, available 
within the paradigm of data mining, from networks and graphs of symptoms, signs and lab tests. 
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Data mining knowledge discovery involves approximate predictions with variable degrees of 
certainty depending on the availability and quality of training data. Table 4.2 illustrates some of 
the standard algorithms used within the paradigm of data mining to perform diagnosis prediction 
(classification) as well as to provide new proximity diagnosis rules (association). Other attempts 
to define proximity rules include the use of fuzzy linguistic rules [Hasan et al. 2010], neural 
networks [Al-Shayea 2011] and predictive techniques based on data mining [Gorunescu 2007]. 
However, the diagnosis predictions based on these methods depend solely on static techniques 
that use the weights of the symptoms and rule order defined by the rule firing mechanism.  
 
Table 4.2: A Sample of Notable Data Mining Classification and Association Algorithms 
 
4.2. Incorporating Clinical Pathways for Medical Diagnosis Recommendation 
 
Clinical pathways are guidelines and recommendations for the treatment and management of 
diseases generated by a team of clinical professionals, with a clear clinical intention or goal – 
either to diagnose a disease, or to perform a treatment [Chen 2006]. Clinical pathways are 
designed for a group of patients with similar needs, and are very useful for differential diagnosis 
[Nikoskelainen 2005]. 
 
Clinical pathway knowledge is dynamic and requires continuous adaptation and customization in 
order to become easily usable by an adopting institution as a guideline for treating a group of 
patients. In this sense, clinical pathways require a reasoning engine that can cope with dynamic 
data [Alexandrou et al. 2009]. For this reason, traditional expert systems cannot easily be used 
for modeling clinical pathways as their knowledge representation (e.g. static rules) and reasoning 
(e.g. backward chaining) techniques rely on pre-built approaches and respond only to specified 
queries. One approach to cope with the dynamic nature of clinical pathways is to employ an 
innovative adaptive rule-based engine, which can handle the implantation of evolving clinical 
pathways knowledge into its rule base. By implantation we mean directly transferring clinical 
pathway knowledge into rules compatible with a particular adaptive rule-based system. 
Algorithm Java Version Type Description Reference 
C4.5 J48 Classification Decision Tree-based algorithm [Quinlan 1999] 
IREP JRIP Classification Rule-based algorithm [Cohen 1995] 
NaiveBayes NaiveBayes Classification Probabilistic classification 
algorithm 
[Domingos 1997] 
NBTree NBTree Classification A hybrid classification 
algorithm combining the 
Naive Bayes algorithm with 
any other classification 
algorithm which is decision-
tree based  
[Kohavi 1996] 
Apriori Apriori Association A classic algorithm for 
producing association rules 
[Agrawal 1994] 
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Another approach to integrating clinical pathways into medical decision support systems is to 
guide their dynamic variation through ontologies. There are attempts in their infant stage to 
generate an ontology-based approach for clinical pathways representation. Instead of directly 
translating clinical pathways into rules for a specific rule engine, ontologies can be constructed 
to represent clinical pathway knowledge in a standard and relational way. Then, the resulting 
clinical pathway ontology (CPO) is translated into rules that are compatible with a specific 
adaptive rule-based system. It is easy to convert ontology-based rules to knowledge 
representation specific to any rule engine. On the other hand, it is much more difficult to convert 
rules from one format into another. However, engineering, specifically designing and 
implementing, ontologies for clinical pathways is an important challenge [Chabalier et al. 2007, 
Ye et al. 2009]. The best notable ontology known to date is the KEGG Pathways41 database 
representing molecular dataset pathway maps used for biological interpretation of higher-level 
systemic function.  Lin [Lin 2009] attempted to develop such flexible clinical pathways by 
adding meta rules for updating a clinical pathway ontology. Many other researchers followed the 
same ontological approach [Chen et al. 2004, Chen 2006, Popescu et al. 2004, Ye et al. 2009, Hu 
et al. 2011, and Huang et al. 2011].  Another variation of the ontological approach is combining 
CPO along with SWRL42 (Semantic Web Rules Language) rules to handle exceptional scenarios 
in clinical pathway execution [Alexandrou et al. 2009, Alexandrou et al. 2008]. However, these 
research attempts have not discussed in detail the structure of their proposed clinical pathway 
ontologies. They have not provided the implementation of clinical pathway ontologies. In the 
absence of publicly available implementations of clinical pathways ontologies, the implantation 
approach represents the only viable approach for implementing clinical pathways. 
In this chapter, we are developing, as part of the evidence-based approach for disease diagnosis 
prediction, truly flexible clinical pathways using easily editable rules that can be updated 
frequently by the clinicians as well as the system developers. The rules we developed are from 
several clinical pathways for diabetes [Victoria Dept. of Health 2009], hypertension [NHS 2004], 
anemia [Goodnough et al. 2005], and calcemia. We call these rules the clinical pathways 
confirmation rules. The confirmation rules take their data from a relational patient database that 
stores and manages the dynamically changing clinical tests and data. The DSO ontology crawler 
assists in selecting the right group of confirmation rules. It does so by selecting the clinical 
pathway rules for diseases that show certain observed patient symptoms. Thus the confirmation 
rules are agile in two senses: the rule selection is directed by the DSO ontology, and the rules 
utilize data from a frequently changing clinical database. Figure 4.3 illustrates the evidence-
based DDx recommendation model. We call a rule engine based on dynamic updateable clinical 
pathways rules, and supported by diagnosis ontologies for context-aware reasoning an evidence-
based DDx recommendation model. The word "evidence" refers to the clinical pathway. 
                                                          
41
 http://www.genome.jp/kegg/pathway.html#global 
42
 http://www.w3.org/Submission/SWRL/ 
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Our DSO and PO ontologies contribute significantly to our evidence-based DDx 
recommendation model. As new clinical data arrives, the two ontologies select only data relevant 
to the diagnosis of a specific case. They then feed the selected data to the patient database, which 
in turn passes the data to the rule engine. Upon receiving the selected data, the rule engine would 
then compare it to the clinical pathway confirmation rules. This process considerably enhances 
the reasoning and data selection mechanisms. It optimizes the rule firing process by refining the 
data input to only include data relevant to a specific diagnostic case.  
The intelligence of our clinical pathways and ontology driven evidence-based recommender is 
complemented by the interactivity with clinicians. First of all, interactivity with the physician is 
essential for any medical recommendation system. During the start of the differential diagnosis 
process, our ontology driven recommender guides the clinician to prepare a list of possible 
diagnoses. As pointed out in section 3.2, our DSO crawler provides clinicians with relational 
queries that guide them in preparing a list of possible diagnoses, and in choosing the right 
clinical pathways. When the ontology driven recommender proposes a list of possible diagnoses, 
the clinician should be able to order the system to rule out one or some of the possible diseases, 
include diseases not given by the recommender or even select one of the diseases as the 
diagnosis based on knowledge not available to the system. This iterative interaction, in the 
process of differential diagnosis, between the clinician and the recommender greatly improves 
the chances of accurate diagnosis.   
As the system guides the clinician along the clinical pathways of a disease, it asks the clinician 
for information such as test results and based on that information decides to move closer towards 
a diagnosis by taking one of the pathways.  The element of interactivity here is that the clinician 
is given the power to use his/her cognition to approve or disapprove each rule-based decision, 
taken by the recommender, to select one pathway or another in the clinical pathways. If the 
clinician approves a decision, the recommender moves forward along the pathway. If the 
clinician disapproves a decision, the physician selects an alternative path/decision and the 
recommender moves forward with the diagnosis process based on this decision. The clinician 
should able to update, override, or define exceptions to the rules used by the recommender based 
on medical experience or interacting with the recommender. A key interaction is that each 
diagnosis made by the evidence-based recommender must be confirmed by the clinician. 
Actually, our evidence-based component of the DDx recommender will not be able to update the 
data files of the proximity-based recommender (described in section 5) before the authentication 
and confirmation of the clinician. The defining criteria for interactivity is to engage the physician 
to make use of his/her cognitive knowledge in the diagnosis process better yet to learn from 
his/her heuristic knowledge, learn from clinical data, and to verify medical diagnosis decisions. 
This interactive iterative process of differential diagnosis allows the recommender to become 
dynamic, context-sensitive, and clinician-centric as well as to yield adaptive and evolving 
clinical pathways. This added value process sets the DDx recommender apart from traditional 
static expert systems or clinical support systems. Actually adding the interactivity feature to the 
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clinical pathways is very important as many of the diseases pathways are increasingly complex 
and the clinicians are overwhelmed with information and have no time to spend researching 
them. Without the element of interactivity, clinicians may send a patient down the wrong path 
which can result in less than optimum clinical outcomes. 
Figure D1, a sequence diagram, in Appendix D is another way to illustrate the evidence-based 
diagnosis recommendation model. 
 
Fig 4.3: Illustration of Evidence-based Diagnosis Recommendation Model 
 
4.3. Incorporating Proximity Rules for Medical Diagnosis Recommendation 
 
Many techniques have been proposed to build disease diagnosis models using the notion of 
proximity. Table 4.3 lists some of the notable attempts: 
 
Table 4.3: Proximity Models Used in Disease Diagnosis Recommendation 
Model Name Reference 
Fuzzy Logic [Adlassnig 1980] 
K-Nearest Neighbour Neural 
Network 
[Peterson 2009] 
Naïve Bayes Classifiers [Isam et al. 2007] 
Rough Sets [Anderson 2007] 
Confidence Association Rules [Gamberger et al. 1999] 
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In all these models except confidence association rules (data mining), complex mathematical 
derivations that cannot easily be employed for the process of differential diagnosis are needed. 
To support a medical expert in discovering clinically useful knowledge form ill-defined 
attributes and missing values as in most cases in disease diagnosis, one needs to avoid strict 
mathematical formulation requiring an exact number of parameters. With confidence association 
rules, however, proximity is introduced at a simplistic level using probabilistic thresholds 
attached to each knowledge rule or what is called confidence factors. These factors represent 
static indicators of the likelihood of a rule's applicability and success. Estimating these factors is 
a challenging research problem as there are no universal static factors that can fit all types of 
diagnostic problems [Balcázar 2009].  
 
With data mining one can build a model according to the continuous change in the clinical 
process. However, the classical data mining techniques require proper understanding of the data 
in advance [Famili and Ouyang 2003]. Therefore, the data mining process will not be effective 
without the availability of a training dataset as well as clear knowledge of the data hierarchies. 
For the purpose of introducing knowledge about the data hierarchies, there are some recent 
research attempts to use ontologies in directing the prediction of the data mining techniques 
[Brisson and Collard 2008]. However, there is no ontology-driven data mining approach for 
disease diagnosis recommendation. For this purpose, this chapter introduces a new method for 
extracting proximity rules driven by a patient ontology that we developed from generic patient 
data records. The use of our patient ontology will help clinicians to extract relevant datasets from 
any available silo of patient records. Our patient ontology contains 241 major classes. These 
classes represent various patient attributes divided in four major categories: patient medical 
condition, patient allergies, patient medical history, and patient information (age, height, etc.). 
The medical condition category includes condition name, associated symptoms and lab tests. The 
patient medical history includes history of hospitalization, history medical conditions, family 
medical history, and any record of patient drinking or smoking. The is an OWL type where we 
published an online version of it at our university flash server 
(http://flash.lakeheadu.ca/~omohamme/PatientOntology.owl). Figure 4.4 provides a snippet of our 
patient ontology.  
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Fig. 4.4: Snippet of Patient Ontology as viewed by Protégé Ontology Editor 
 
Clinicians need to extract, from patient data records, the relevant symptoms and test data for a 
certain diagnostic case. Using the proximity-based DDx recommendation approach, the patient 
and DSO ontologies will select relevant patient attributes, lab test attributes, and certain possible 
diseases under consideration for diagnosis. Training data for the selected clinical variables will 
be then used by data mining classification algorithms to learn diagnosis trends. After that these 
classification algorithms use the learned diagnosis trends to predict the diagnosis for provided 
test data (i.e. new clinical data cases that require diagnosis). Note that learned diagnosis trends 
are only valid predictors of diagnosis for test data, when the clinical attributes of the test data 
largely match the clinical attributes of the training data. The association algorithms use the 
training data to learn rules relating diagnosis variables (clinical attributes) and other diagnosis 
variables, and rules relating diagnosis variables and possible diagnoses. These newly generated 
rules can be used to make diagnosis predictions/recommendations. These newly generated rules 
can also be added to, or can override or update clinical pathway rules from the evidence-based 
approach. Using the proximity-based DDx recommendation model, clinicians can ask the 
following queries in order to conduct both association and classification data mining processes: 
 
1. Find whether or not a patient has a certain disease based on the patient's demographic 
information, and lab test results. (Classification using Test Data) 
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2. Find associations/rules describing the relationship between a patient's demographic 
information and lab test results on one hand, and a certain possible diagnosis on the other 
hand.  (Association Rules) 
 
Figure 4.5 illustrates our vision of employing an ontology-driven data mining (proximity) 
approach for providing DDx recommendations. The approach uses classification algorithms to 
predict diagnosis for new test cases based on some available training data. Also based on the 
available training data, it uses association algorithms to find rules for diagnosis recommendation 
for the diagnosis cases in the training data.  
 
Fig. 4.5: Ontology-Driven Data Mining (ODDM) Model for DDx Recommendation 
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Figure D2, a sequence diagram, in Appendix D is another way to illustrate the proximity-based 
diagnosis recommendation model. 
Clinicians use the ODDM DDx recommender to obtain diagnostic recommendations based on 
previously available training data. The ODDM DDx recommender attempts to construct a model 
for the training data (e.g. Decision Tree or Association Rules) and uses this model to determine 
the diagnosis recommendation for the new cases. Interaction with clinicians is crucial for this 
model. Interaction with the clinician in this model is done through data. Clinicians provide 
diagnosis data to the proximity-based DDx recommender, which uses to make diagnosis 
predictions and rules through its data mining algorithms. Once a prediction is made by the 
recommender, the prediction is shown to the clinician which decides to either accept or modify 
(or correct) the recommendation. In either case, the diagnosis accepted by the clinician will be 
added to the database used by the recommender. Every time a confirmed diagnosis case is added 
to the database, the knowledge base of the recommender widens allowing it to find more 
accurate trends among the diagnosis cases and to learn from the knowledge of the clinicians.        
Our ODDM DDx recommender stores the test data in a format that is identical to the training 
dataset format. We chose the ARFF format which defines clearly the data and its description (i.e. 
metadata) in one file. The data mining algorithm is the mechanism that creates a data mining 
model. To create a model, an algorithm first analyzes a set of training data (dataset) and looks for 
specific patterns and trends. The algorithm uses the results of this analysis to define the 
parameters of the mining model. These parameters are then applied across the entire test data to 
extract actionable patterns and detailed statistics. The mining model that an algorithm creates can 
take various forms including43: 
 
 A set of rules (e.g. describe how products are grouped together in a transaction) 
 A decision tree (e.g. predicts whether a particular customer will buy a product) 
 A mathematical model (e.g. forecasts sales) 
 A set of clusters that describe how the cases in a dataset are related 
 
There are many available Java Data Mining APIs (e.g. Oracle JDM44, JDMP45, Weka46 ) which 
we can incorporate into our DDx recommender. However, we chose the Weka API [Bouckaert et 
al. 2010] because it is open-source and their data mining classes can be incorporated in any Java 
implementation like our DDx recommender. Weka is a collection of machine learning algorithms 
for data mining tasks. The algorithms can either be applied directly to a dataset or called from 
your own Java code. Weka contains tools for data pre-processing, classification, regression, 
clustering, association rules, and visualization. It is also well-suited for developing new machine 
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 http://www.globaldataconsulting.net/bi-stickers/microsoft-data-mining-algorithms 
44
 http://download.oracle.com/docs/cd/B28359_01/datamine.111/b28131/java_api.htm 
45
 http://www.jdmp.org/documentation/api-docs/ 
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 http://www.cs.waikato.ac.nz/ml/weka/ 
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learning schemes46. In Appendix A, we show how we used the Weka API for data mining work 
as part of our proximity-based DDx recommendation process.  
 
4.4. Selecting a Rule Engine for Medical Diagnosis Recommendation 
 
Many clinical applications have to deal with the dynamic changes of clinical pathways. A 
solution is to have a rule engine, which is basically a set of tools that enable clinicians and 
developers to build decision logic based on clinical data. The rule engine applies rules and 
actions as defined by end users without affecting how the application runs. The application is 
built to deal with the rules, which are designed separately. Examples of rule engines include 
Drools47, Fair Isaac Blaze Advisor48, ILOG JRules49, and Jess50, to name a few. The lack of 
standards, however, may be a major factor in deterring businesses from using rule-based 
applications. Most rule engines have proprietary APIs, making them difficult to integrate with 
applications. If a rule engine is no longer supported and the business decides to adopt another 
rule engine, most of the application code will need to be rewritten. However, the JSR 94 is an 
attempt to standardize rule engine implementations for Java technology. The four rule engines 
mentioned earlier support JSR 94. JSR 94 provides guidelines for the rule administration and 
rule runtime APIs, but it defines no guidelines for what language to use to define the rules and 
actions51.  
 
The underlying idea of a rule engine is to externalize the business or application logic. A rule 
engine can be viewed as a sophisticated interpreter of if-then statements. The if-then statements 
are the rules. A rule engine is a great tool for efficient decision making because it can make 
decisions based on thousands of facts quickly, reliably, and repeatedly52. 
 
Among the four notable JSR 94 compatible rule engines, we choose Drools. Drools is an open 
source rules engine, written in the Java language, which uses the Rete algorithm53 to evaluate the 
rules you write. Drools rule engine lets you express your business logic rules in a declarative 
way. You can write rules using a non-XML native language that is quite easy to learn and 
understand. Also you can embed Java code directly in a rules file, which makes Drools rules 
even more expressive and flexible.  
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 http://www.jboss.org/drools 
48
 http://www.w3.org/2004/12/rules-ws/paper/55/ 
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 http://logic.stanford.edu/POEM/externalpapers/iRules/WP-JRules50Strengths.pdf 
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4.5. The Drools Rule Engine 
 
With many traditional programming-based rule engines, complex rules are difficult to automate, 
especially when a single change to a rule can impact hundreds of rules and processes. Drools 
enable us to accurately automate and change even the most complex rules with relative ease, and 
integrate seamlessly into the Java environment. 
 
4.5.1 Using the Drools Rule Engine 
 
As mentioned in the previous section, using a rule engine can significantly reduce the complexity 
of components that implement the business-rules logic. Actually an application that uses a rules 
engine to express rules using a declarative approach has an even a higher chance of being more 
maintainable and extensible than one that doesn't19. With Drools developers and business users 
alike are able to implement the complex business logic for their application in a declarative 
manner [Olivieri 2008]. Drools examine objects to find patterns and uses rules that describe 
these patterns to invoke certain actions54. 
 
Drools is a reasoning engine that includes a forward chaining rule engine with a declarative form 
of rule representation. For the purpose of this thesis, we use the JBoss Rules Workbench IDE as 
a tool to write and test the rules. The JBoss Rules workbench is delivered as an Eclipse plugin, 
which allows you to author and manage rules from within Eclipse.  
4.5.2 Drools Rule Firing Mechanism 
Since Drools is a forward chaining rule engine, it reacts to incoming lab test data by checking 
rules that might fire and creates other data or to signal diagnosis. Figure 4.6 illustrates the 
general concept behind Drools rule firing mechanism. The firing mechanism requires the 
creation of a database and interface that allows clinicians to enter medical test data results. The 
rule firing mechanism is responsible to check dynamically if there is any update to the database 
which may trigger rules to fire. In the following details below we illustrate how we created the 
database and the dashboard for inserting medical test results by the clinicians. 
                                                          
54
http://www.cisco.com/en/US/docs/net_mgmt/active_network_abstraction/3.5.1/administration/user/guide/rul
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Fig. 4.6: Rule Firing Mechanism in the Evidence-Based Disease Diagonsis Recommender 
 
The Database for Medical Lab Test Results 
 
In our implementation we used the Apache Derby database55 to create a modern database 
management system for storing medical test data results. However, the database uses its own 
server and thus will not affect the performance of our DDx recommender system. 
 
The goal of our database is to link diseases to their corresponding lab tests. In other words for 
each disease define the lab tests needed to reach a diagnosis. First, we create a table (Table 4.4) 
of diseases chosen for our prototype. Second, we create a table (Table 4.5) of lab tests for the 
diseases defined in table 4.4. Finally, another table is needed for individual test result items for 
each lab test in table 4.6. Other tables are created to connect diseases to lab tests, and lab tests to 
test results.   
Table 4.4: Diseases Table 
 
Table 4.5: Medical Lab Tests 
 
 
 
 
                                                          
55
 http://db.apache.org/derby/ 
 68 
Table 4.6: Test Results 
 
 
Inserting Test Results 
 
When test results need to be added to the database, one needs to consult the database and insert 
the result at the right place. For example if we want to insert a test result into table 4.6 for the 
fasting plasma glucose test with the amount of 130 mg/dL, we need to consult the database and 
added to the table. The resulting updated table is shown in Table 4.7. When an update occurs to 
the database, the drools rule engine fires the medical rules, which in turn take the test results and 
make decisions regarding diagnosis recommendations. Actually, the rules engine is notified of an 
update to the database and will fire the matching rules. Table 4.8 illustrates the result of this 
update. As can be seen, the test results table is updated to include the diagnosis result of positive 
(Diagnosis = 1) in the test result entry of 130 mg/dL fasting plasma glucose (FPG). This means 
a test result of 130 mg/dL FPG indicates a positive diagnosis of diabetes.    
Table 4.7: Updated Test Results Table 
 
Table 4.8: Updated Test Results Table 
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In the case of this example, the Drools rule below (Figure 4.7) will be fired. The rule will 
indicate a positive diagnosis of diabetes. 
rule "3 - When a fasting plasma glucose test is perfomed to diagnose 
Diabetes, then a result higher than 125 mg/dL or higher indicates positive 
diabetes" 
 
when 
 
 t:Test(testName == "Fasting plasma glucose") 
 d:Disease(diseaseName == "diabetes mellitus" || diseaseName == 
"diabetes mellitus type 2" 
    || diseaseName == "diabetes mellitus type 1" || diseaseName == 
"diabetes" || diseaseName == "Diabetes") 
  
 tr:TestResult(id == 1 && unit == "mg/dL" && description == "glucose - 
FPG" && amount > 125) 
 
then 
 tr.setNormal(false); 
 tr.setDiagnosis(true); 
 tr.setResult("positive test for diabetes"); 
end 
Fig. 4.7: Drools rule Fired in this Example 
 
The two pieces of code below fire a state full knowledge session. In a state full knowledge 
session, all of the medical rules are examined and those rules which conditions are satisfied are 
fired in a forward chaining cycle. Figure 4.8 shows the main program, which fetches all the 
diseases, tests, and test results from the database tables above (Tables 4.4-4.8). Then these 
objects are passed to the rule firing function (line 29, figure 4.8). In figure 4.9, in line 21 the 
rules for the rule firing session are fetched from the drools rule file "medrules.drl" (see 
Appendix A for this rules file). In lines 28 & 29, these rules are fed into a state full knowledge 
session for rule firing. In a state full knowledge session for rule firing, when the condition for 
one rule is met and the rule fires taking some action or making some conclusion in the process, 
that action or conclusion can be used to satisfy the conditions for other rules. This process 
continues iteratively until there are no more rules to fire. This is basically the forward chaining 
process56 57. After the rule firing session ends, the main program updates the database records 
(line 35, figure 4.8) to persist the conclusions made by the rules fired. The medical rules react 
with the disease, test, and test result objects to make conclusions about diagnosis.        
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 http://en.wikipedia.org/wiki/Forward_chaining 
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Fig. 4.8: Main Program Firing Medical Rules 
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Fig. 4.9: Drools Rule Engine - State full Knowledge Rule Firing Session  
4.6. Medical Data & Data Pre-processing for Proximity-Based Diagnosis 
Recommendation 
 
4.6.1 Selecting Suitable Medical Dataset for Proximity-Based Diagnosis Recommendation 
Data Mining approaches are used to extract meaningful information from data stored in large 
databases. Medical databases/datasets has been used so far by data mining processes in the area 
of disease diagnosis only for disease prediction as such a task becomes important in a variety of 
applications such as health insurance, tailored health communication and public health. Disease 
prediction is usually performed using publically available datasets such as HCUP58, NHANES59 
or MDS60 that were initially designed for health reporting or health cost evaluation but not for 
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disease prediction [Popescu and Khalilia, 2011]. Healthcare Cost and Utilization Project (HCUP, 
pronounced "H-Cup") is a family of health care databases and related software tools and 
products developed through a Federal-State-Industry partnership and sponsored by the Agency 
for Healthcare Research and Quality (AHRQ). HCUP databases bring together the data 
collection efforts of State data organizations, hospital associations, private data organizations, 
and the federal government to create a national information resource of patient-level health care 
data. HCUP includes the largest collection of longitudinal hospital care data in the United States, 
with all-payer, encounter-level information beginning in 1988. These databases enable research 
on a broad range of health policy issues, including cost and quality of health services, medical 
practice patterns, access to health care programs, and outcomes of treatments at the national, 
State, and local market levels61. The National Health and Nutrition Examination Survey 
(NHANES) dataset is a collection of studies designed to assess the health and nutritional status 
of adults and children in the United States26. The Long Term Care Minimum Data Set (MDS) is 
a standardized, primary screening and assessment dataset of health status which forms the 
foundation of the comprehensive assessment for all residents of long-term care facilities certified 
to participate in Medicare or Medicaid. The MDS contains items that measure physical, 
psychological and psycho-social functioning. 
 
The HCUP NIS dataset represents data of hospital inpatient stays, containing data from about a 
thousand hospitals that constitute a 20% stratified sample of US community hospitals. There is 
one dataset for each year from 1988 to 2009 each containing from five to eight million stays. We 
will mainly be using data from the NIS core database for our data mining work within our 
proximity-based DDx recommendation model. We obtained the license for the NIS 2009 data 
from the HCUP Central Distributor under a data use agreement, and a licence number for use of 
the data given to us after taking for a 15-min mandatory online course on proper use of the data.  
 
For each NIS data record (i.e. hospital visit), there are 126 clinical and nonclinical data 
elements62. Nonclinical elements include patient demographics, hospital identification, 
admission date, zip code, calendar year, total charges and length of stay. Clinical elements 
include procedures, procedure categories, diagnosis codes and diagnosis categories. Every record 
contains a vector of 15 diagnosis codes (1 primary diagnosis and 14 secondary diagnoses). The 
diagnosis codes are represented using the International Classification of Diseases, Ninth 
Revision, Clinical Modification (ICD-9-CM)63. The International Statistical Classification of 
Disease is designed and published by the World Health Organization (WHO). The ICD-9 codes 
are alphanumeric codes, 3-5 characters long and used by hospitals, insurance companies and 
other facilities to describe health conditions of the patient. Every code represents a disease, 
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condition, symptom, or cause of death. There are numerous codes, over 14,000 ICD-9 codes and 
3,900 procedures codes. 
 
 The NIS 2009 archive, containing data only from year 2009, is divided into four distinct 
databases [Concaro et al.]: 
 
(1) The Inpatient Core database, containing the inpatient discharge-level data; no patient 
identifier is provided in such data set, so that no patient level analysis is allowed; 
(2) The Hospital Weights database, recording data and attributes concerning the sampled 
hospitals; 
(3) The Disease Severity Measures database, containing information from different sets of 
disease severity measures concerning the inpatient stays; 
(4) The Diagnosis and Procedure Groups database, containing data elements and attributes 
concerning diagnosis and procedures included in the Inpatient Core records. 
 
4.6.2 Data Pre-processing, Transformation and Filtering 
 
In order to assist our proximity-based DDx recommendation, two stages of data pre-processing 
need to be done. The first stage of the data pre-processing we call Java pre-processing and is 
done using Java programs. The second stage we call Weka pre-processing and is done using the 
Weka data pre-processing tab. The first stage involves arranging the data into an ARFF file that 
can be read by Weka. With the NIS data, this involves several steps. First, the data is first 
converted into SAS format (table format) from its native ASCII format. Then, using a Java API 
called SassyReader64 we retrieve data from the SAS table format. Then using Java’s file writing 
classes and methods, we arrange the data into ARFF format. We select certain attributes we are 
interested in from the NIS data. Then, we create a header where each selected data variable is 
determined as attribute or class, given a name, and a type. Then the data is arranged into (patient) 
records with each variable value separated by a comma. The diagnosis data is encoded using 
ICD-9-CM. To decode the diagnosis information, a list of ICD-9-CM diagnosis codes and their 
corresponding diagnosis is needed. This list is provided at the NIS website65. A Java program 
uses this list to decode the diagnosis information and store it into the ARFF data file. Some string 
manipulation is also required. This is done in several stages. The following diagram (Figure 
4.10) clarifies this process. 
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Fig. 4.10: NIS 2009 Data Format Conversion, Decoding, and Querying (Pre-processing) 
 
The last data preparation that we need to perform involves filtering relevant data models for 
diagnosis. Since we are concentrating our efforts on certain types of diseases, we developed five 
filters to extract relevant data from NIS. Tables 4.9 to Table 4.13 provide the filtered format for 
four main diseases (2 Tables for Type 2 Diabetes, 1 for Anemia, 1 for Hypertension and 1 for 
Calcemia). 
Table 4.9: Diabetes Data 1 (Number of records = 63) 
Variable Name Variable Type 
(Attribute or 
Class) 
Possible Values for 
Variable 
Description 
ageYears Attribute 0-125 years Patient's age in years 
ageDays Attribute 0-365 days Patient's age in days if patient is 
less than a year old 
Gender Attribute 0.0 (Male), 1.0 (Female) Patient's gender 
fasting_plasma_glucose Attribute All real numbers in the 
range 60-150 mg/dL 
Glucose levels in the patient's 
blood 
prim_diag Class Normal, Diabetes Type 2 Whether the patient has type 2 
diabetes or not  
 
Table 4.10: Diabetes Data 2 (Number of records = 768) 
Variable Name Variable Type 
(Attribute or Class) 
Possible Values for Variable Description 
Preg Attribute 0-17 times Number of times pregnant 
Plas Attribute 0-199 mg/dL Plasma glucose 
concentration in an oral 
glucose tolerance test 
Pres Attribute 0-122 mmHg Diastolic blood pressure of 
the patient 
Skin Attribute 0-99 mm Triceps skin fold thickness 
Insu Attribute 0-846 mu U/ml 2-Hour serum insulin 
 
Mass Attribute All real numbers between 0-67.1 Body mass index (BMI) 
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Pedi Attribute All real numbers between 0.078-
2.42 
Diabetes pedigree function 
Age Attribute 21-81 years Patient’s age in years 
Diagnosis Class 0 (Normal), 1 (Diabetes) Whether a patient has 
diabetes or not 
 
Table 4.11: Anemia Data (Number of records = 117) 
Variable Name Variable Type (Attribute 
or Class) 
Possible Values for 
Variable 
Description 
ageYears Attribute 0-125 years Patient's age in years 
ageDays Attribute 0-365 days Patient's age in days if 
patient is less than a year 
old 
Gender Attribute 0.0 (Male), 1.0 (Female) Patient's gender 
Rbc Attribute All real numbers in the 
range 25-49 % 
Percentage of red blood 
cells in the blood 
Haemoglobin Attribute All real numbers in the 
range 7.7-17.2 mg/dL 
Amount of hemoglobin in 
the blood 
prim_diag Class Normal, Anemia Whether a patient has 
anaemia or not 
 
Table 4.12: Blood Pressure Data (Number of records  = 834) 
Variable Name Variable Type 
(Attribute or Class) 
Possible Values for 
Variable 
Description 
ageYears Attribute 0-125 years Patient's age in years 
ageDays Attribute 0-365 days Patient's age in days if 
patient is less than a year 
old 
Gender Attribute 0.0 (Male), 1.0 (Female) Patient's gender 
systolicBloodPressure Attribute All integers between 60-169 
mmHg 
Systolic blood pressure 
of a patient 
diastolicBloodPressure Attribute All integers between 40-119 
mmHg 
Diastolic blood pressure 
of a patient 
prim_diag Class Hypotension, Normal, 
Hypertension 
Whether a patient's blood 
pressure is low 
(Hypotension), normal, 
or high (Hypertension) 
 
Table 4.13: Calcemia Data (Number of records = 21) 
Variable Name Variable Type (Attribute 
or Class) 
Possible Values for 
Variable 
Description 
ageYears Attribute 0-125 years Patient's age in years 
ageDays Attribute 0-365 days Patient's age in days if 
patient is less than a year 
old 
Gender Attribute 0.0 (Male), 1.0 (Female) Patient's gender 
calcium_levels Attribute All real numbers between Calcium level in a patient's 
 76 
7.8-13.4 mg/dL bloodstream 
prim_diag Class Hypocalcemia, Normal, 
Hypercalcemia 
Whether the patient has 
low calcium levels in the 
bloodstream 
(Hypocalcemia), or normal 
levels, or elevated levels 
(Hypercalcemia) 
 
The second stage basically involves using Weka filters. Specifically, we use the discretize filter 
to transform continuous data variables in discrete variables. This is needed for the association 
algorithms to be able to analyze data.                    
 
4.7. Weka Data Mining Tool for Proximity-Based Diagnosis Recommendation 
 
The Weka environment66 (Bouckaert 2010), developed by the University of Waikato in New 
Zealand67, is a collection of machine learning algorithms for data mining tasks. Weka contains 
tools for data pre-processing, classification, regression, clustering, association rules, and 
visualization. The Weka environment consists of two parts: a GUI interface and a Java API.  The 
Java API is the engine Weka runs on as all the machine learning algorithms used by Weka are 
implemented in Java. The programmer can use the Java API to create simple interfaces to allow 
novice users, with little knowledge of data mining, to conduct data mining operations on their 
data. The results should reveal interesting trends in the data displayed in a way the novice user 
can understand. On the other hand, the GUI interface allows users to visualize and conduct 
filtering operations on data, apply different classification, regression, clustering, and association 
rules algorithms, and configure algorithm parameters. This allows the advanced user to conduct 
several experiments on a dataset to extract various trends. In this chapter, we will be using the 
GUI interface to show several data mining operations for proximity-based diagnosis 
recommendation. In this next chapter, we will be showcasing the Weka Java API as part of the 
prototype.           
4.8. Testing the Proximity-Based Diagnosis Recommender 
 
Since the Weka environment is easy to learn, clinicians may use the Weka GUI tool to conduct 
various pre-processing, classification, regression, clustering, association rules, and visualization 
operations on the medical data prepared in ARFF format. Appendix A illustrates the usage of 
Weka GUI toolkit for classification and association. In the next chapter (Chapter 5) instead of 
using Weka GUI, we are going to use an alternative approach where our prototype will take 
advantage of the Weka Java API. Appendix B lists diagnosis predictions for data records in 
tables 4.10-4.13 obtained using various classification algorithms provided by Weka. Appendix 
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C lists diagnosis rules for data records in tables 4.10-4.13 obtained using the Apriori association 
algorithm provided by Weka. Both the Weka GUI and Weka API were used to obtain the results 
in Appendices B & C. 
4.9. Validation of Evidence & Proximity-based DDx Recommendations 
Our overall DDx recommendation model allows clinicians to use both the evidence-based and 
proximity-based DDx recommenders for assistance in diagnosing a specific patient's case. In rare 
cases, both recommenders for a specific patient's case may provide different diagnosis results. 
This is due to the fundamental difference between the two recommenders. As explained earlier, 
the evidence-based DDx recommender reaches a diagnosis decision based on applying clinical 
pathways rules to the data of the patient case under investigation. On the other hand, the 
proximity-based DDx recommender relies on data mining algorithms to extracts rules from data 
of previous cases. These proximity rules are then applied to the data of the patient case under 
investigation in order to obtain a diagnosis. Consequently, the diagnosis results of the two 
recommenders may be different in some cases especially if the datasets used by the data mining 
algorithms of the proximity-based DDx recommender are not large and representative. If the 
datasets are representative, we expect that both recommenders’ diagnosis results will most likely 
correlate. 
 In cases of differences in the predictions of the two recommenders, it is up to the clinician to 
examine both results and make his/her own decision about the patient’s case. The clinician may 
choose one of the recommender’s results or decide on a third result. The result indicated by the 
clinician is saved to the patient database. Both recommenders benefit from this process. A new 
confirmed diagnosis is added to the proximity-based DDx recommender's training dataset, which 
will help improve its accuracy of prediction. The new confirmed case would also update the set 
of proximity (association) rules of the specific disease that was under investigation. In the overall 
DDx recommendation model, the updated proximity rules are compared to the clinical pathway 
rules of the evidence-based recommender. In the case there are any differences between the two 
rule sets, the clinician would be allowed to compare these differences in the two rule sets. For 
each difference, the clinician can decide to support the proximity-based rules or the clinical 
pathways rules, or the clinician can also decide to support neither. If the clinician supports 
neither, he/she can write a new rule to settle the difference. The overall DDx recommender 
would replace the rules in both rule sets with the new rule written by the clinician. This is the 
spirit of our overall DDx recommendation model which is to give the clinician the power to 
make the final diagnosis decisions.  
4.9.1 Evidence-based vs. Proximity-based Rules Comparison 
 
In this section, we will examine a number of rule pairings. These rule pairings represent 
equivalent evidence-based and proximity-based rules. On the one hand, there is the evidence-
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based rule(s) that describe a certain condition, and on the other hand there is proximity-based 
rule(s) that describe the same condition. By describe the same condition we mean that they refer 
to the same variable(s)/attribute(s) in their condition sections. So we have a pair of rules, and we 
call them equivalent because they describe the same condition. 
 
We will look at the following two listings: 
 
Both the evidence-based rule (listing 4.2) and the proximity-based rules (listing 4.3) refer to the 
same attribute (fasting plasma glucose) in their conditions sections. Therefore, these two rules 
are said to be equivalent but not exactly equal. The evidence-based rule says that if the fasting 
plasma glucose is less than 109.8 mg/dL then this should be considered normal. On the other 
hand, the proximity rules 7 & 17 (see listing 4.3) have the combined effect of indicating that if 
the fasting plasma glucose is less than 76.6 mg/dL then this is considered a normal result. Of 
course here the evidence-based result is the most accurate since it is based on prior medical 
knowledge (clinical pathways) while the proximity-based result is based on only 64 patient 
cases. It seems that significantly more patient cases are required to achieve a more accurate 
result. We say this because if we compare the proximity-based rules with the evidence-based rule 
we find a 30% error rate with the maximum normal FPG used by the proximity-based rules. If 
we look at the equivalent rules that check for the abnormal/diabetic FPG we find that the 
proximity-based rule (see listing 4.5), based on the same 64 patient cases, is closer to the 
evidence-based rule (see listing 4.4). The evidence-based rule states that if the FPG test result is 
higher than 125 mg/dL then the result indicates diabetes, while the proximity-based result states 
that an FPG result higher than 139 mg/dL indicates diabetes. The proximity-based rule here has 
an error rate of 17%. 
 
However, we have found more encouraging results in our investigation of proximity-based 
association rules. We used a table of more numerous hypertension patient cases (840 patient 
cases) where patients underwent blood pressure testing and the results were either classified as 
normal, hypertensive (high blood pressure), or hypotensive (low blood pressure). The proximity-
based rules produced by the association algorithm from the hypertension patient cases are more 
in line with the evidence-based rules based on the clinical pathways of hypertension. For 
example, the evidence-based rule in listing 4.6 states that a diastolic blood pressure of more than 
90 mmHg is considered hypertensive. The corresponding equivalent proximity rules in listing 4.7 
state that a diastolic blood pressure of more than 87.4 mmHg is considered hypertensive. The 
difference in the maximum normal diastolic blood pressure is only 3%. The effect is that these 
rules validate each other, and the proximity-based process is successful at producing accurate 
rules.  
 
A full table comparing all the equivalent evidence-based and proximity-based rule sets is 
presented in Appendix E. Table E1 provides a comparison of equivalent proximity and 
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evidence-based rule sets. The accuracy of the proximity-based rules as a function of the number 
of known patient cases available to the association algorithm is provided in Table E2 and 
graphed in Figure E1.                      
 
rule "1 - If a fasting plasma glucose test is performed to diagnose Diabetes, 
then a result 109.8 mg/dL or less indicates negative diagnosis or normal 
glucose levels" 
 
when 
 
 t:Test(testName == "Fasting plasma glucose") 
 d:Disease(diseaseName == "diabetes mellitus" || diseaseName == 
"diabetes mellitus type 2" 
    || diseaseName == "diabetes mellitus type 1" || diseaseName == 
"diabetes" || diseaseName == "Diabetes") 
  
 tr:TestResult(id == 1 && unit == "mg/dL" && description == "glucose - 
FPG" && amount <= 109.8 && amount > 0) 
 
then 
 tr.setNormal(true); 
 tr.setDiagnosis (false); 
 tr.setResult ("Normal healthy glucose levels, no evidence of 
diabetes"); 
end 
Listing 4.2: Clinical Pathways Evidence-based Rule for Diabetes 
 
7. fasting_plasma_glucose='(-inf-66.145453]'  ==> prim_diagnosis=Normal    conf:(1) 
17. fasting_plasma_glucose='(66.145453-76.643973]'  ==> prim_diagnosis=Normal      conf:(1) 
Listing 4.3: Proximity-based Rule for Diabetes 
rule "3 - When a fasting plasma glucose test is performed to diagnose 
Diabetes, then a result higher than 125 mg/dL or higher indicates positive 
diabetes" 
 
when 
 
 t:Test(testName == "Fasting plasma glucose") 
 d:Disease(diseaseName == "diabetes mellitus" || diseaseName == 
"diabetes mellitus type 2" 
    || diseaseName == "diabetes mellitus type 1" || diseaseName == 
"diabetes" || diseaseName == "Diabetes") 
  
 tr:TestResult(id == 1 && unit == "mg/dL" && description == "glucose - 
FPG" && amount > 125) 
 
then 
 tr.setNormal(false); 
 tr.setDiagnosis(true); 
 tr.setResult("positive test for diabetes"); 
end Listing 4.4: A Second Clinical Pathways Evidence-based Rule for Diabetes 
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12. fasting_plasma_glucose='(150.13361-inf)' 12 ==> prim_diagnosis=DIABETES UNCOMPL TYPE II    conf:(1) 
24. fasting_plasma_glucose='(139.635091-150.13361]'  ==> prim_diagnosis=DIABETES UNCOMPL TYPE II           conf:(1) 
Listing 4.5: A Second Proximity-based Rule for Diabetes 
 
rule "8 - If a blood pressure test is performed to diagnose hypertension, 
then a result of more than 90 mmHg diastolic blood pressure would signal 
hypertension" 
 
when  
  
 d:Disease(diseaseName == "Hypertension" || diseaseName == 
"hypertension") 
 t:Test(testName == "Blood pressure" || testName == "blood pressure") 
 tr:TestResult(id == 5 && unit == "mmHg" && amount >= 90  && 
(description == "Diastolic" || description == "diastolic")) 
 
then 
 
 tr.setNormal(false); 
 tr.setDiagnosis(true); 
 tr.setResult("hypertension - high diastolic blood pressure"); 
  
end 
Listing 4.6: A Clinical Pathways Evidence-based Rule for Hypertension 
 
62. ageDays='All' DiastolicBloodPressure='(103.2-111.1]'  ==> prim_diagnosis=HYPERTENSION NOS  conf:(1) 
67. ageDays='All' DiastolicBloodPressure='(111.1-inf)'  ==> prim_diagnosis=HYPERTENSION NOS     conf:(1) 
71. DiastolicBloodPressure='(87.4-95.3]' ==> prim_diagnosis=HYPERTENSION NOS     conf:(1) 
89. ageDays='All' DiastolicBloodPressure='(95.3-103.2]'  ==> prim_diagnosis=HYPERTENSION NOS    conf:(1) 
Listing 4.7: A Proximity-based Rule for Hypertension 
 
4.9.2 Evidence-based vs Proximity-based Predictions 
 
In this section, we compare prediction results for specific patient cases obtained from our 
evidence-based DDx recommender and from our proximity-based DDx recommender. Appendix 
E provides a comparison of predictions from both of the recommenders for two diseases 
(Anemia in Table E3 and Diabetes in Table E4).  The comparison indicates clearly that the 
predictions from both recommenders for most patient cases match. When comparing the 
accuracy of the proximity-based rules for anemia and calcemia in tables E3 & E4 with the 
accuracy of these rules in table E1, the accuracy is lower in tables E3 & E4. This simply means 
that the test cases in tables E3 & E4 need to be more carefully chosen to become more 
representative of the full range of values covered by the rules. We did our best to select 
representative test cases and they largely reaffirmed the high degree of accuracy of the 
proximity-based rules.   
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This chapter provided two approached for differential diagnosis recommendation based on 
building an upper inferential engine on top of our Ontology Crawler described in chapter 3. The 
first approach is based on an evidence-based diagnosis strategy where disease diagnosis 
knowledge is stored in the form of rules and based on these rules one can identify any given 
diagnosis case. Drools rule engine and a database are used to construct the framework for the 
evidence-based part. Chapter 5 will explore the idea of using the framework based on our 
developed prototype for differential diagnosis where clinicians may interact with GUI to infer 
the diagnosis recommendation for any given case study. The second approach is the proximity-
based approach where we employed data mining techniques for predicting diagnosis 
recommendation based on a large dataset. For this purpose, we have used the NIS licensed 
dataset and the Weka data mining environment for drawing diagnostic recommendations for a set 
of diseases that we used in chapter 3 (Diabetes, Anemia, Hypertension and Calcemia). We used 
several data mining algorithms to classify data as well as an association algorithm to infer the 
most interesting rules associating clinical variables and diagnosis. Similarly we are going to 
demonstrate in Chapter 5 how to use our developed prototype for proximity-based diagnosis 
recommendation. We trust that using the two approaches, clinicians can provide better diagnostic 
recommendations with more reliable accuracy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 82 
Chapter 5: System Demonstration 
 
5.1. Clinical Diagnosis Support Systems 
 
Clinical diagnosis support software systems (CDSS) help clinicians in diagnosing clinical cases. 
Most of the clinicians are still relying on a manual clinical diagnosis process. A manual clinical 
diagnosis is a very complex, cumbersome and error prone process; even very experienced 
doctors sometimes fail to diagnose a clinical condition correctly at an early stage [Reddy 2010]. 
For this purpose, CDSS are considered important and useful to assist physicians and other health 
professionals with decision making tasks, such as determining diagnosis from patient data. 
However, modern CDSS need to be more interactive to help determine diagnosis, analysis, etc. 
of patient data. Traditional CDSS would literally make decisions for the clinician. The clinician 
would input the information and wait for the CDSS to output the "right" choice and the clinician 
would simply be expected to act on that output68. The new methodology of using CDSS to assist 
forces the clinician to interact with the CDSS utilizing both the clinician’s knowledge and the 
CDSS to make a better analysis of patients data than either human or CDSS could make on their 
own [Berner 2007]. The objective of this thesis is to use the notion of Differential Diagnosis 
(DDx) along with several emerging technologies from the paradigm of semantic web to develop 
a semantically enriched interactive CDSS model. We call this model the DDx recommendation 
model. The differential diagnosis methodology provides a systematic method for interactivity 
used to identify unknowns. This method, essentially a process of elimination, is used by 
physicians, nurse practitioners, physician assistants, and other trained medical professionals to 
diagnose the specific disease in a patient. In our model, the process of elimination is guided by 
the DSO ontology along with the clinical pathways rules. However, not all medical diagnoses 
follow strict pathways with available lab tests as some diagnoses are based on intuition or 
estimations of likelihood. For this purpose, our work considers another type of differential 
diagnosis that uses proximity in decision making. Our proximity-based DDx recommender uses 
a focused data mining approach for providing possible diagnoses. We call the focused approach 
as Ontology Driven Data Mining since the DSO & patient ontologies help clinicians in extracting 
the right attributes and classes from the raw clinical data. The details of the two complimentary 
DDx approaches have been introduced in Chapters 3 and 4. The benefits of developing such 
semantically enriched interactive CDSS model can be summarized as follows: 
 
- (i) to influence healthcare providers to reduce variability of outcomes across various 
health professionals and increase the standardisation of processes towards evidence-based 
guidelines 
- (ii) to combine and synthesise complex related pieces of information 
                                                          
68
 http://www.wix.com/pjq19007/nursinginformatics 
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- (iii) to support the generation of patient-specific (medical history) and context specific 
prompts and reminders [Bouamrane 2010] 
- (iv) to identify patterns within the patient data which must be acted upon (e.g. abnormal 
or inconsistent findings, alerts, ordering of tests and further investigations, referral to 
specialist consultant...) [Bouamrane 2010] 
- (v) to provide diagnostic recommendations to  health care providers 
 
The developed DDx recommender needs to be used by clinicians at various levels of the clinical 
processes including observation, opinion, instruction and intervention [Kuhn 2007] (see Figure 
5.1): 
 
 Clinical Observation: information created by an act of observation, measurement, 
questioning, or testing of the patient's substance (tissue, urine etc), including by the 
patient himself (e.g. taking own blood glucose measurement), in short, the entire stream 
of information captured by the investigator, used to characterise the patient system 
 
 Clinical Opinion: thoughts of the clinician about what the observations mean, and what 
to do about them, created during evaluation activities, including all diagnoses, 
assessments, speculative plans, etc 
 
 Clinical Instruction: opinion-based instructions sufficiently detailed so as to be directly 
executable by investigator agents (people or machines), in order to effect a desired 
intervention (including obtaining a sample for further investigation, as in a biopsy); and 
 
 Clinical Intervention: a record of intervention actions that have occurred, due to clinical 
instructions or otherwise 
 
Fig. 5.1: Forms of Interactions with our DDx Recommender 
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For this purpose the DDx recommender needs to be prototyped in way to enable clinicians to 
easily make informed diagnostic choices and to be able to query and interact with the DDx 
recommender in flexible manners.  
 
5.2. Prototyping our Differential Diagnosis Recommender 
 
Prototyping requires rigorous software engineering methodologies that rely on agility. One of the 
main goals of agile development69 is to improve the reaction to changes. Changing user 
interfaces (UI) is expensive in term of time and resources. Indeed, UI changes do not only impact 
the UI layer, but also requires several architectural changes. To support developing flexible UI, 
we have looked into tools satisfying the developer needs (quick development, support all the 
possible clinical interactions, understandable results) as well as the clinician’s needs. For this 
purpose we chose "Google Web Toolkit (GWT)"70 for our DDx wire framing and prototyping. 
Although wire framing in software industry is a phase used at the early development process, we 
use it at a later stage when the research concepts of our DDx recommender started to become 
mature. However, the use of wire framing for DDx recommendation allows us to do many 
prototyping processes such as: 
 Test and refine ontology navigation and crawling  
 See how content lays out on the UI pages 
 Study and rapidly refine the UI design of forms and interactive elements 
 Evaluate overall effectiveness of the page layout against DDx usability best practices 
 Determine the integration requirements between the various components and APIs  
 Provide the most effective screen workflow 
From a developer's point of view, one can easily change the wireframe in response to changes in 
the requirement. The wireframe produced by the wire framing tool is a natural Java Swing 
component that can be adjusted easily from the Java project or via the same wire framing toolkit. 
Figure 5.2 illustrates the DDx recommender's style of screen workflow. 
                                                          
69
 http://www.agile-process.org/ 
70
 http://code.google.com/webtoolkit/ 
 85 
Fig. 5.2: The Style for the DDx Recommender Workflow 
5.3. Validation Scenarios for the DDx Recommendation Prototype 
 
This section provides test scenarios of the three main components of the DDx recommendation 
prototype. Section 5.3.1 provides test scenarios for using the DSO ontology crawler relations R1-
R6. Here, we only provide test scenarios for the relations R2, R3, and R5. Relations R1-R6 
answer queries relating symptoms to diseases (and vice versa) and are discussed in detail in 
chapter 3. Section 5.3.2 provides a test scenario for the Evidence-based DDx recommender 
(chapter 4). Finally, section 5.3.3 presents a test scenario for the Proximity-based DDx 
recommender (chapter 4).    
 
5.3.1: Validation of the DDx Recommender’s DSO Ontology Crawler Relations 
 
The R1(described in chapter 3) relation is where the DSO Ontology Crawler receives a single 
symptom as input, and outputs diseases that cause this symptom. Our R1 scenario starts by the 
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clinician accessing the DSO Ontology Crawler by clicking the "Differential Diagnosis 
Investigation" button in the main window of the DDx Recommender (Figure 5.3). Then in the 
next screen, the clinician presses "Investigate R1/R2" button to access the R1 function (Figure 
5.4). Then for this scenario, let's suppose the clinician would like to view diseases that cause the 
symptom fatigue. In this case, the clinician selects the fatigue symptom from a list of symptoms 
provided by the DSO Crawler. The clinician then presses the "Get Diseases of Symptoms (Text 
View)" button to get a list of the diseases that cause fatigue (Figure 5.5). The clinician can also 
get a graph view connecting the symptom to the diseases that cause it by pressing the "Get 
Diseases of Symptoms (Graph View)". The DDx recommender will display the graph in a 
separate screen (Figure 5.6).      
 
Fig. 5.3: Accessing the DSO Crawler Component of the DDx Recommender  
 
Fig. 5.4: R1-R6 Relations Window of the DSO Crawler
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Fig. 5.5: Result of running R1 for the Fatigue Symptom 
 
 
 
Fig. 5.6: Jung Graph View showing result of running R1 for 
the Fatigue Symptom 
For R2 (chapter 3), the clinician can select a list of symptoms 
and the DSO Crawler should return a list of diseases where 
each disease causes all the given symptoms. Figure 5.7 
illustrates a scenario where the clinician selects fatigue and 
headache symptoms and the DSO Crawler returns a list of 
diseases that cause these symptoms.  
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Fig. 5.7: R1/R2 Scenario for the DSO Crawler of the DDx Recommender 
  
 
Fig. 5.8: R3 Scenario for the DSO Crawler of the DDx Recommender
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Fig. 5.9: R5 Scenario for the DSO Crawler of the DDx Recommender   
 
5.3.2: Validation Scenario for the Evidence-based DDx Recommender 
To run the evidence-based DDx recommender, the clinician needs to press on the "Differential 
Diagnosis Evidence Driven Recommendation" button in the main window of the DDx 
recommender (Figure 5.10). In this scenario, a clinician initially observes two symptoms on a 
patient namely fatigue and a headache. In our prototype, the clinician selects the two symptoms 
from a list of symptoms (See Figure 5.11 below). Then the clinician presses the “Show Possible 
Diseases” button to prompt our DDx recommender to show diseases that display the selected 
symptoms. The DDx recommender, using its DSO crawler described in chapter 3, returns a list 
of diseases that display the selected symptoms. Among the diseases returned are hypertension 
and anemia. Let’s suppose that the clinician ruled out the remaining diseases that display fatigue 
and headache as symptoms. Now the clinician would like to look into the possibility that the 
patient has hypertension. The clinician would take the patient’s blood pressure, perhaps several 
times at different times in a day. As far as our prototype is concerned, the clinician selects 
hypertension from the list of possible diseases, and presses “Provide Patient Data for Selected 
Disease” button in order to further examine the possibility of the hypertension diagnosis. The 
DDx recommender then would present to the clinician a screen that prompts the clinician to enter 
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blood pressure of the patient (systolic & diastolic blood pressures). The DDx recommender 
recognizes, through it clinical pathways rules, that blood pressure is the most important indicator 
of hypertension and that's why it asks the clinician to take the patient's blood pressure and enter 
the systolic and diastolic blood pressure measurements of the patient (Figure 5.12). Next, the 
clinician enters the systolic and diastolic blood pressure measurements of the patient and presses 
the "Narrow Diagnosis" button (Figure 5.13). The DDx recommender takes the blood pressure 
measurements and feeds them to the Drools rule engine of the evidence-based DDx 
recommender. The rule engine takes the blood pressure data, and applies it to the clinical 
pathways rules related to hypertension. Based on these rules in the rule engine’s rule base, the 
blood pressure measurement is determined to be either normal or hypertensive. In this case, both 
systolic and diastolic blood pressures are determined to be normal (Figure 5.14). The end result 
is that hypertension is ruled out. Now only anemia remains in the list of possible diseases. For 
anemia, the main lab test is CBC (Complete Blood Count) involving blood tests. There are two 
main measures for CBC. The measure is of the percentage of red blood cells in a sample of 
blood. The second one is hemoglobin levels and is a measure of hemoglobin levels in a sample 
of blood. The clinician must order the CBC test in order to investigate diagnosis of anemia. Once 
the results come in, the clinician can use the aid of the DDx recommender in the diagnosis of 
anemia. The clinician must select anemia in the list of possible disease and “Provide Patient Data 
for Selected Disease” button in order to further examine the possibility of the anemia diagnosis 
(Figure 5.15). Then, the DDx recommender presents the diagnosis rules for the diagnosis of 
anemia (Figure 5.16). Next, the clinician enters the hemoglobin levels and percentage of red 
blood cells in the blood sample of the patient. The clinician then presses the "Narrow Diagnosis" 
button to ask the DDx recommender to investigate the possible diagnosis of anemia (Figure 
5.17). When it comes to interpreting the test results of the CBC test, normal and abnormal results 
differ depending on whether the patient is male or female. Therefore, the DDx recommender will 
ask the clinician for the patient's sex as well as age.  The clinician then would enter the patient's 
sex and age (Figure 5.18). The DDx recommender takes the CBC lab test measurements and 
feeds them to the Drools rule engine of the evidence-based DDx recommender. The rule engine 
takes the hemoglobin and red blood cell percentage data, and applies it to the clinical pathways 
rules related to anemia. Based on these rules in the rule engine’s rule base and the CBC test 
results in this case, the DDx recommender determines that the patient has anemia. Therefore, the 
DDx recommender suggests a diagnosis of anemia to the patient (Figure 5.19). Since only one 
disease (Anemia) remains in the list of possible diseases, the DDx recommender has no more 
diseases to investigate. The last step the DDx recommender performs in this diagnosis sequence 
is part of the cooperation between the evidence-based and proximity-based DDx recommenders. 
The above process was controlled by the evidence-based DDx recommender. As part of the 
cooperation between both recommenders, the evidence-based recommender will write its 
findings to the proximity-based recommender. For each of disease recognized by the DDx 
recommender, the proximity-based recommender maintains records of patient data where a 
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diagnosis is recorded based on the evidence-based recommender's conclusion. In figure 5.20, the 
evidence-based recommender writes the diagnosis of anemia as a patient record in a table of 
records for anemia where the diagnosis is either confirmed anemia or no indication of anemia 
(normal). The last record in figure 5.20 belongs to the patient's case we are discussing in this 
scenario. It shows the patient's age in years (25.0), age in days (0.0), sex (1.0) where 0.0 stands 
for male and 1.0 stands for female, the percentage of red blood cells in patient's blood sample 
(33), the hemoglobin levels in the blood sample (11), and a positive diagnosis of anemia 
(Anemia). This scenario would also add a record to the hypertension table of the proximity-based 
recommender where the diagnosis is "Normal" or no indication of hypertension (Figure 5.21). 
The last record in figure 5.21 is the record added in this scenario, It shows the patient’s age in 
years (23.0), age in day (0.0), sex(1.0 or female), systolic blood pressure (123), diastolic blood 
pressure (78), and the diagnosis of either normal or hypertension (Normal).      
  
 
Fig. 5.10: Selection of the Evidence-based DDx Recommender from the Main GUI Window 
of the DDx Recommender 
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Fig. 5.11: Main GUI Window of the Evidence-based DDx Recommender      
 
Fig. 5.12: DDx Recommender's GUI Window for Clinical Pathways Rules for Hypertension  
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Fig. 5.13: Clinician Enters Blood Pressure of Patient into DDx Recommender 
 
Fig. 5.14: DDx Recommender Rules Out Hypertension 
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Fig. 5.15: Clinician Using DDx Recommender to Examine the Possible Diagnosis of Anemia  
 
Fig. 5.16: DDx Recommender’s Clinical Pathways Rules for Anemia  
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Fig. 5.17: Clinician Enters Test Data for Anemia and Prompts DDx Recommender to Fire its 
Clinical Pathways Rules 
 
Fig. 5.18: DDx Recommender Prompts Clinician to Enter Patient's Sex and Age 
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Fig. 5.19: DDx Recommender Suggests to Clinician a Diagnosis of Anemia 
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Fig. 5.20: Anemia Patient Record Table of the Proximity-based DDx Recommender 
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Fig. 5.21: Hypertension Patient Record Table of the Proximity-based DDx Recommender 
 
 
5.3.3. Validation of the Proximity-based DDx Recommender 
 
To start using the proximity-based DDx recommender, the clinician needs to press the 
"Differential Diagnosis Proximity Driven Recommendation" button (Figure 5.12). The next 
screen would appear which gives the clinician two choices: making diagnosis recommendations 
for patient cases based on known similar patient cases (First choice) or finding diagnosis rules 
relating various clinical patient attributes and lab data on one hand, and diagnosis of a certain 
disease on the other hand (Second choice). These two choices are discussed in detail in chapter 4. 
The first choice relies on classification and is accessed by pressing the "Answer D1" button 
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(Figure 5.22) where D1 is a relation implementing the first choice. D1 evaluates patient cases 
based previous similar patient cases. The second choice relies on association and is accessed by 
pressing the "Answer D2" button (Figure 5.22) where D2 is a relation implementing the second 
choice. D2 produces diagnosis rules, based on known patient cases, relating clinical data to the 
diagnosis of a certain disease. 
 
First D1 Scenario 
 
For our first scenario, we will test a D1 Scenario. The clinician presses the “Answer D1” button. 
The next screen prompts the clinician to select one of four classification algorithms (discussed in 
chapter 4) to perform D1 (Figure 5.23). Let’s say the clinician selects the J48 algorithm in this 
scenario and presses the "Proceed >>" button (Figure 5.24). The next screen (Figure 5.25) asks 
the clinician whether he/she would like to view the diagnosis prediction trends learned by the 
classification algorithm from recorded patient cases where patients were examined for a certain 
disease and determined to either have or not have the disease (option 1), or get diagnosis 
predictions for new patient cases based on the recorded patient cases (option 2). Let’s say the 
clinician would like to proceed with option 1. The clinician would select the "Use Training Data 
to Find Trends in the Data" option and presses the "Proceed >>" button (Figure 5.25). The next 
(Figure 5.26) screen allows the clinician to select the disease for which to display diagnosis 
trends. Currently, we have known patient case data for four diseases (Diabetes, Anemia, 
Calcemia, and Hypertension). The clinician can select any of the listed data tables (Figure 5.26), 
and let's suppose in this scenario he/she selects diabetes data and clicks on "Proceed To Results" 
button. Then, the DDx recommender applies the selected data mining classification algorithm to 
the selected data table to find trends in the data. Next, the DDx recommender displays the results 
of classification namely classification statistics (Figure 5.27), and a description of the resulting 
classification tree (Figure 5.28). Interpreting the classification statistics was discussed in chapter 
4 while interpreting the classification tree is straightforward. The classification tree shows that if 
the fasting plasma glucose levels in the blood are less than 89.5 mg/dL, then glucose levels in the 
blood are normal. Otherwise, the glucose levels are too high and indicate diabetes.          
 
Fig. 5.22: Main GUI Window of the Proximity-based DDx Recommender 
 101 
 
Fig. 5.23: Classification Algorithm Selection Window of the Proximity-based DDx 
Recommender 
 
Fig. 5.24: J48 Classification Algorithm selected to perform Proximity-based DDx 
Recommendation 
 
Fig. 5.25: Selecting First Classification Option for the D1 Relation of the Proximity-based 
DDx Recommender 
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Fig. 5.26: List of Data Tables for the Proximity-based Recommender 
 
Fig. 5.27: Classification Statistics & J48 Tree for Diabetes of the Proximity-based DDx      
Recommender 
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Fig. 5.28: J48 Classification Tree for Diabetes Table of the Proximity-based DDx      
Recommender 
 
Second D1 Scenario 
 
In this scenario, the clinician is not interested in viewing diagnosis trends obtained from 
previously known patient cases (option 1), but instead would like to get diagnosis predictions for 
new patient cases based on the previously known patient cases (option 2). To do so, the clinician 
proceeds the same way as in the first scenario until the classification options window is reached 
(Figure 5.29). When the clinician to gets to that window, he selects the second option namely 
"Perform Classification - Predict the Value of the Class Variable for given Test Data" and clicks 
on the "Proceed >>" button (Figure 5.29). Next, the DDx recommender, for each of the four 
diseases, has a number of test data records on file meaning a number of diagnosed patient cases 
but the diagnosis is not recorded on file and therefore unknown to the DDx recommender. The 
DDx recommender can use the diagnosis trends learned from previously diagnosed patient cases, 
where the diagnosis is known by the DDx recommender to predict the diagnosis of the test 
records. The accuracy of prediction is determined by the number of predictions for the test 
records where the prediction matches the actual diagnosis for the test record. It also allows the 
clinician to add to new records to the test records. First, the clinician must select the test file with 
test records for a specific disease. The next screen (Figure 5.30) prompts the clinician to select 
one of the test files available to the DDx recommender. Let's say in this scenario, the clinician 
selects the hypertension file of test data, and clicks the "Proceed >>" button (Figure 5.30). So the 
next screen (Figure 5.31) asks the clinician if he/she would like to add records to the test records 
or use the existing test records on file. Let's say in this scenario that the clinician would like to 
add test records so the clinician selects the "Add Records to the Test Data File then Classify" 
option and clicks the "Proceed >>" button (Figure 5.31). The following screen allows the 
clinician to enter a new hypertension patient case. The clinician would be prompted to enter the 
patient's age, sex, systolic and diastolic blood pressures. The clinician enters the required 
information (Figure 5.32). Now the clinician can enter another record, and let's say the clinician 
decides to enter another record, so he presses the "Enter Another Record" button (Figure 5.32). 
The clinician enters another record and decides not to enter any more records, so she/he clicks 
the "Proceed >>" button (Figure 5.33). Now the DDx recommender applies learned diagnosis 
trends to the test data, and makes diagnosis predictions for the test data. It writes the diagnosis 
predictions in a predictions file. For each test file available to the proximity-based DDx 
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recommender, there is a corresponding predictions file that contains diagnosis predictions for 
each test record in the test file. Therefore, the diagnosis predictions file has the same patient 
records in the test file but with the diagnosis predictions added. The test file has patient cases 
with no diagnosis indicated. The test file for this scenario is given in figure 5.34, and the 
corresponding predictions file is given in figure 5.35 for comparison purposes.      
          
 
Fig. 5.29: Selecting Second Classification Option for the D1 Relation of the Proximity-based 
DDx Recommender 
 
Fig. 5.30: Test Data File Selection Screen of the Proximity-based DDx Recommender 
 
Fig. 5.31: Test Data Records Screen of the Proximity-based DDx Recommender 
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Fig. 5.32: Screen for Adding New Hypertension Test Record to the Hypertension Test 
Records File of the Proximity-based DDx Recommender 
 
Fig. 5.33: Adding Another New Hypertension Test Record to the Hypertension Test 
Records File of the Proximity-based DDx Recommender 
 
Fig. 5.34: Hypertension Test File of the Proximity-based DDx Recommender 
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Fig. 5.35: Hypertension Diagnosis Predictions File of the Proximity-based DDx 
Recommender 
 
First D2 Scenario 
 
In this scenario, the clinician would like to find diagnosis rules relating various clinical patients’ 
attributes and lab test data on one hand, and diagnosis of a certain disease on the other hand. 
These rules are called association rules. The clinician can access the association rules component 
from the main window of the proximity-based DDx recommender. The clinician clicks the 
"Answer D2" button in order to access the association rules component (Figure 5.36). Next, the 
proximity-based DDx recommender asks the clinician to select the disease diagnosis training 
data he/she wishes to find association rules for. The clinician selects one of the five available 
disease diagnosis training data related to the diagnosis of Diabetes, Anemia, Calcemia, and 
Hypertension. Let's say in this scenario the clinician selects the Anemia data file (Figure 5.37). 
Each record in the Anemia training data file contains a patient's age and sex, a percentage of red 
blood cells in a blood sample of the patient's blood, hemoglobin levels in the blood sample, and a 
diagnosis of positive for anemia or negative (Normal). The association rules algorithm studies 
these data records to find rules relating any one or a group of the clinical attributes (in this case 
age, sex, hemoglobin levels, and percentage of red blood cells are the clinical attributes) to the 
diagnosis result. These rules have confidence factors determined by the percentage of the 
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training data records they apply to. The rules with high confidence factors are the most 
interesting. The resulting association rules from this case are presented in Appendix C. 
 
 
Fig. 5.36: Accessing the Association Rules Component of the Proximity-based DDx 
Recommender 
 
Fig 5.37: Selection of the Diagnosis Data for the Apriori Association Rules Algorithm of the 
Proximity-based DDx Recommender  
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Chapter 6: Conclusions and Future Research 
 
6.1. Conclusions 
 
We presented in this thesis a new Differential Diagnosis (DDx) recommendation model. It is a 
comprehensive model for computer-aided disease diagnosis recommendation. The realization of 
this comprehensive model requires a number of resources to be researched and developed first. 
In this thesis, we identified the following resources to be lacking or currently unavailable: 
Suitable medical diagnosis ontology: The amount of information that must be taken into 
account in medical diagnosis is huge and subject to evolution. Ontologies are a means for 
formalizing the concepts of the domain of interest. In our model, one important function of the 
DDx recommender is to be able to make connections between symptoms and diseases. 
Unfortunately, there is no ontology that makes relations between symptoms and diseases. In 
chapter 2, we developed a “kernel” ontology that makes such connection. We call this ontology 
the Diseases Symptoms Ontology (DSO). The development of the DSO is based on aligning two 
already existed standard/OBO ontologies (DOID and SYMP). The two OBO ontologies provide 
essential knowledge representation for diseases and symptoms as a separate model, but not the 
relations between them (e.g. what are the symptoms of each disease). As these relations are 
required in the reasoning process of our DDx recommendation model, we have created kernel 
diseases symptoms ontology (DSO) combining DOID & SYMP and thus combining diseases and 
symptoms into one ontology structure. Although the developed kernel DSO defines the causality 
relations between diseases and symptoms for a dozen diseases and their related symptoms, the 
DSO structure and the alignment techniques used allow the expansion to create further 
relationships between additional diseases and their related symptoms. However, since the 
numbers of diseases are quite huge (e.g. DOID identified over than 8000 diseases), and since for 
each disease there are a number of related symptoms, a full implementation of the DSO would 
require the creation of tens of thousands of causality relations between diseases and symptoms so 
that is a large amount of work. Therefore, we believe that the development of a complete DSO 
ontology is an open community-wide research challenge. In chapter 2, we introduced a 
systematic way to allow a research community effort and to our future research to efficiently 
accomplish creating a more complete DSO.  
Suitable Patient Ontology: The proliferation of medical terms related to patient disease 
diagnosis is a major obstacle in the sharing of medical information (e.g. electronic medical 
records, emergency forms, and traige notes) among shareholders (e.g., hospitals, clinicians, 
pharmaceutical companies etc.). Hence there is a need for a uniform structure that contains 
attributes from various medical documents and relations between these attributes. Chapter 4 
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addresses this problem and introduces a patient ontology (PO). The developed patient ontology 
contains attributes which are commonly found in various patient medical records. In our 
prototype, the PO is used to assist the DDx recommender in selecting attributes that are relevant 
to a certain diagnosis. 
Suitable Clinical Pathways Rules/Ontology: Since 2006 there were many attempts to start 
developing adaptive clinical pathways for disease diagnosis and treatment. For example, Helen 
Chen [Chen 2006] of Agfa Healthcare proposed to initiate a W3C AHPP taskforce within the 
W3C Semantic Web for Health Care and Life Sciences Interest Group 
(http://www.w3.org/2001/sw/hcls/). Clinical pathways are becoming standardized tools to 
translate evidence-based recommendations into locally practicable, process-specific algorithms 
that reduce practice variations and optimize quality of care. However, clinical pathways are only 
known in a form that is only readable to humans and not machines (e.g. care maps71). Chapter 4 
described the many attempts to establish a machine readable clinical pathways ontologies that 
ended with no real success as the problem of creating a comprehensive clinical pathways 
acceptable to all healthcare institutions for large number of diseases represent a huge task that 
requires healthcare community-wide efforts. Given the lack of such a comprehensive clinical 
pathways ontology, we developed in chapter 4 an alternative method to create adaptive clinical 
pathways in a form of dynamic rules. However, creating a clinical pathway rules for even one 
disease could require hundreds of interrelated rules. Actually the task of creating clinical 
pathways rules for all the known diseases needs the creation of hundreds of thousands of rules. 
Chapter 4 described a simplified method for creating these dynamic rules which can be placed in 
an external text file (Drools File in our prototype) and using a format that can be easily 
understood by clinicians for the purpose of adding new rules or modifying existing rules. In our 
prototype we used the described method and created the clinical pathways rules for the diagnosis 
and management of four diseases. This method can be repeated for any number of other diseases.  
Suitable Reference Medical Diagnosis Medical Dataset: The third lacking resource is patient 
diagnosis data. Much of the diagnosis data ranging from a patient's demographic information 
(age, weight, height, sex, etc) to lab test results are not publicly available. Therefore, we found it 
difficult to obtain such data. For some of the more common diseases like diabetes and 
hypertension data for some of the diagnosis variables are publicly available. We have used this 
data in our prototype specifically we used the NIS dataset (see chapter 4). The lack of the 
availability of diagnosis data limits the choices, in front of the proximity-based recommender, of 
diagnosis variables to those variables where data values are available. This negatively affects the 
work the DSO & PO ontologies do for the proximity-based recommender. As mentioned in 
chapter 4, the DSO & PO ontologies select the relevant diagnosis variables for a specified 
diagnostic case. The proximity-based recommender is supposed to take these diagnosis variables, 
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form a table called the training table made up of values for these diagnosis variables and the 
diagnosis prediction obtained from patient records, and this data table to data mining algorithms 
so they can predict diagnosis for new cases for the particular diagnosis of interest as well as 
generate diagnosis rules for the diagnosing the specific diagnosis. Data mining predictions 
depend on the quality of the available data. For the selected diagnosis variables for which data is 
not available or lacking, these variables cannot be used by the proximity-based recommender in 
the data mining process that results in diagnosis predictions. The DSO & PO ontologies 
determined that a set of variables should be considered for a certain diagnosis, yet the proximity-
based recommender cannot consider any of the variables unless it has sufficient data for a 
variable and this data must also be related to the specific diagnostic case. Therefore, the lack of 
data would render required diagnostic variables unusable and this is a hindering factor for a DDx 
recommendation process which relies on data mining.  
 
Besides creating the essential resources for building effective medical diagnosis systems, our 
DDx recommendation model identifies the following novel components and methods to enable 
disease diagnosis prediction: 
 
1.   DDx Evidence-based Relational Query Engine (DSO Ontology Crawler) 
The ontology crawler is the component primarily used in our differential diagnosis engine for 
retrieving information from the DSO ontology using representative querying relations that are 
likely to be asked by clinicians when trying to diagnose diseases. Our DSO ontology crawler 
uses six representative relations (R1-R6 see chapter 3) to address the common queries that health 
care professionals use during the process of differential diagnosis. Figure 3.3 that was introduced 
in Chapter 3 lists these relations along with their formal representation. Our DSO ontology 
crawler component consists of the Apache Jena semantic web framework72, which we used to 
our program the six relations for combining the ontological attributes in a meaningful way for 
the purpose of inferring new knowledge necessary for the differential diagnosis process. The 
most significant part of this component is that our ontology crawler replaces the SPARQL 
primitive querying engine by implementing the necessary clinical differential diagnosis relations 
using Jena OWL API primitives. Our ontology crawler has been designed to act as a kernel 
component of our DDx recommendation model and hence it is an important part of the overall 
architecture that aims to serve health care providers with the notion of a differential diagnosis 
recommendation system. We find it useful to re-introduce Figure 3.3 from chapter 3 briefly 
illustrates the six differential diagnosis querying relationships.  
2.    Ontology-Driven Evidence-based DDx Recommendation 
The second important component in our DDx recommendation model is the ontology-driven 
evidence-based recommendation component. This component is built on our ontology crawler to 
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represent the standardized rules and procedures used for diagnosing diseases. In this direction the 
component identified twelve common diseases and implemented their clinical pathways rules. 
 
The transformation of clinical pathway knowledge and other medical knowledge for disease 
diagnosis into rules is a prerequisite for our evidence-based DDx recommender. The evidence-
based DDx recommender employs these rules in a forward chaining process driven by the Drools 
rule engine to find appropriate diagnosis recommendations. The rule firing process is initiated by 
the DSO & PO ontologies (hence ontology-driven). The DSO & PO ontologies select the clinical 
data most relevant to a specific diagnostic case and feed it to the rule engine. Upon receiving the 
selected data, the rule engine initiates the forward chaining rule firing process. It compares the 
data to the clinical pathway rules in order to reach diagnostic conclusions. The ontologies 
optimize the rule firing process by refining the data input to only include data relevant to a 
specific diagnostic case. The evidence-based component utilizes relational database components 
(we used Apache Derby73 database and Hibernate DB driver74) to store patient data as the as well 
as an ontology reasoner (we used Pellet75). Figure 4.3 of Chapter 4 is an illustration of the 
ontology-driven evidence-based DDx recommendation model. For more information on the 
evidence-based DDx recommender, please see chapter 4. 
 
3.   Ontology-Driven Proximity-based DDx Recommendation 
This is the third major component of our DDx recommendation model, which is built upon the 
ontology crawler and the evidence-based recommendation component. The sole function of this 
component is to enable clinicians to predict the diagnosis of certain new cases based on some 
previously available training data. Because of the predictive nature of this component's 
functionality, we call it the proximity-based recommendation component. This component has 
two major tasks. The first is to extract, from patient data records, the relevant symptoms and test 
data for a certain diagnostic case based on semantic web technologies for matching and 
navigation, with the aid of the DSO and the PO ontologies. The matching and navigation process 
is made on the data produced by the evidence-based component or any training data provided by 
other clinical systems or medical repositories. Through the PO and DSO ontologies and their 
crawlers (query engines), this component will select relevant patient attributes, lab test attributes, 
and certain possible diseases under consideration for diagnosis. Training data for the selected 
clinical variables will be then used by the second task that involves data mining classification 
algorithms to learn diagnosis trends. After that training, these classification algorithms use the 
learned diagnosis trends to predict the diagnosis for provided test data (i.e. new clinical data 
cases that require diagnosis). Note that learned diagnosis trends are only valid predictors of 
diagnosis for test data, when the clinical attributes of the test data largely match the clinical 
attributes of the training data. The second task may use an alternative group of data mining 
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algorithms that involves applying association algorithms on the training data to learn rules 
relating diagnosis variables (clinical attributes) with other diagnosis variables, and rules relating 
diagnosis variables and possible diagnoses. These newly generated rules can be used to make 
diagnosis predictions/recommendations. We programmed this component using an incorporation 
of the Weka Java API along with other predictive and analytical components. Figure 4.5 from 
chapter 4 is a good illustration of the proximity-based DDx recommender otherwise called the 
ontology-driven data mining DDx recommender. For more information on this component, 
please see chapter 4. 
 
4.   DDx Integration (Evidence-based with Proximity-based Diagnosis) 
This is our fourth major component where we integrate the first three components to form our 
overall DDx recommendation model. The evidence-based and proximity-based approaches for 
DDx recommendation can cooperate to form an overall DDx recommendation model. Results 
generated by the evidence-based DDx recommender can be used for prediction by the data 
mining algorithms of the proximity-based DDx recommender. On the other hand, data mining 
algorithms from the proximity-based approach generate rules that can be used to update the rule 
base of the evidence-based approach. Figure 4.1 re-introduced from Chapter 4 illustrate our 
overall DDx integral recommendation model. Figure 3.2 re-introduced from chapter 3 illustrates 
the various API's used in our prototype implementation of our overall DDx integral 
recommendation model.   
 
6.2. Future Research 
 
Here is a list of some of the possible research extensions and expansions from our current 
research work: 
1. Extending the DSO Ontology to cover related diseases groups (e.g. Geriatric DSO that links 
all the common diseases and their symptoms for people of old age). This research extension 
is quite important as it will support the new initiative of medical diagnosis knowledge 
personalization [Cristina Romero-Tris, David Riaño and Francis Real 2010]. The extended 
DSO need to incorporate the ICD-10 coding for the related disease groups. It is important to 
note that the current DSO Ontology includes twelve common diseases that share some 
common symptoms and signs.  
2. Enhancing the PO Ontology to conform to the requirements of major EMR (Electronic 
Medical Record) standards like HL7 (http://www.hl7.org/ehr/). The current PO has been 
developed to be rather a generic ontology that can work with any EMR standard. However, 
conforming to HL7 standard will enable our DDx recommendation system to build an HL7 
messaging interface to enables physicians and healthcare institutions to connect with each 
other. We propose in this direction to use the InterSystems Ensemble APIs 
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(http://www.intersystems.com/hl7/index.html) to develop such messaging interface that can 
be added to our current DDx recommendation system. 
3. Although the use of Drools rules76 provides a convenient and intuitive way for clinicians to 
describe and classify diagnostic knowledge contents for our DDx recommendation system, it 
remains hard to use these rules with other automated software agents for reasoning. In this 
direction we are proposing to convert the rules that are related to a specific disease or group 
of related diseases into OWL ontologies, thus enabling reasoning on them by other semantic 
web applications. This conversion process will assist in the process of producing incremental 
clinical pathways ontologies (ICPO) for specific diseases or for a group of related diseases. 
We are proposing to perform the conversion of rules into OWL ontology using the method 
introduced by Fausto Giunchiglia, Ilya Zaihrayeu, and Feroz Farazi [Giunchiglia et al. 2008]. 
The process of producing ICPO needs to use a sound ontology enrichment technique. 
Ontology enrichment is the activity of extending ontology by adding new elements (e.g. 
concepts, relations, properties, axioms) [Castano 2007]. 
4. Expanding the integration between the evidence-based and the proximity-based diagnosis 
components. Our current integration concentrates much on linking the evidence-based 
component to the proximity-based by adding the confirmed diagnosis from the evidence-
based component to the training dataset of the proximity-based component. In our integration 
model, we have proposed that diagnosis rules produced by the proximity-based component 
be added to, or override, or confirm, or negate existing diagnosis rules in the rule set of the 
evidence-based component. However, the rules produced by the proximity-based component 
are in a different format from the rules of the evidence-based component. Therefore, the rules 
from the proximity-based component must be converted into the rule format of the evidence-
based component in order for proper comparison of the rules to be possible.   
5. Expanding our DDx recommender querying relations. In this direction we are intending to 
generate the second level of DDx querying relations so clinicians can specifically query the 
DDx recommender about a specific disease or a group of related diseases. Our six DDx 
relations developed in this thesis represent the most generic questions used by the clinicians 
to diagnose any unknown disease.  
6. Further comparing the different classification and association data mining algorithms and 
their efficiency in accurately predicting disease diagnosis. We are intending to use the set of 
confirmed diagnosis cases as produced by the evidence-based component and hide their final 
diagnosis for analysing the different data mining diagnosis accuracy prediction. We are also 
proposing to experiment with other prediction techniques like clustering in predicting 
diagnosis for group of related diseases. 
                                                          
76
 http://www.jboss.org/drools 
 114 
 
7. There are many possible implementations for our DDx recommendation model into useful 
healthcare applications. The following are some of the proposed direct applications: 
 
a. Application 1 - Home Care DDx Recommender: This application requires the 
addition of mobile client interfaces (e.g. Android or iPhone) to monitor some of the 
patient’s parameters related to certain chronic diseases like diabetes and hypertension. 
We are proposing to use the MORF technology [Benlamri and Docksteader 2010]. 
 
b. Application 2 - Web Clinicians Disease Diagnosis Recommender: This application 
will enable clinicians to use our DDx recommender from the web. This could be a 
web implementation using the evidence-based component and/or the proximity-based 
component. 
 
c. Application 3 - Web Discharge and Referral System: This application will enable 
clinicians to build a patient disease diagnosis record for discharge or referral 
purposes. We are proposing to package the discharge summary in one of the most 
popular formats like the Continuity of Care records77 or the Continuity of Care 
Document78. 
 
d. Application 4 - Collaborative DDx Recommender. In this application we are 
proposing to extend our current DDx recommender prototype to add a social 
networking environment for a clinical community of practice. For this purpose we are 
proposing to integrate one of the open-source social networking engines like Elgg79 
with our DDx recommendation architecture. This extension will enable the healthcare 
community of practice to collaboratively use our DDx recommender for more 
effectively diagnosing diseases as well as for community collaboration and learning. 
 
e. Application 5 – DSL Based DDx Recommender: In this application we are proposing 
to replace the various UI components by domain specific natural language (DSL) 
commands. In this direction we need to define the required syntax of the clinician's 
DSL commands and interactions as well as to identify their parsing and processing 
components. 
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Appendix A 
 
Evidence-based Clinical Pathways Rules File 
#created on: 3-Jun-2011 
#last modified: 16-Feb-2012 
package medRules.test 
 
#list any import classes here. 
 
import medRules.test.Disease; 
import medRules.test.Test; 
import medRules.test.TestResult; 
import java.util.LinkedList; 
import java.util.List; 
 
#declare any global variables here 
 
 
rule "1 - If a fasting plasma glucose test is perfomed to diagnose Diabetes, 
then a result 109.8 mg/dL or less indicates negative diagnosis or normal 
glucose levels" 
 
when 
 
 t:Test(testName == "Fasting plasma glucose") 
 d:Disease(diseaseName == "diabetes mellitus" || diseaseName == 
"diabetes mellitus type 2" 
    || diseaseName == "diabetes mellitus type 1" || diseaseName == 
"diabetes" || diseaseName == "Diabetes") 
  
 tr:TestResult(id == 1 && unit == "mg/dL" && description == "glucose - 
FPG" && amount <= 109.8 && amount > 0) 
 
then 
 tr.setNormal(true); 
 tr.setDiagnosis(false); 
 tr.setResult("Normal healthy glucose levels, no evidence of diabetes"); 
end 
 
rule "2 - If a fasting plasma glucose test is perfomed to diagnose Diabetes, 
then a result 109.8-125 mg/dL indicates positive pre-diabetes" 
 
when 
 
 t:Test(testName == "Fasting plasma glucose") 
 d:Disease(diseaseName == "diabetes mellitus" || diseaseName == 
"diabetes mellitus type 2" 
    || diseaseName == "diabetes mellitus type 1" || diseaseName == 
"diabetes" || diseaseName == "Diabetes") 
  
 tr:TestResult(id == 1 && unit == "mg/dL" && description == "glucose - 
FPG" && amount > 109.8 && amount <= 125) 
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then 
 
 tr.setNormal(false); 
 tr.setDiagnosis(false); 
 tr.setResult("Abnormal glucose levels indicate a state of pre-diabetes 
and increased risk of developing type 2 diabetes"); 
end 
 
 
rule "3 - When a fasting plasma glucose test is perfomed to diagnose 
Diabetes, then a result higher than 125 mg/dL or higher indicates positive 
diabetes" 
 
when 
 
 t:Test(testName == "Fasting plasma glucose") 
 d:Disease(diseaseName == "diabetes mellitus" || diseaseName == 
"diabetes mellitus type 2" 
    || diseaseName == "diabetes mellitus type 1" || diseaseName == 
"diabetes" || diseaseName == "Diabetes") 
  
 tr:TestResult(id == 1 && unit == "mg/dL" && description == "glucose - 
FPG" && amount > 125) 
 
then 
 tr.setNormal(false); 
 tr.setDiagnosis(true); 
 tr.setResult("positive test for diabetes"); 
end 
 
rule "4 - If an oral glucose tolerance test is perfomed to diagnose Diabetes, 
then a result of less than 140 mg/dL indicates negative pre-diabetes" 
 
when 
 
 t:Test(testName == "Oral glucose tolerance") 
 d:Disease(diseaseName == "diabetes mellitus" || diseaseName == 
"diabetes mellitus type 2" 
    || diseaseName == "diabetes mellitus type 1" || diseaseName == 
"diabetes"  || diseaseName == "Diabetes")  
 tr:TestResult(id == 2 && unit == "mg/dL" && description == "glucose - 
OGGT" && amount <= 140 && amount > 0) 
 
then 
 tr.setNormal(true); 
 tr.setDiagnosis(false); 
 tr.setResult("Normal healthy glucose levels, no evidence of diabetes"); 
end 
 
rule "5 - If an oral glucose tolerance test is perfomed to diagnose Diabetes, 
then a result of 140-200 mg/dL indicates positive pre-diabetes" 
 
when 
 
 t:Test(testName == "Oral glucose tolerance") 
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 d:Disease(diseaseName == "diabetes mellitus" || diseaseName == 
"diabetes mellitus type 2" 
    || diseaseName == "diabetes mellitus type 1" || diseaseName == 
"diabetes"  || diseaseName == "Diabetes")  
 tr:TestResult(id == 2 && unit == "mg/dL" && description == "glucose - 
OGGT" && amount > 140 && amount <= 200) 
 
then 
 tr.setNormal(false); 
 tr.setDiagnosis(false); 
 tr.setResult("Abnormal glucose levels indicate a state of pre-diabetes 
and increased risk of developing type 2 diabetes"); 
end 
 
rule "6 - If an oral glucose tolerance test is perfomed to diagnose Diabetes, 
then a result of of 200 mg/dL or higher indicates a positive diagnosis of 
diabetes" 
 
when 
 
 t:Test(testName == "Oral glucose tolerance") 
 d:Disease(diseaseName == "diabetes mellitus" || diseaseName == 
"diabetes mellitus type 2" 
    || diseaseName == "diabetes mellitus type 1" || diseaseName == 
"diabetes"  || diseaseName == "Diabetes")  
 tr:TestResult(id == 2 && unit == "mg/dL" && description == "glucose - 
OGGT" && amount > 200) 
 
then 
 tr.setNormal(false); 
 tr.setDiagnosis(true); 
 tr.setResult("High glucose levels indicate diabetes"); 
end 
 
rule "7 - If a blood pressure test is performed to diagnose hypertension, 
then a result of 60-80 mmHg diastolic blood pressure would signal normal bp" 
 
when  
 
 d:Disease(diseaseName == "Hypertension" || diseaseName == 
"hypertension") 
 t:Test(testName == "Blood pressure" || testName == "blood pressure") 
 tr:TestResult(id == 5 && unit == "mmHg" && amount <= 80 && (description 
== "Diastolic" || description == "diastolic") && amount >= 60) 
 
then 
 
 tr.setNormal(true); 
 tr.setDiagnosis(false); 
 tr.setResult("Normal healthy diastolic bp, no indication of 
hypertension"); 
  
end 
 
rule "8 - If a blood pressure test is performed to diagnose hypertension, 
then a result of more than 90 mmHg diastolic blood pressure would signal 
hypertension" 
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when  
  
 d:Disease(diseaseName == "Hypertension" || diseaseName == 
"hypertension") 
 t:Test(testName == "Blood pressure" || testName == "blood pressure") 
 tr:TestResult(id == 5 && unit == "mmHg" && amount >= 90  && 
(description == "Diastolic" || description == "diastolic")) 
 
then 
 
 tr.setNormal(false); 
 tr.setDiagnosis(true); 
 tr.setResult("hypertension - high diastolic blood pressure"); 
  
end 
 
rule "9 - If a blood pressure test is performed to diagnose hypertension, 
then a result of 90-120 mmHg systolic blood pressure would signal normal bp" 
 
when  
  
 d:Disease(diseaseName == "Hypertension" || diseaseName == 
"hypertension") 
 t:Test(testName == "Blood pressure" || testName == "blood pressure") 
 tr:TestResult(id == 4 && unit == "mmHg" && amount <= 120 && 
(description == "systolic" || description == "Systolic") && amount >= 90) 
 
then 
 
 tr.setNormal(true); 
 tr.setDiagnosis(false); 
 tr.setResult("Normal healthy systolic bp, no indication of 
hypertension"); 
  
end 
 
rule "10 - If a blood pressure test is performed to diagnose hypertension, 
then a result of more than 140 mmHg systolic blood pressure would signal 
hypertension" 
 
when  
  
 d:Disease(diseaseName == "Hypertension" || diseaseName == 
"hypertension") 
 t:Test(testName == "Blood pressure" || testName == "blood pressure") 
 tr:TestResult(id == 4 && unit == "mmHg" && amount >= 140 && 
(description == "systolic" || description == "Systolic")) 
 
then 
 
 tr.setNormal(false); 
 tr.setDiagnosis(true); 
 tr.setResult("hypertension - high systolic blood pressure"); 
  
end 
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rule "11 - If a blood pressure test is performed to diagnose hypertension, 
then a result between 80-89 mmHg diastolic blood pressure would indicate pre-
hypertension" 
 
when  
  
 d:Disease(diseaseName == "Hypertension" || diseaseName == 
"hypertension") 
 t:Test(testName == "Blood pressure" || testName == "blood pressure") 
 tr:TestResult(id == 5 && unit == "mmHg" && amount > 80 && amount <= 89 
&& (description == "Diastolic" || description == "diastolic") && amount > 0) 
 
then 
 
 tr.setNormal(false); 
 tr.setDiagnosis(false); 
 tr.setResult("pre-hypertension, diastolic bp not normal"); 
  
end 
 
 
rule "12 - If a blood pressure test is performed to diagnose hypertension, 
then a result between 120-139 mmHg systolic blood pressure would indicate 
pre-hypertension" 
 
when  
  
 d:Disease(diseaseName == "Hypertension" || diseaseName == 
"hypertension") 
 t:Test(testName == "Blood pressure" || testName == "blood pressure") 
 tr:TestResult(id == 4 && unit == "mmHg" && amount >= 120 && amount <= 
139 && (description == "systolic" || description == "Systolic")) 
 
then 
 
 tr.setNormal(false); 
 tr.setDiagnosis(false); 
 tr.setResult("pre-hypertension, systolic bp not normal"); 
  
end 
 
rule "13 - If an arterial blood gas test is performed to diagnose adult 
respiratory distress syndrome, then a result between 75-100 PaO2 is normal" 
 
when  
  
 d:Disease(diseaseName == "adult respiratory distress syndrome" || 
diseaseName == "Adult respiratory distress syndrome") 
 t:Test(testName == "Arterial blood gas" || testName == "arterial blood 
gas") 
 tr:TestResult(id == 6 && unit == "PaO2" && amount >= 75 && amount <= 
100) 
 
then 
 
 tr.setNormal(true); 
 tr.setDiagnosis(false); 
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 tr.setResult("normal PaO2, no indication of adult respiratory distress 
syndrome"); 
  
end 
 
 
rule "14 - If an arterial blood gas test is performed to diagnose adult 
respiratory distress syndrome, then a result below 75 PaO2 indicates 
diagnosis of Adult respiratory distress syndrome" 
 
when  
  
 d:Disease(diseaseName == "adult respiratory distress syndrome" || 
diseaseName == "Adult respiratory distress syndrome") 
 t:Test(testName == "Arterial blood gas" || testName == "arterial blood 
gas") 
 tr:TestResult(id == 6 && unit == "PaO2" && amount < 75 && amount > 0) 
 
then 
 
 tr.setNormal(false); 
 tr.setDiagnosis(true); 
 tr.setResult("Adult respiratory distress syndrome"); 
  
end 
 
rule "15 - If a CBC (Complete Blood Count) test is performed to diagnose 
Anemia, then a count of 38.8-50 % of red blood cells in the blood for males 
indicates normal rbc levels" 
 
when 
 
 d:Disease(diseaseName == "Anemia" || diseaseName == "anemia") 
 t:Test(testName == "Complete blood count" || testName == "CBC") 
 tr:TestResult(id == 9 && unit == "%" && description == "% RBC, male" && 
amount >= 38.8 && amount <= 50)  
 
then 
 
 tr.setNormal(true); 
 tr.setDiagnosis(false); 
 tr.setResult("normal percentage of red blood cells in blood, negative 
test for anemia"); 
 
end 
 
rule "16 - If a CBC (Complete Blood Count) test is performed to diagnose 
Anemia, then a count of 34.9-44.5 % of red blood cells in the blood for 
females indicates normal rbc levels" 
 
when 
 
 d:Disease(diseaseName == "Anemia" || diseaseName == "anemia") 
 t:Test(testName == "Complete blood count" || testName == "CBC") 
 tr:TestResult(id == 10 && unit == "%" && description == "% RBC, female" 
&& amount >= 34.9 && amount <= 44.5)  
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then 
 
 tr.setNormal(true); 
 tr.setDiagnosis(false); 
 tr.setResult("normal percentage of red blood cells in blood, negative 
test for anemia"); 
 
end 
 
rule "17 - If a CBC (Complete Blood Count) test is performed to diagnose 
Anemia, then 13.5-17.5 mg/dL of hemoglobin the blood for males indicates 
normal rbc levels" 
 
when 
 
 d:Disease(diseaseName == "Anemia" || diseaseName == "anemia") 
 t:Test(testName == "Complete blood count" || testName == "CBC") 
 tr:TestResult(id == 8 && unit == "mg/dL" && description == "hemoglobin, 
male" && amount >= 13.5 && amount <= 17.5)  
 
then 
 
 tr.setNormal(true); 
 tr.setDiagnosis(false); 
 tr.setResult("normal hemoglobin levels in blood, negative test for 
anemia"); 
 
end 
 
rule "18 - If a CBC (Complete Blood Count) test is performed to diagnose 
Anemia, then 12-15.5 mg/dL of hemoglobin the blood for females indicates 
normal rbc levels" 
 
when 
 
 d:Disease(diseaseName == "Anemia" || diseaseName == "anemia") 
 t:Test(testName == "Complete blood count" || testName == "CBC") 
 tr:TestResult(id == 7 && unit == "mg/dL" && description == "hemoglobin, 
female" && amount >= 12 && amount <= 15.5)  
 
then 
 
 tr.setNormal(true); 
 tr.setDiagnosis(false); 
 tr.setResult("normal hemoglobin levels in blood, negative test for 
anemia"); 
 
end 
 
rule "19 - If a CBC (Complete Blood Count) test is performed to diagnose 
Anemia, then a count of less than 38.8 % of red blood cells in the blood for 
males indicates anemia" 
 
when 
 
 d:Disease(diseaseName == "Anemia" || diseaseName == "anemia") 
 t:Test(testName == "Complete blood count" || testName == "CBC") 
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 tr:TestResult(id == 9 && unit == "%" && description == "% RBC, male" && 
amount < 38.8 && amount > 0)  
 
then 
 
 tr.setNormal(false); 
 tr.setDiagnosis(true); 
 tr.setResult("percentage of red blood cells in blood indicates 
anemia"); 
 
end 
 
rule "20 - If a CBC (Complete Blood Count) test is performed to diagnose 
Anemia, then a count of less than 34.9 % of red blood cells in the blood for 
females indicates anemia" 
 
when 
 
 d:Disease(diseaseName == "Anemia" || diseaseName == "anemia") 
 t:Test(testName == "Complete blood count" || testName == "CBC") 
 tr:TestResult(id == 10 && unit == "%" && description == "% RBC, female" 
&& amount < 34.9 && amount > 0)  
 
then 
 
 tr.setNormal(false); 
 tr.setDiagnosis(true); 
 tr.setResult("low percentage of red blood cells in blood indicates 
anemia"); 
 
end 
 
rule "21 - If a CBC (Complete Blood Count) test is performed to diagnose 
Anemia, then less than 13.5 mg/dL of hemoglobin the blood for males indicates 
anemia" 
 
when 
 
 d:Disease(diseaseName == "Anemia" || diseaseName == "anemia") 
 t:Test(testName == "Complete blood count" || testName == "CBC") 
 tr:TestResult(id == 8 && unit == "mg/dL" && description == "hemoglobin, 
male" && amount < 13.5 && amount > 0)  
 
then 
 
 tr.setNormal(false); 
 tr.setDiagnosis(true); 
 tr.setResult("low hemoglobin levels in blood indicate anemia"); 
 
end 
 
rule "22 - If a CBC (Complete Blood Count) test is performed to diagnose 
Anemia, then less than 12 mg/dL of hemoglobin the blood for females indicates 
anemia" 
 
when 
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 d:Disease(diseaseName == "Anemia" || diseaseName == "anemia") 
 t:Test(testName == "Complete blood count" || testName == "CBC") 
 tr:TestResult(id == 7 && unit == "mg/dL" && description == "hemoglobin, 
female" && amount < 12 && amount > 0)  
 
then 
 
 tr.setNormal(false); 
 tr.setDiagnosis(true); 
 tr.setResult("low hemoglobin levels in blood indicate anemia"); 
  
end 
 
rule "23 - If a blood test is performed to diagnose calcemia, then 9-10.5 
mg/dL of calcium in the blood indicates normal calcium levels" 
 
when 
 
 d:Disease(diseaseName == "Calcemia" || diseaseName == "calcemia" || 
diseaseName == "hypercalcemia" || diseaseName == "Hypercalcemia") 
 t:Test(testName == "blood test" || testName == "Blood test") 
 tr:TestResult(id == 11 && unit == "mg/dL" && description == "calcium 
levels" && amount >= 9 && amount <= 10.5) 
  
then 
 
 tr.setNormal(true); 
 tr.setDiagnosis(false); 
 tr.setResult("normal calcium levels in blood, negative test for 
hypercalcemia"); 
 
end 
 
rule "24 - If a blood test is performed to diagnose calcemia, then more than 
10.5 mg/dL of calcium in the blood indicates calcemia" 
 
when 
 
 d:Disease(diseaseName == "Calcemia" || diseaseName == "calcemia" || 
diseaseName == "hypercalcemia" || diseaseName == "Hypercalcemia") 
 t:Test(testName == "blood test" || testName == "Blood test") 
 tr:TestResult(id == 11 && unit == "mg/dL" && description == "calcium 
levels" && amount > 10.5) 
  
then 
 
 tr.setNormal(false); 
 tr.setDiagnosis(true); 
 tr.setResult("calcemia - elevated/high calcium levels in the blood"); 
 
end 
 
rule "25 - If a blood pressure test is performed to diagnose hypertension, 
then a result of 60-90 mmHg systolic blood pressure would signal hypotension" 
 
when  
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 d:Disease(diseaseName == "Hypertension" || diseaseName == 
"hypertension") 
 t:Test(testName == "Blood pressure" || testName == "blood pressure") 
 tr:TestResult(id == 4 && unit == "mmHg" && amount <= 90 && (description 
== "systolic" || description == "Systolic") && amount >= 60) 
 
then 
 
 tr.setNormal(false); 
 tr.setDiagnosis(true); 
 tr.setResult("Low systolic bp indicates hypotension"); 
  
end 
 
rule "26 - If a blood pressure test is performed to diagnose hypertension, 
then a result of 40-60 mmHg diastolic blood pressure would signal 
hypotension" 
 
when  
 
 d:Disease(diseaseName == "Hypertension" || diseaseName == 
"hypertension") 
 t:Test(testName == "Blood pressure" || testName == "blood pressure") 
 tr:TestResult(id == 5 && unit == "mmHg" && amount >= 40 && (description 
== "Diastolic" || description == "diastolic") && amount <= 60) 
 
then 
 
 tr.setNormal(true); 
 tr.setDiagnosis(false); 
 tr.setResult("Low diastolic bp indicates hypotension"); 
  
end 
 
rule "27 - If a blood test is performed to diagnose calcemia, then 7-9 mg/dL 
of calcium in the blood indicates low calcium levels" 
 
when 
 
 d:Disease(diseaseName == "Calcemia" || diseaseName == "calcemia" || 
diseaseName == "hypercalcemia" || diseaseName == "Hypercalcemia") 
 t:Test(testName == "blood test" || testName == "Blood test") 
 tr:TestResult(id == 11 && unit == "mg/dL" && description == "calcium 
levels" && amount >= 7 && amount <= 9) 
  
then 
 
 tr.setNormal(false); 
 tr.setDiagnosis(true); 
 tr.setResult("low calcium levels in blood, positive test for 
hypocalcemia"); 
 
end 
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Using Weka GUI toolkit for Classification and Association 
 
Using Weka, one can perform some essential pre-processing steps on the data using the pre-
processing tab (See Figure A1). 
 
Fig. A1: Weka GUI Pre-processing Tab 
 
The Preprocess tab allows the user to enter data into the tool in several formats, apply various 
filters to the data, and visualize the data. One filter we will be using is the Discretize filter. To 
select the Discretize filter, click the Choose button (see figures A2 & A3 below), select filters 
→ unsupervised → attribute → Discretize 
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Fig. A2: Choose Filter Button in the Weka GUI Pre-processing Tab 
 138 
 
Fig. A3: Discretize Filter Button in Weka 
 
Next, we open the NIS diabetes data file (Table 4.8) to data mining operations.  Once the data is 
imported into the tool, the Preprocess tab shows several things about the data. In the figure 
below (figure A4), the display inside the black box shows the attributes and class variable of the 
diabetes data. The blue box displays statistics about the values of the selected attribute in the 
black box. The red is a bar graph of the values of the selected variable. In this case, the selected 
variable is called fasting_plasma_glucose. It is a test used to determine glucose levels in the 
blood. The bars are colour coded to show the correlation/relationship between the values of the 
attribute and the value of the class variable or classification. In this case, the class variable is 
prim_diagnosis short for primary diagnosis. It has two values in this data either positive 
diagnosis of type 2 (code blue) diabetes or no indication of type 2 diabetes (code red). Here, all 
the data records with a fasting_plasma_glucose level in the range 55-91 mg/dL are coded red or 
no indication of type 2 diabetes. Also, all the patient records in the range of 125-161 mg/dL 
meaning all these patients have type 2. This means is the fasting_plasma_glucose is very 
indicative of whether a patient has type 2 diabetes or not.  
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diabetes.
 
Fig. A4: Diabetes Data 1 Statistics in the Weka Pre-processing Tab 
Using Weka for Classification 
In this section we are demonstrating how one can use Weka for classification to predict the value 
of the class attribute based on the values of the other given training attributes. For this purpose, 
we need first to use one of the classification algorithms provided by Weka. We are going to use 
the data provided in table 4.8. In this classification example, we aim to determine whether 
patients have type 2 diabetes (value of class attribute) or not based on the values of attributes 
age, gender, and fasting_plasma_glucose. Using Weka, the Classify tab provides access to a 
variety of classification algorithms ranging from bayes algorithms to rule-based algorithms to 
lazy algorithms to tree-based algorithms. In this example, we will go through the process of 
classification using the J48 Java implementation of the C4.5 decision tree classification 
algorithm. Then we will tabulate results for other classification algorithms. So let us start by 
using the Classify tab and then selecting select the Choose button (see figure A5). 
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Fig. A5: Weka GUI Classify Tab 
 
 Then, we select the J48 tree based algorithm by selecting trees→J48 (figure A6) 
 
Fig. A6: Weka J48 Classification Algorithm 
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Next, under Test options, we select Use training set, and then click Start (figure A7) 
 
 
Fig. A7: Weka GUI Training Set Option in the Classify Tab 
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The Classifier output window will report the following results (figure A8): 
 
 
Fig. A8: Classifier Output Window in the Weka GUI Classify Tab showing results of running 
the J48 Classification Algorithm on Table 4.8 
 
In the green box, the pruned J48 decision tree is shown. A graph of this tree is below in figure 
A9. 
 
Fig. A9: J48 Decision Tree for Diabetes Data 1 Classification of the value of the Primary 
Diagnosis Class Variable 
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The blue box shows the accuracy of the classification. In this case, all (100%) 63 
instances/records were correctly classified as uncomplicated type 2 diabetes or normal. The 
green shows the confusion matrix of the classification. The matrix has four entries as follows: 
 
[Diabetes CA Diabetes, Diabetes CA Normal; Normal CA Diabetes, Normal CA Normal] 
where CA stands for classified as. 
 
To verify the accuracy of the classification, it is possible to use a number of test patient records 
where the value of the class variable is unknown to the classification algorithm. 
 
In our example, a typical test record looks like this: 
 
Age, Gender, FPG, Primary_Diagnosis 
32, 1.0, 87, ? 
 
The value of the class attribute is unknown and is predicted by the classification algorithm based 
on the value of the other attributes. The classification algorithm uses the knowledge it gained 
from the data where the value of the class variable is known (called training data) to predicted 
the value of the class variable for the test data (and assign the value instead of the question 
mark). Usually, the value of the class attribute is known but not given to the classification 
algorithm so the classification algorithm can predict the value and these predictions can be 
compared to the actual values. Prediction accuracy can then be recorded and accuracy of 
prediction of several algorithms on a data set can be compared.        
 
Under Test options, we select Supplied test set and click Set..., then select the file with the test 
records, finally click Start (see figure A10 below)  
 
  
Fig. A10: Classifying Test Records using the Weka Classify Tab  
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Next the results of classification can be saved to a file. The saved results can then be compared 
to the actual values. 
 
In our example, the following represents the test data (figure A11): 
 
Fig. A11: Diabetes Test Records in ARFF Format 
 
Note that the primary diagnosis is unknown here. These are the test records where the algorithm 
needs to predict primary diagnosis. After the J48 classification algorithm runs, the predicted 
values for primary diagnosis are saved to the file below (figure A12): 
 
   
Fig. A12: Predicted Classification of Diabetes Test Records in ARFF Format 
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The actual results for primary diagnosis for the test results were previously saved into a third file 
(figure A13): 
 
 
Fig. A13: Actual Classification of Diabetes Test Records in ARFF Format 
 
Using a program, the actual results are then compared with the predicted results and the accuracy 
of prediction is calculated. In our example, using the J48 algorithm the accuracy is 100%. Using 
Weka we can use other classification algorithms that may provide different accuracies and 
results. The JRIP rule-based classification algorithm would also give 100% accuracy in this 
example. JRIP algorithm produces rules that fit the data which may be of interest to the clinician, 
and assigns confidence odds/probabilities for these rules. The confidence factor indicates JRIP's 
confidence in the rule. The rule found by JRIP found to apply to this data is listed below. It states 
that if fasting_plasma_glucose is >= 127.914274 then primary diagnosis is Type 2 Diabetes with 
100% confidence (odds indicated in brackets-see rule below); otherwise the diagnosis is normal 
or no indication of Type 2 Diabetes with 100% confidence.  
 
JRIP 
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Another algorithm that indicates 100% accuracy with this data is NaiveBayes. NaiveBayes 
outputs classification statistics for the data. See figure A14 below. Notice under gender, 17 
males were diagnosed with diabetes and 11 were normal. In comparison, 16 females were 
diagnosed with diabetes and 23 were normal. This suggests Type 2 diabetes is more common 
among males. Also note under fasting_plasma_glucose, the glucose levels for those with Type 2 
diabetes have a mean of 146 mg/dL (well into the diabetes region), while the glucose levels for 
the normal cases have a mean of 70 mg/dL which falls into the normal range for an FPG test.  
 
Naive Bayes 
 
Fig. A14: Results of the Naive Bayes Classification Algorithm when Applied to Diabetes 
Data 1 Data Table   
 
The NBTree is another algorithm which indicates 100% accuracy for the diabetes data. This 
algorithm is a decision tree version of the NaiveBayes algorithm. It produces similar output. See 
figure C15 below. 
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NBTree 
 
 
Fig. C15: Results of the NBTree Classification Algorithm when Applied to Diabetes Data 1 
Data Table   
  
Now we will present, below in table C1, the accuracy of prediction figures for different 
classification algorithms for the above NIS diabetes data, and for the other NIS data tables 
(Tables B1, B2, and B3) in Appendix B. We will also present the J48 decision tree, the NBTree 
statistics, and the NaiveBayes statistics for the other data tables in Appendix B. 
 
Table A1: Comparing the Accuracy of different Classification Algorithms for Diabetes Data 1 (See Table 
4.8) 
Algorithm Algorithm Type Prediction Accuracy 
Zero R Rule-based 50.79 
JRIP Rule-based 100 
NNGE Rule-based 100 
J48 Decision Tree-based 100 
NBTree Decision Tree-based 100 
NaiveBayes Bayes Probabilistic Classifier 100 
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4.9.2 Association Rules 
Association algorithms are a different type, as compared to classification algorithms, of data 
mining algorithms. Their purpose is not to predict the value of the class variable. Rather, the 
purpose of association algorithms is to learn rules, with a specified minimum confidence factor, 
that describe the relationship between attributes and other attributes, and between attributes and 
class. We will be using one association algorithm to learn association rules from each of our 
medical data tables. The association algorithm is called Apriori. To run the association 
algorithm, a perquisite is that a discretize filter must be applied to all the attributes and class 
variables in the data. In other words, all the variables must be discrete not continuous. To apply 
the discretize filter, we select it as shown above and click Apply. We check to make sure the data 
is now completely discrete. Then, we can run the algorithm. For our example, to run the 
algorithm, we go to the Association tab. Then we select choose→Apriori, and then click Start. 
 
For the diabetes data 1 table 4.8, 103 rules with a confidence of 0.70 or higher are found by 
Apriori. The rules have the if then format: if(condition & condition1 & ....) then result1 & 
result2 & ..... Below, we will selectively show only the rules where the result is a conclusion 
about the value of the primary diagnosis variable. For example, look at rule 7 below. It states that 
if the fasting_plasma_glucose is between –infinity & 66.145 mg/dL then (==>) the primary 
diagnosis is normal. The rule has a confidence of 1 (conf:(1)). Also, the minimum possible value 
for fasting_plasma_glucose is 0 mg/dL. So when the rule says if the fasting_plasma_glucose is 
between –infinity & 66.145 mg/dL, it is equivalent to saying if the fasting_plasma_glucose is 
between 0 & 66.145 mg/dL. As another example, look at rule 48. It states if gender is male & 
fasting_plasma_glucose is between 150.134 & max, then the primary diagnosis is Diabetes 
Uncompl type II or Type 2 diabetes without complications.          
 
7. fasting_plasma_glucose='(-inf-66.145453]'  ==> prim_diagnosis=Normal    conf:(1) 
9. ageDays='(-inf-3.7]' fasting_plasma_glucose='(-inf-66.145453]'  ==> prim_diagnosis=Normal     conf:(1) 
12. fasting_plasma_glucose='(150.13361-inf)' 12 ==> prim_diagnosis=DIABETES UNCOMPL TYPE II    conf:(1) 
14. ageDays='(-inf-3.7]' fasting_plasma_glucose='(150.13361-inf)'  ==> prim_diagnosis=DIABETES UNCOMPL TYPE II     
conf:(1) 
15. fasting_plasma_glucose='(150.13361-inf)'  ==> ageDays='(-inf-3.7]' prim_diagnosis=DIABETES UNCOMPL TYPE II  
conf:(1) 
17. fasting_plasma_glucose='(66.145453-76.643973]'  ==> prim_diagnosis=Normal      conf:(1) 
21. ageDays='(-inf-3.7]' gender=1.0 fasting_plasma_glucose='(-inf-66.145453]' ==> prim_diagnosis=Normal     conf:(1) 
24. fasting_plasma_glucose='(139.635091-150.13361]'  ==> prim_diagnosis=DIABETES UNCOMPL TYPE II           conf:(1) 
28. ageDays='(-inf-3.7]' fasting_plasma_glucose='(139.635091-150.13361]'  ==> prim_diagnosis=DIABETES UNCOMPL 
TYPE II    conf:(1) 
29. fasting_plasma_glucose='(139.635091-150.13361]'  ==> ageDays='(-inf-3.7]' prim_diagnosis=DIABETES UNCOMPL 
TYPE II   conf:(1) 
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35. ageDays='(-inf-3.7]' fasting_plasma_glucose='(129.136571-139.635091]'  ==> prim_diagnosis=DIABETES UNCOMPL 
TYPE II     conf:(1) 
 36. fasting_plasma_glucose='(129.136571-139.635091]' ==> ageDays='(-inf-3.7]' prim_diagnosis=DIABETES UNCOMPL 
TYPE II    conf:(1) 
42. ageYears='(9.5-19]' fasting_plasma_glucose='(150.13361-inf)' ==> prim_diagnosis=DIABETES UNCOMPL TYPE II    
conf:(1) 
46. ageDays='(-inf-3.7]' fasting_plasma_glucose='(76.643973-87.142493]'  ==> prim_diagnosis=Normal    conf:(1) 
 47. gender=0.0 fasting_plasma_glucose='(139.635091-150.13361]'  ==> prim_diagnosis=DIABETES UNCOMPL TYPE II   
conf:(1) 
 48. gender=0.0 fasting_plasma_glucose='(150.13361-inf)'  ==> prim_diagnosis=DIABETES UNCOMPL TYPE II    conf:(1) 
 49. gender=1.0 fasting_plasma_glucose='(150.13361-inf)' ==> prim_diagnosis=DIABETES UNCOMPL TYPE II    conf:(1) 
51. ageYears='(9.5-19]' ageDays='(-inf-3.7]' fasting_plasma_glucose='(150.13361-inf)' ==> prim_diagnosis=DIABETES 
UNCOMPL TYPE II    conf:(1) 
57.ageDays='(-inf-3.7]' gender=0.0 fasting_plasma_glucose='(150.13361-inf)' ==> prim_diagnosis=DIABETES 
UNCOMPL TYPE II   conf:(1) 
60.ageDays='(-inf-3.7]' gender=1.0 fasting_plasma_glucose='(150.13361-inf)' ==> prim_diagnosis=DIABETES 
UNCOMPL TYPE II   conf:(1) 
74. ageYears='(-inf-9.5]' ageDays='(-inf-3.7]' gender=1.0 ==> prim_diagnosis=Normal    conf:(0.88) 
79. ageYears='(-inf-9.5]'  ==> prim_diagnosis=Normal     conf:(0.83) 
82. ageYears='(-inf-9.5]' ageDays='(-inf-3.7]'  ==> prim_diagnosis=Normal    conf:(0.8) 
84. ageYears='(9.5-19]' gender=0.0 ==> prim_diagnosis=DIABETES UNCOMPL TYPE II     conf:(0.78) 
86. ageYears='(9.5-19]' ageDays='(-inf-3.7]' gender=0.0 ==> prim_diagnosis=DIABETES UNCOMPL TYPE II    conf:(0.78)      
 
The rules that make a conclusion about the value of primary diagnosis for the rest of the data 
tables are presented in Appendix C. 
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Appendix B 
 
Diabetes Data 2 – Classification Algorithms’ Prediction Accuracies & Results 
 
Table B1: Comparing the Accuracy of different Classification Algorithms for Diabetes Data 2 (See Table 
4.10) 
Algorithm Algorithm Type Prediction Accuracy 
Zero R Rule-based 65.10 
JRIP Rule-based 79.30 
NNGE Rule-based 100 
J48 Decision Tree-based 84.11 
NBTree Decision Tree-based 78.26 
NaiveBayes Bayes Probabilistic Classifier 76.30 
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J48 Tree 
 
 
Fig. B1: J48 Decision Tree for Diabetes Data 2 
 
NBTree 
 
NBTree 
------------------ 
: NB0 
 
Leaf number: 0 Naive Bayes Classifier 
 
                                                    Class 
Attribute           tested_negative               tested_positive 
                             (0.65)                                (0.35) 
==================================================== 
preg 
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  '(-inf-6.5]'                 427.0                          174.0 
  '(6.5-inf)'                    75.0                            96.0 
  [total]                       502.0                          270.0 
 
plas 
  '(-inf-99.5]'                 182.0                         17.0 
  '(99.5-127.5]'               211.0                        79.0 
  '(127.5-154.5]'               86.0                        77.0 
  '(154.5-inf)'                   25.0                        99.0 
  [total]                          504.0                      272.0 
 
pres 
  'All'                         501.0                           269.0 
  [total]                      501.0                          269.0 
 
skin 
  'All'                          501.0                           269.0 
  [total]                      501.0                           269.0 
 
insu 
  '(-inf-14.5]'               237.0                        140.0 
  '(14.5-121]'              165.0                          28.0 
  '(121-inf)'                 101.0                        103.0 
  [total]                        503.0                         271.0 
 
mass 
  '(-inf-27.85]'               196.0                         28.0 
  '(27.85-inf)'                306.0                       242.0 
  [total]                         502.0                       270.0 
 
pedi 
  '(-inf-0.5275]'              362.0                    149.0 
  '(0.5275-inf)'               140.0                    121.0 
  [total]                          502.0                    270.0 
 
age 
  '(-inf-28.5]'                297.0                        72.0 
  '(28.5-inf)'                 205.0                      198.0 
  [total]                        502.0                      270.0 
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Naive Bayes Classifier 
 
                                                Class 
Attribute      tested_negative            tested_positive 
                        (0.65)                             (0.35) 
=============================================== 
preg 
  mean                   3.4234                     4.9795 
  std. dev.              3.0166                     3.6827 
  weight sum     500                          268 
  precision              1.0625                    1.0625 
 
plas 
  mean                 109.9541              141.2581 
  std. dev.             26.1114                 31.8728 
  weight sum     500                        268 
  precision              1.4741                   1.4741 
 
pres 
  mean                  68.1397          70.718 
  std. dev.             17.9834          21.4094 
  weight sum     500                  268 
  precision              2.6522           2.6522 
 
skin 
  mean                  19.8356         22.2824 
  std. dev.             14.8974         17.6992 
  weight sum      500                268 
  precision               1.98              1.98 
 
insu 
  mean                  68.8507        100.2812 
  std. dev.              98.828        138.4883 
  weight sum                500             268 
  precision               4.573           4.573 
 
mass 
  mean                  30.3009         35.1475 
  std. dev.              7.6833          7.2537 
  weight sum                500             268 
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  precision              0.2717          0.2717 
 
pedi 
  mean                   0.4297          0.5504 
  std. dev.              0.2986          0.3715 
  weight sum                500             268 
  precision              0.0045          0.0045 
 
age 
  mean                  31.2494         37.0808 
  std. dev.             11.6059         10.9146 
  weight sum                500             268 
  precision              1.1765          1.1765 
 
Anemia Data – Classification Algorithms’ Prediction Accuracies & Results 
 
Table B2: Comparing the Accuracy of different Classification Algorithms for Anemia Data(See Table 
4.11) 
Algorithm Algorithm Type Prediction Accuracy 
Zero R Rule-based 50.43 
JRIP Rule-based 99.15 
NNGE Rule-based 100 
J48 Decision Tree-based 100 
NBTree Decision Tree-based 100 
NaiveBayes Bayes Probabilistic Classifier 96.58 
 
J48 Tree 
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Fig. B2: J48 Decision Tree for Anemia Data 
 
JRIP rules 
 
(hemoglobin <= 12.685495) => prim_diagnosis=ANEMIA NOS- (55.0/0.0) 
(hemoglobin <= 13.415326) and (gender = 0.0) => prim_diagnosis=ANEMIA NOS- 
(2.0/0.0) 
 => prim_diagnosis=Normal (60.0/1.0) 
 
Naive Bayes Classifier 
 
                                             Class 
Attribute      ANEMIA NOS-          Normal 
                     (0.5)                              (0.5) 
======================================= 
ageYears 
  mean              64.3765                 56.931 
  std. dev.         25.6589                 26.1904 
  weight sum    58                          59 
  precision          1.6964                  1.6964 
 
ageDays 
  mean                    3                     6.8814 
  std. dev.         12.8452              40.0767 
  weight sum   58                        59 
  precision        58                       58 
 
gender 
  0.0                  21.0                     28.0 
  1.0                  39.0                     33.0 
  NaN                1.0                       1.0 
  [total]            61.0                      62.0 
 
rbc 
  mean              31.3905             41.6596 
  std. dev.           3.419                 3.7279 
  weight sum   58                       59 
  precision           0.211                0.211 
 
hemoglobin 
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  mean              10.1618            14.5302 
  std. dev.           1.3376               1.1866 
  weight sum    58                      59 
  precision          0.0818               0.0818 
 
NBTree 
 
NBTree 
------------------ 
 
gender = 0.0: NB 1 
gender = 1.0: NB 2 
gender = NaN: NB 3 
 
Leaf number: 1 Naive Bayes Classifier 
 
                             Class 
Attribute              ANEMIA NOS-      Normal 
                            (0.43)                      (0.57) 
=============================================== 
ageYears 
  'All'                        21.0                      28.0 
  [total]                    21.0                       28.0 
 
ageDays 
  'All'                        21.0                      28.0 
  [total]                     21.0                      28.0 
 
gender 
  0.0                          21.0                     28.0 
  1.0                            1.0                       1.0 
  NaN                          1.0                       1.0 
  [total]                      23.0                     30.0 
 
rbc 
  '(-inf-38.944935]'     21.0                   1.0 
  '(38.944935-inf)'        1.0                 28.0 
  [total]                        22.0                 29.0 
 
hemoglobin 
  '(-inf-13.524468]'      21.0                1.0 
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  '(13.524468-inf)'         1.0              28.0 
  [total]                         22.0             29.0 
 
 
Leaf number: 2 Naive Bayes Classifier 
 
                             Class 
Attribute              ANEMIA NOS-       Normal 
                              (0.54)                     (0.46) 
=============================================== 
ageYears 
  'All'                         39.0                      33.0 
  [total]                      39.0                     33.0 
 
ageDays 
  'All'                         39.0                      33.0 
  [total]                      39.0                     33.0 
 
gender 
  0.0                           1.0                        1.0 
  1.0                         39.0                     33.0 
  NaN                         1.0                       1.0 
  [total]                      41.0                    35.0 
 
rbc 
  '(-inf-34.829141]'    39.0                     1.0 
  '(34.829141-inf)'       1.0                   33.0 
  [total]                      40.0                    34.0 
 
hemoglobin 
  '(-inf-12.374101]'    39.0                   1.0 
  '(12.374101-inf)'       1.0                 33.0 
  [total]                       40.0                 34.0 
 
 
Leaf number: 3 Naive Bayes Classifier 
 
                     Class 
Attribute      ANEMIA NOS-           Normal 
                     (0.5)                             (0.5) 
======================================= 
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ageYears 
  'All'                  1.0                             1.0 
  [total]               1.0                            1.0 
 
ageDays 
  'All'                  1.0                            1.0 
  [total]               1.0                            1.0 
 
gender 
  0.0                   1.0                           1.0 
  1.0                   1.0                           1.0 
  NaN                 1.0                           1.0 
  [total]               3.0                           3.0 
 
rbc 
  'All'                 1.0                            1.0 
  [total]               1.0                           1.0 
 
hemoglobin 
  'All'                  1.0                             1.0 
  [total]               1.0                            1.0 
 
Blood Pressure Data – Classification Algorithms’ Prediction Accuracies & Results 
Table B3: Comparing the Accuracy of different Classification Algorithms for Blood Pressure Data (See 
Table 4.12) 
Algorithm Algorithm Type Prediction Accuracy 
Zero R Rule-based 50.36 
JRIP Rule-based 100 
NNGE Rule-based 100 
J48 Decision Tree-based 100 
NBTree Decision Tree-based 100 
NaiveBayes Bayes Probabilistic Classifier 100 
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J48 Tree 
 
 
Fig. B3: J48 Decision Tree for Blood Pressure Data 1  
 
JRIP 
 
(ageYears <= 47) and (systolicBloodPressure <= 114) and 
(systolicBloodPressure >= 98) => prim_diagnosis=Normal (6.0/0.0) 
(systolicBloodPressure <= 89) => prim_diagnosis=ORTHOSTATIC 
HYPOTENSION (408.0/0.0) 
 => prim_diagnosis=HYPERTENSION NOS (420.0/0.0) 
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Naive Bayes 
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NBTree 
 
 
Calcemia Data – Classification Algorithms’ Prediction Accuracies & Results 
Algorithm Algorithm Type Prediction Accuracy 
Zero R Rule-based 71.43 
JRIP Rule-based 80.95 
NNGE Rule-based 100 
J48 Decision Tree-based 100 
NBTree Decision Tree-based 100 
NaiveBayes Bayes Probabilistic Classifier 100 
Table B4: Comparing the Accuracy of different Classification Algorithms for Calcemia (See Table 4.13) 
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J48 Tree 
 
 
Fig. B4: J48 Decision Tree for Calcemia Data 
 
Naive Bayes 
 
 163 
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NBTree 
 
 
 
 
JRIP 
 
 
 
 
 
 
 165 
Appendix C 
Selected Association Rules for Diabetes Data 2 (Table 4.9) 
 
2. skin='(-inf-9.9]' pedi='(-inf-0.3122]' class=tested_negative  ==> insu='(-inf-84.6]'    conf:(1) 
7. mass='(20.13-26.84]' age='(-inf-27]'  ==> class=tested_negative    conf:(0.97) 
8. plas='(79.6-99.5]' age='(-inf-27]' ==> class=tested_negative   conf:(0.95) 
9. plas='(79.6-99.5]' insu='(-inf-84.6]'  ==> class=tested_negative    conf:(0.94) 
10. skin='(19.8-29.7]' age='(-inf-27]'  ==> class=tested_negative    conf:(0.93) 
11. plas='(79.6-99.5]'  ==> class=tested_negative     conf:(0.92) 
12. insu='(-inf-84.6]' mass='(20.13-26.84]'  ==> class=tested_negative    conf:(0.91) 
13. mass='(20.13-26.84]'  ==> class=tested_negative     conf:(0.9) 
14. plas='(99.5-119.4]' age='(-inf-27]'  ==> class=tested_negative    conf:(0.89) 
15. insu='(-inf-84.6]' pedi='(-inf-0.3122]' age='(-inf-27]'  ==> class=tested_negative   conf:(0.89) 
16. pedi='(-inf-0.3122]' age='(-inf-27]'  ==> class=tested_negative    conf:(0.88) 
17. skin='(9.9-19.8]'  ==> class=tested_negative    conf:(0.87) 
18. pres='(61-73.2]' age='(-inf-27]'  ==> class=tested_negative   conf:(0.85) 
 9. mass='(26.84-33.55]' age='(-inf-27]'  ==> class=tested_negative   conf:(0.85) 
20. preg='(-inf-1.7]' insu='(-inf-84.6]' age='(-inf-27]' ==> class=tested_negative    conf:(0.84) 
21. insu='(-inf-84.6]' age='(-inf-27]'  ==> class=tested_negative     conf:(0.83) 
22. preg='(-inf-1.7]' age='(-inf-27]' ==> class=tested_negative    conf:(0.83) 
23. preg='(1.7-3.4]' insu='(-inf-84.6]'  ==> class=tested_negative    conf:(0.83) 
25. preg='(1.7-3.4]' age='(-inf-27]'  ==> class=tested_negative    conf:(0.82) 
26. age='(-inf-27]'  ==> class=tested_negative     conf:(0.82) 
27. pres='(48.8-61]'  ==> class=tested_negative   conf:(0.81) 
29. plas='(99.5-119.4]' pedi='(-inf-0.3122]'  ==> class=tested_negative     conf:(0.81) 
30. pedi='(0.3122-0.5464]' age='(-inf-27]'  ==> class=tested_negative    conf:(0.8) 
31. preg='(-inf-1.7]' class=tested_negative  ==> age='(-inf-27]'    conf:(0.8) 
32. preg='(-inf-1.7]' insu='(-inf-84.6]'  ==> class=tested_negative     conf:(0.78) 
35. plas='(79.6-99.5]'  ==> insu='(-inf-84.6]' class=tested_negative     conf:(0.76) 
36. insu='(-inf-84.6]' pedi='(-inf-0.3122]' ==> class=tested_negative     conf:(0.75) 
 38. pres='(73.2-85.4]' pedi='(-inf-0.3122]'  ==> class=tested_negative    conf:(0.75) 
 
 
Selected Association Rules for Blood Pressure (Table 4.10) 
 
11. systolicBloodPressure='(147.2-158.1]' ==> prim_diagnosis=HYPERTENSION NOS     conf:(1) 
12. DiastolicBloodPressure='(47.9-55.8]'  ==> prim_diagnosis=ORTHOSTATIC HYPOTENSION   conf:(1) 
14. ageDays='All' systolicBloodPressure='(147.2-158.1]'  ==> prim_diagnosis=HYPERTENSION NOS   conf:(1) 
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 15. systolicBloodPressure='(147.2-158.1]'  ==> ageDays='All' prim_diagnosis=HYPERTENSION NOS    conf:(1) 
17. ageDays='All' DiastolicBloodPressure='(47.9-55.8]' ==> prim_diagnosis=ORTHOSTATIC HYPOTENSION  conf:(1) 
20. DiastolicBloodPressure='(-inf-47.9]'  ==> prim_diagnosis=ORTHOSTATIC HYPOTENSION     conf:(1) 
22. ageDays='All' DiastolicBloodPressure='(-inf-47.9]' ==> prim_diagnosis=ORTHOSTATIC HYPOTENSION conf:(1) 
26. systolicBloodPressure='(-inf-70.9]' ==> prim_diagnosis=ORTHOSTATIC HYPOTENSION  conf:(1) 
29. ageDays='All' systolicBloodPressure='(-inf-70.9]'   ==> prim_diagnosis=ORTHOSTATIC HYPOTENSION   conf:(1) 
34. systolicBloodPressure='(70.9-81.8]' ==> prim_diagnosis=ORTHOSTATIC HYPOTENSION     conf:(1) 
36. ageDays='All' systolicBloodPressure='(70.9-81.8]'  ==> prim_diagnosis=ORTHOSTATIC HYPOTENSION  conf:(1) 
41. ageDays='All' systolicBloodPressure='(158.1-inf)'  ==> prim_diagnosis=HYPERTENSION NOS     conf:(1) 
46. ageDays='All' systolicBloodPressure='(136.3-147.2]' 125 ==> prim_diagnosis=HYPERTENSION NOS 125    conf:(1) 
49. systolicBloodPressure='(81.8-92.7]' 121 ==> prim_diagnosis=ORTHOSTATIC HYPOTENSION 121    conf:(1) 
51. ageDays='All' systolicBloodPressure='(81.8-92.7]' 121 ==> prim_diagnosis=ORTHOSTATIC HYPOTENSION 121    
conf:(1) 
55. gender=1.0 systolicBloodPressure='(147.2-158.1]' 117 ==> prim_diagnosis=HYPERTENSION NOS 117    conf:(1) 
57. ageDays='All' gender=1.0 systolicBloodPressure='(147.2-158.1]' 117 ==> prim_diagnosis=HYPERTENSION NOS 117    
conf:(1) 
62. ageDays='All' DiastolicBloodPressure='(103.2-111.1]' 116 ==> prim_diagnosis=HYPERTENSION NOS 116    conf:(1) 
67. ageDays='All' DiastolicBloodPressure='(111.1-inf)' 112 ==> prim_diagnosis=HYPERTENSION NOS 112    conf:(1) 
71. DiastolicBloodPressure='(87.4-95.3]' 98 ==> prim_diagnosis=HYPERTENSION NOS 98    conf:(1) 
74. ageDays='All' DiastolicBloodPressure='(87.4-95.3]' 98 ==> prim_diagnosis=HYPERTENSION NOS 98    conf:(1) 
77. gender=1.0 DiastolicBloodPressure='(-inf-47.9]' 96 ==> prim_diagnosis=ORTHOSTATIC HYPOTENSION 96    
conf:(1) 
79. ageDays='All' gender=1.0 DiastolicBloodPressure='(-inf-47.9]' 96 ==> prim_diagnosis=ORTHOSTATIC 
HYPOTENSION 96    conf:(1) 
84. ageDays='All' gender=1.0 DiastolicBloodPressure='(47.9-55.8]' 95 ==> prim_diagnosis=ORTHOSTATIC 
HYPOTENSION 95    conf:(1) 
89. ageDays='All' DiastolicBloodPressure='(95.3-103.2]' 94 ==> prim_diagnosis=HYPERTENSION NOS 94    conf:(1) 
94. gender=1.0 systolicBloodPressure='(-inf-70.9]' 88 ==> prim_diagnosis=ORTHOSTATIC HYPOTENSION 88    conf:(1) 
96. ageDays='All' gender=1.0 systolicBloodPressure='(-inf-70.9]' 88 ==> prim_diagnosis=ORTHOSTATIC HYPOTENSION 
88    conf:(1) 
100. gender=1.0 systolicBloodPressure='(158.1-inf)' 86 ==> prim_diagnosis=HYPERTENSION NOS 86    conf:(1) 
102. ageDays='All' gender=1.0 systolicBloodPressure='(158.1-inf)' 86 ==> prim_diagnosis=HYPERTENSION NOS 86    
conf:(1) 
 
Selected Association Rules for Calcemia (Table 4.11) 
 
4. ageYears='(63-72]'==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
6. ageYears='(72-81]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)    conf:(1) 
8. calcium_levels='(10.6-11.16]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)    conf:(1) 
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10. ageYears='(63-72]' ageDays='(-inf-4.4]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
14. ageYears='(72-81]'  ==> ageDays='(-inf-4.4]' prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
16. ageDays='(-inf-4.4]' calcium_levels='(10.6-11.16]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
20. ageYears='(81-inf)'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
28. calcium_levels='(-inf-8.36]'  ==> prim_diagnosis=HYPOCALCEMIA (Begin 1997)     conf:(1) 
29. calcium_levels='(11.72-12.28]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
30. calcium_levels='(12.28-12.84]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
31. calcium_levels='(12.84-inf)'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
33. ageYears='(72-81]' gender=1.0  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)  conf:(1) 
35. ageYears='(81-inf)' ageDays='(-inf-4.4]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
42. ageDays='(-inf-4.4]' calcium_levels='(-inf-8.36]'  ==> prim_diagnosis=HYPOCALCEMIA (Begin 1997)     conf:(1) 
46. ageDays='(-inf-4.4]' calcium_levels='(12.28-12.84]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
49. ageDays='(-inf-4.4]' calcium_levels='(12.84-inf)'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
52. gender=1.0 calcium_levels='(12.28-12.84]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)    conf:(1) 
55. ageYears='(72-81]' ageDays='(-inf-4.4]' gender=1.0  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
59. ageDays='(-inf-4.4]' gender=1.0 calcium_levels='(12.28-12.84]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997) 
3    conf:(1) 
70. calcium_levels='(11.16-11.72]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)    conf:(1) 
76. ageYears='(54-63]' ageDays='(-inf-4.4]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
79. ageYears='(54-63]' gender=1.0  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)    conf:(1) 
84. ageYears='(63-72]' gender=0.0  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)    conf:(1) 
87. ageYears='(63-72]' gender=1.0  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)    conf:(1) 
88. ageYears='(63-72]' calcium_levels='(12.28-12.84]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
90. ageYears='(72-81]' calcium_levels='(10.6-11.16]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
93. ageYears='(81-inf)' gender=1.0  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
94. ageYears='(81-inf)' calcium_levels='(10.6-11.16]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)    conf:(1) 
105. ageDays='(-inf-4.4]' calcium_levels='(11.16-11.72]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
107. ageDays='(-inf-4.4]' calcium_levels='(11.72-12.28]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
108. gender=0.0 calcium_levels='(10.6-11.16]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)    conf:(1) 
109. gender=0.0 calcium_levels='(11.72-12.28]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)    conf:(1) 
110. gender=0.0 calcium_levels='(12.84-inf)'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
112. gender=1.0 calcium_levels='(-inf-8.36]'  ==> prim_diagnosis=HYPOCALCEMIA (Begin 1997)     conf:(1) 
113. gender=1.0 calcium_levels='(10.6-11.16]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
115. gender=1.0 calcium_levels='(11.16-11.72]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)    conf:(1) 
119. ageYears='(54-63]' ageDays='(-inf-4.4]' gender=1.0  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
125. ageYears='(63-72]' ageDays='(-inf-4.4]' gender=0.0  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
133. ageYears='(63-72]' ageDays='(-inf-4.4]' gender=1.0  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
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136. ageYears='(63-72]' ageDays='(-inf-4.4]' calcium_levels='(12.28-12.84]'  ==> prim_diagnosis=HYPERCALCEMIA 
(Begin 1997)     conf:(1) 
140. ageYears='(63-72]' gender=1.0 calcium_levels='(12.28-12.84]' ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)    
conf:(1) 
144. ageYears='(72-81]' ageDays='(-inf-4.4]' calcium_levels='(10.6-11.16]'  ==> prim_diagnosis=HYPERCALCEMIA 
(Begin 1997)  conf:(1) 
147. ageYears='(81-inf)' ageDays='(-inf-4.4]' gender=1.0  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)    conf:(1) 
150. ageYears='(81-inf)' ageDays='(-inf-4.4]' calcium_levels='(10.6-11.16]'  ==> prim_diagnosis=HYPERCALCEMIA 
(Begin 1997)    conf:(1) 
153. ageDays='(-inf-4.4]' gender=0.0 calcium_levels='(10.6-11.16]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)  
conf:(1) 
156. ageDays='(-inf-4.4]' gender=0.0 calcium_levels='(12.84-inf)'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997) 2    
conf:(1) 
160. ageDays='(-inf-4.4]' gender=1.0 calcium_levels='(-inf-8.36]'  ==> prim_diagnosis=HYPOCALCEMIA (Begin 1997) 2    
conf:(1) 
164. ageDays='(-inf-4.4]' gender=1.0 calcium_levels='(10.6-11.16]' ==> prim_diagnosis=HYPERCALCEMIA (Begin 1997)  
conf:(1) 
168. ageDays='(-inf-4.4]' gender=1.0 calcium_levels='(11.16-11.72]'  ==> prim_diagnosis=HYPERCALCEMIA (Begin 
1997)    conf:(1) 
171. ageDays='(-inf-4.4]' calcium_levels='(11.16-11.72]'  ==> gender=1.0 prim_diagnosis=HYPERCALCEMIA (Begin 
1997)    conf:(1) 
176. ageYears='(63-72]' ageDays='(-inf-4.4]' gender=1.0 calcium_levels='(12.28-12.84]' ==> 
prim_diagnosis=HYPERCALCEMIA (Begin 1997)     conf:(1) 
 
Selected Association Rules for Calcemia (Table 4.12) 
 
5. hemoglobin='(9.691263-10.640166]'  ==> prim_diagnosis=ANEMIA NOS-    conf:(1) 
9. hemoglobin='(14.435776-15.384679]' ==> prim_diagnosis=Normal    conf:(1) 
10. ageDays='(-inf-29]' hemoglobin='(9.691263-10.640166]'  ==> prim_diagnosis=ANEMIA NOS-     conf:(1) 
13. ageDays='(-inf-29]' hemoglobin='(14.435776-15.384679]' ==> prim_diagnosis=Normal   conf:(1) 
18. rbc='(32.365973-34.813761]'  ==> prim_diagnosis=ANEMIA NOS-     conf:(1) 
20. ageDays='(-inf-29]' rbc='(32.365973-34.813761]'  ==> prim_diagnosis=ANEMIA NOS-     conf:(1) 
23. hemoglobin='(8.742361-9.691263]'  ==> prim_diagnosis=ANEMIA NOS-   conf:(1) 
25. ageDays='(-inf-29]' hemoglobin='(8.742361-9.691263]'  ==> prim_diagnosis=ANEMIA NOS-     conf:(1) 
27. rbc='(29.918184-32.365973]'  ==> prim_diagnosis=ANEMIA NOS-     conf:(1) 
31. rbc='(39.709338-42.157127]'  ==> prim_diagnosis=Normal     conf:(1) 
33. ageDays='(-inf-29]' rbc='(29.918184-32.365973]'  ==> prim_diagnosis=ANEMIA NOS-    conf:(1) 
35. ageDays='(-inf-29]' rbc='(39.709338-42.157127]'  ==> prim_diagnosis=Normal     conf:(1) 
39. rbc='(44.604915-47.052703]' ==> prim_diagnosis=Normal    conf:(1) 
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46. ageDays='(-inf-29]' rbc='(44.604915-47.052703]'  ==> prim_diagnosis=Normal    conf:(1) 
49. gender=0.0 rbc='(44.604915-47.052703]'  ==> prim_diagnosis=Normal   conf:(1) 
51. gender=1.0 rbc='(32.365973-34.813761]'  ==> prim_diagnosis=ANEMIA NOS-     conf:(1) 
53. gender=1.0 hemoglobin='(12.537971-13.486874]'  ==> prim_diagnosis=Normal     conf:(1) 
56. ageDays='(-inf-29]' gender=0.0 rbc='(44.604915-47.052703]'  ==> prim_diagnosis=Normal     conf:(1) 
62. ageDays='(-inf-29]' gender=1.0 rbc='(32.365973-34.813761]'  ==> prim_diagnosis=ANEMIA NOS-     conf:(1) 
68. hemoglobin='(13.486874-14.435776]'  ==> prim_diagnosis=Normal   conf:(0.95) 
71. ageDays='(-inf-29]' hemoglobin='(13.486874-14.435776]'  ==> prim_diagnosis=Normal     conf:(0.95) 
86. hemoglobin='(12.537971-13.486874]'  ==> prim_diagnosis=Normal    conf:(0.8) 
89. ageYears='(85.5-inf)' ageDays='(-inf-29]'  ==> prim_diagnosis=ANEMIA NOS-     conf:(0.76) 
 
 
 
 
 
 
 
 Appendix D 
  
Fig. D1: Sequence Diagram for the Evidence-based DDx Recommender 
 
  
Fig. D2: Sequence Diagram for the Proximity-based DDx Recommender 
  
Fig. D3: Class Diagram for the Overall DDx Recommender 
 
 
 
 
  
Fig. D4: Component Diagram of the Overall DDx Recommender 
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Appendix E 
 
Table E1: Comparison of Equivalent Proximity and Evidence-based Rule Sets 
Rule 
Condition’s 
Attribute 
Related 
Diagnosis 
Evidence-
based Rule 
Proximity-
based Rule 
Number 
of 
Patient 
Records 
Accuracy of 
Proximity-
based Rule 
(%) 
Maximum 
Normal FPG 
Diabetes 109.8 mg/dL 76.6 mg/dL 64 69.8 
Minimum 
Diabetic FPG 
Diabetes 125 mg/dL 139.6 mg/dL 64 89.5 
Minimum 
Hypertensive 
Systolic Blood 
Pressure 
Hypertension 140 mmHg 147.2 mmHg 860 95.0 
Minimum 
Normal Systolic 
Blood Pressure 
Hypertension 90 mmHg 92.7 mmHg 
 
860 97.0 
Minimum 
Hypertensive 
Diastolic Blood 
Pressure 
Hypertension 90 mmHg 87.4 mmHg 860 97.0 
Minimum 
Normal 
Diastolic Blood 
Pressure 
Hypertension 60 mmHg 55.8 mmHg 860 93.0 
Normal 
Percentage of 
Red Blood 
Cells in the 
Blood for Males  
Anemia 38.8 - 50.0 % 39.7 - 47.1 % 120 96.0 
Normal 
Percentage of 
Red Blood 
Cells in the 
Blood for 
Females 
Anemia 34.9 - 44.5 % 32.4 - 47.1 % 120 93.7 
Normal 
Hemoglobin 
Levels in the 
Blood for Males 
Anemia 13.5 - 17.5 
mg/dL 
12.5 - 15.4 
mg/dL  
120 90.3 
Normal 
Hemoglobin 
Anemia 12 - 15.5 
mg/dL 
12.5 - 15.4 
mg/dL  
120 97.7 
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Levels in the 
Blood for 
Females 
Maximum 
Hypotensive 
Diastolic Blood 
Pressure 
Hypotension 60 mmHg 55.8 mmHg 860 93.0 
Minimum 
Hypotensive 
Diastolic Blood 
Pressure 
Hypotension 40 mmHg 47.9 mmHg 860 83.5 
Minimum 
Bound for High 
Calcium Levels 
in the Blood 
Calcemia 10.5 mg/dL 10.6 mg/dL 23 99.1 
Minimum 
Normal of 
Calcium Levels 
in the Blood 
Calcemia 9 mg/dL 9.48 mg/dL 23 94.9 
 
Table E2: Accuracy of Proximity-based Rules as a function of Number of known Patient Cases available 
to Data Mining Algorithm 
Number of Patient 
Records 
Average Accuracy of Proximity-based 
Rule 
64 79.7 
860 95.5 
120 94.4 
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Anemia 
51 Female 29.25 11.43 Positive for 
Anemia 
Positive for 
Anemia 
41 Male 36.75 12.78 Positive for 
Anemia 
Normal 
36 Male 48.00 14.43 Normal Normal 
64 Male 43.67 16.23 Normal Normal 
46 Male 39.00 12.78 Positive for 
Anemia 
Normal 
68 Female 37.00 12.9 Normal Normal 
91 Female 32.95 11.86 Positive for 
Anemia 
Positive for 
Anemia 
59 Female 41.40 14.96 Normal Normal 
 
Table E4: Comparison of Proximity-based vs. Evidence-based Predictions for Diabetes Patient Cases 
(Accuracy of Proximity-based Recommender = 3/4 = 75%) 
Age Gender Fasting 
Plasma 
Glucose 
(mg/dL) 
Evidence-
based 
Diagnosis 
Proximity-
based 
Diagnosis 
80 Female 136.28 Diabetes Diabetes 
95 Female 64.42 Normal Normal 
45 Female 101.60 Normal Diabetes 
38 Male 129.9 Diabetes Diabetes 
 
 
